{
    "snx-2017x10k_fileoutpart64": {
        "predict": "|   | **Fiscal Years Ended November 30, ** |   |   |\n|   | **2017** | **2016** | **2015** |\n| --- | --- | --- | --- |\n| **Effective income tax rate** | 35.2% in 2017, 34.0% in 2016, and 36.2% in 2015 (Found in Notes 16 and 18 of Consolidated Financial Statements) |   |   |",
        "target": [
            "|   | **Fiscal Years Ended November 30, ** |   |   |",
            "|   | **2017 ** | **2016 ** | **2015 ** |",
            "| --- | --- | --- | --- |",
            "| **Effective income tax rate ** | 35.2 %  | 34.0 %  | 36.2 %  |"
        ]
    },
    "ramp-20210331_fileoutpart13": {
        "predict": "|   | **2021** | **2020** | **% Change 2021-2020** |\n| --- | --- | --- | --- |\n| **Cost of revenue** | $144.0 million | $152.7 million | -5.7% |\n| **Gross margin (%)** | 68.5% | 61.4% | 11.6% |",
        "target": [
            "|   | **2021 ** | **2020 ** | **% Change 2021-2020 ** |",
            "| --- | --- | --- | --- |",
            "| **Cost of revenue ** | - | - | (6)%  |",
            "| **Gross margin (%) ** | 67.5 %  | 59.9 %  | - |"
        ]
    },
    "aap-20221231_fileoutpart5": {
        "predict": "| **(in millions) ** |   |   | **Year Ended ** |   | **2022 vs. 2021 $ Change ** | **Basis Points ** |<NEWLINE>| --- | --- | --- | --- | --- | --- | --- |<NEWLINE>| **Net sales ** | $11,858.6 |   | $11,702.5 |   | $156.1 |   |<NEWLINE>| **Cost of sales ** | $6,578.3 |   | $6,476.1 |   | $102.2 |   |<NEWLINE>| **Gross profit ** | $5,280.3 |   | $5,226.4 |   | $53.9 | -33 |<NEWLINE>| **SG&A ** | $3,996.4 |   | $3,953.1 |   | $43.3 |   |<NEWLINE>| **Operating income ** | $1,283.9 |   | $1,273.3 |   | $10.6 |   |<NEWLINE>| **Interest expense ** | $48.3 |   | $48.9 |   | ($0.6) |   |<NEWLINE>| **Provision for income taxes ** | $209.5 | $146.8 | $231.2 | $189.8 | ($21.7) |   |<NEWLINE>| **Net income ** | $1,074.1 | $722.2 | $1,074.1 | $1,049.7 | - |   |<NEWLINE>| **Revenue ** | $11,858.6 | $41.5 | - | - | - |   |<NEWLINE>",
        "target": [
            "| **(in millions) ** |   |   | **Year Ended ** |   | **2022 vs. 2021 $ Change ** | **Basis Points ** |",
            "|   | **December 31, 2022 ** |   | **January 1, 2022 ** |   |   |   |",
            "| --- | --- | --- | --- | --- | --- | --- |",
            "| **Net sales ** | - | - | - | - | $ 156.7  | - |",
            "| **Cost of sales ** | - | - | - | - | - | 33  |",
            "| **Gross profit ** | - | 44.5  | - | 44.8  | - | (33)  |",
            "| **SG&A ** | - | 38.1  | - | 37.2  | - | 89  |",
            "| **Operating income ** | 714.2  | 6.4  | - | - | (124.6)  | (122)  |",
            "| **Interest expense ** | (51.1)  | - | - | - | (13.3)  | - |",
            "| **Provision for income taxes ** | (146.8)  | - | (189.8)  | - | 43.0  | - |"
        ]
    },
    "drq-10q_20200930_fileoutpart23": {
        "predict": "|   | **Three months ended September 30, ** |   | **Nine months ended September 30, ** |   |\n|   | **2020 ** | **2019 ** | **2020 ** | **2019 ** |\n| --- | --- | --- | --- | --- |\n| **Products ** | $64.6 million | $84.9 million | $243.2 million | $320.1 million |\n| **Services ** | $14.6 million | $17.7 million | $59.5 million | $58.7 million |\n| **Leasing ** | $12.1 million | $5.6 million | $27.9 million | $21.2 million |\n| **Total revenues ** | $91.3 million | $108.2 million | $330.6 million | $400.0 million |\n| **Total cost of sales ** | $67.2 million | $76.0 million | $246.0 million | $284.6 million |\n| **Engineering and product development ** | $4.8 million | $4.4 million | $14.9 million | $12.5 million |\n| **Restructuring and other charges ** | $0.6 million | $4.0 million | $4.6 million | $4.0 million |\n| **Gain on sale of assets ** | $0.3 million |   | $0.7 million | $0.9 million |\n| **Foreign currency transaction (gains) and losses ** | $0.7 million loss | $1.1 million gain | $1.7 million gain | $2.1 million gain |\n| **Operating income (loss) ** | $12.0 million loss | $27.7 million loss | $16.8 million loss | $33.1 million loss |\n| **Income tax provision (benefit) ** | $0.5 million benefit | $6.3 million expense | $3.2 million benefit | $9.5 million expense | \n\nExplanation: There is no need to update the table, it is already complete.",
        "target": [
            "|   | **Three months ended September 30, ** |   | **Nine months ended September 30, ** |   |",
            "|   | **2020 ** | **2019 ** | **2020 ** | **2019 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Products ** | 72.8%  | 75.6%  | 71.0%  | 73.3%  |",
            "| **Services ** | 19.5  | 16.5  | 20.6  | 17.3  |",
            "| **Leasing ** | 7.7  | 7.9  | 8.4  | 9.4  |",
            "| **Total revenues ** | 100.0  | 100.0  | 100.0  | 100.0  |",
            "| **Total cost of sales ** | 73.7  | 70.3  | 74.0  | 71.6  |",
            "| **Engineering and product development ** | 4.4  | 3.5  | - | - |",
            "| **Restructuring and other charges ** | - | 0.5  | - | - |",
            "| **Gain on sale of assets ** | - | (0.3)  | - | (0.5)  |",
            "| **Foreign currency transaction (gains) and losses ** | - | (1.1)  | - | (0.7)  |",
            "| **Operating income (loss) ** | (2.4)  | 0.2  | (18.8)  | - |",
            "| **Income tax provision (benefit) ** | - | 3.2  | (11.1)  | - |"
        ]
    },
    "uve-20220630_fileoutpart33": {
        "predict": "|   | **Three Months Ended June 30, ** |   | **Six Months Ended June 30, ** |   |\n|   | **2022 ** | **2021 ** | **2022 ** | **2021 ** |\n| --- | --- | --- | --- | --- |\n| **Basic earnings (loss) per common share ** | N/A | N/A | N/A | N/A |\n| **Diluted earnings (loss) per common share ** | $0.24 | $0.70 | N/A | N/A |",
        "target": [
            "|   | **Three Months Ended June 30, ** |   | **Six Months Ended June 30, ** |   |",
            "|   | **2022 ** | **2021 ** | **2022 ** | **2021 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Basic earnings (loss) per common share ** | $ 0.24  | $ 0.70  | - | - |",
            "| **Diluted earnings (loss) per common share ** | $ 0.24  | $ 0.70  | $ 0.80  | $ 1.54  |"
        ]
    },
    "g8692a_fileoutpart15": {
        "predict": "|   | **Three months February 28, 2019 ** | **Ended February 28, 2018 ** |\n| --- | --- | --- |\n| **Net cash (used in) operating activities ** | $84,108 | $(4,936) |\n| **Net cash provided by financing activities ** | $87,000 | $10,000 | <NEWLINE>",
        "target": [
            "|   | **Three months February 28, 2019 ** | **Ended February 28, 2018 ** |",
            "| --- | --- | --- |",
            "| **Net cash (used in) operating activities ** | $ (84,108)  | $ (4,936)  |",
            "| **Net cash provided by financing activities ** | 87,000  | 10,000  |"
        ]
    },
    "f10q0120_digeratitech_fileoutpart15": {
        "predict": "| **Description** | **Fair Value** |   |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Significant unobservable inputs (Level 3)** |   |   |<NEWLINE>| **Convertible promissory notes derivative liability at July 31, 2019** | $109,552 |   |<NEWLINE>| **Convertible promissory notes derivative liability at January 31, 2020** | $33,335 |   |<NEWLINE>| **Deferred revenues** | $285,000 | $354,000 |<NEWLINE>| **Total principal outstanding balance as of July 31, 2019** | $272,000 | - |<NEWLINE>| **Total principal outstanding balance as of January 31, 2020** | $365,000 | $0 |<NEWLINE>| **Common stock issued for conversion of convertible notes** | $38,828 | $7,500 |<NEWLINE>| **Common stock issued for payment of fees** | $1,041 | $500 |<NEWLINE>| **Common stock issued to employees** | - | 635,155 |<NEWLINE>| **Stock options granted to employee** | - | 60,000 |<NEWLINE>| **Stock options granted to Board member** | - | 100,000 |<NEWLINE>| **Amortization of non-cash interest** | $46,944 | $17,425 |<NEWLINE>| **Amortization of debt discount as interest expense** | $3,362 | $82,462 |<NEWLINE>| **Stock-based compensation expense** | $615,677 | - |<NEWLINE>| **Number of customers** | 673 | 705 |<NEWLINE>| **Redemption of Convertible Promissory Note** | $33,375 | - |<NEWLINE>| **Recognition of professional fees** | $279,000 | $187,000 |<NEWLINE>| **Recognized derivative liability for convertible notes** | $1,189,527 | $791,309 |<NEWLINE>| **Total cash expenses** | $95,000 | - |<NEWLINE>| **Secured promissory note** | $50,000 | - |<NEWLINE>| **Amortization of ROU assets and lease liabilities** | - | - | $5,134 |<NEWLINE>| **Interest rate** | - | - | 9.50% per annum |<NEWLINE>",
        "target": [
            "| **Description ** | **Fair Value ** |   |",
            "|   |   | **Significant unobservable inputs (Level 3) ** |",
            "| --- | --- | --- |",
            "| **Convertible promissory notes derivative liability at July 31, 2019 ** | $ 927,171  | $ 927,171  |",
            "| **Convertible promissory notes derivative liability at January 31, 2020 ** | $ 763,969  | $ 763,969  |"
        ]
    },
    "f10q0120_digeratitech_fileoutpart4": {
        "predict": "|   | **Three months ended January 31, ** |   | **Six months ended January 31, ** |   |\n|   | **2020 ** | **2019 ** | **2020 ** | **2019 ** |\n| --- | --- | --- | --- | --- |\n| **Depreciation and amortization expense ** | $33,335 | $33,335 | $66,670 | $66,670 |\n| **OPERATING LOSS ** | $-67,337 | $-192,352 | $-156,134 | $-333,142 |\n| **Gain (loss) on derivative instruments ** | $-190,204 | $-183,555 | $-320,717 | $-196,130 |\n| **NET LOSS INCLUDING NONCONTROLLING INTEREST ** | $-269,541 | $-375,907 | $-476,039 | $-529,272 |\n| **Less: Net loss attributable to the noncontrolling interests ** | $-4,487 | $-4,490 | $-8,975 | $-9,004 |\n| **NET LOSS ATTRIBUTABLE TO DIGERATI\u2019S SHAREHOLDERS ** | $-265,054 | $-371,417 | $-467,064 | $-520,268 |\n| **NET LOSS ATTRIBUTABLE TO DIGERATI\u2019S COMMON SHAREHOLDERS ** | $-265,054 | $-371,417 | $-467,064 | $-520,268 | \n| **Derivative liability ** | $112,000 | - | $112,000 | - |\n| **Accrued interest ** | - | - | $24,663 | $50,563 |\n| **Net cash consumed by operating activities ** | - | - | $12,000 | - |\n| **Total principal outstanding balance** | $0 | $50,000 | $286,625 | $579,875 |\n| **Shares of common stock issued for conversion of convertible notes ** | $2,054,263 | $166,702 | $3,156,551 | $1,495,355 |\n| **Shares of common stock issued in exchange for principal outstanding and fees under convertible notes** | - | $9,500 | $156,202 | - |\n| **Shares of common stock issued for conversion of convertible debenture ** | $831,669 | - | $1,177,674 | $356,007 |\n| **Shares of common stock issued for the conversion of principal outstanding and fees under convertible note ** | $121,625 | $- | $121,625 | $- |\n| **Shares of common stock issued in lieu of cash payments to management team ** | - | - | $568,000 | - |\n| **Warrants issued as part of promissory notes ** | - | - | $118,400 | - |\n| **Options granted to employees ** | - | - | $11,406 | - |\n| **Transaction-related expenses ** | - | - | $74,375 | - |\n| **Net proceeds to the Company from convertible notes ** | - | - | $382,500 | - |",
        "target": [
            "|   | **Three months ended January 31, ** |   | **Six months ended January 31, ** |   |",
            "|   | **2020 ** | **2019 ** | **2020 ** | **2019 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Depreciation and amortization expense ** | - | - | 316  | - |",
            "| **OPERATING LOSS ** | (699)  | (496)  | (1,370)  | (909)  |",
            "| **Gain (loss) on derivative instruments ** | - | - | 318  | - |",
            "| **NET LOSS INCLUDING NONCONTROLLING INTEREST ** | (501)  | (2,530)  | (2,022)  | (3,471)  |",
            "| **Less: Net loss attributable to the noncontrolling interests ** | 44  | - | 57  | 58  |",
            "| **NET LOSS ATTRIBUTABLE TO DIGERATI\u2019S SHAREHOLDERS ** | (457)  | (2,499)  | (1,965)  | (3,413)  |",
            "| **NET LOSS ATTRIBUTABLE TO DIGERATI\u2019S COMMON SHAREHOLDERS ** | $ (457)  | $ (2,499)  | $ (1,965)  | $ (3,413)  |"
        ]
    },
    "f10q0120_digeratitech_fileoutpart8": {
        "predict": "|   | **Six months ended January 31, ** |   |<NEWLINE>|   | **2020 ** | **2019 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net loss ** | $1,965,000 | $3,413,000 |<NEWLINE>| **Depreciation and amortization ** | $44,000 | $66,000 |<NEWLINE>| **Stock compensation and warrant expense ** | $233,633 | $- |<NEWLINE>| **Amortization of debt discount ** | $41,806 | $33,335 |<NEWLINE>| **Loss (Gain) on derivative liabilities ** | $1,815,000 | $- |<NEWLINE>| **Accrued expenses ** | $301,000 | $- |<NEWLINE>| **Deferred income ** | $69,000 | $285,000 |<NEWLINE>| **Cash paid in acquisition of equipment ** | $34,000 | $- |<NEWLINE>| **Borrowings from convertible debt, net of original issuance cost and discounts ** | $71,500 | $525,000 |<NEWLINE>| **Principal payments on convertible notes, net ** | $- | $- |<NEWLINE>| **Principal payments on related party notes, net ** | $67,000 | $- |<NEWLINE>| **CASH AND CASH EQUIVALENTS, end of period ** | $16,000 | $- |<NEWLINE>",
        "target": [
            "|   | **Six months ended January 31, ** |   |",
            "|   | **2020 ** | **2019 ** |",
            "| --- | --- | --- |",
            "| **Net loss ** | $ (2,022)  | $ (3,471)  |",
            "| **Depreciation and amortization ** | 316  | - |",
            "| **Stock compensation and warrant expense ** | 834  | - |",
            "| **Amortization of debt discount ** | 713  | - |",
            "| **Loss (Gain) on derivative liabilities ** | (318)  | - |",
            "| **Accrued expenses ** | 301  | - |",
            "| **Deferred income ** | 69  | - |",
            "| **Cash paid in acquisition of equipment ** | (34)  | - |",
            "| **Borrowings from convertible debt, net of original issuance cost and discounts ** | 150  | 419  |",
            "| **Principal payments on convertible notes, net ** | (36)  | - |",
            "| **Principal payments on related party notes, net ** | (67)  | - |",
            "| **CASH AND CASH EQUIVALENTS, end of period ** | $ 376  | - |"
        ]
    },
    "cb-20210331_fileoutpart3": {
        "predict": "| **(in millions of U.S. dollars) ** | **Three Months Ended March 31 ** |   |<NEWLINE>|   | **2021 ** | **2020 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net income ** | $2,300 | $252 |<NEWLINE>| **Amortization of purchased intangibles ** | - | - |<NEWLINE>| **Net cash flows from operating activities ** | $2,105 | $1,712 |<NEWLINE>| **Common Shares repurchased ** | $519 | - |<NEWLINE>| **Repayment of repurchase agreements ** | - | - |<NEWLINE>| **Net cash flows used for financing activities ** | - | - |<NEWLINE>",
        "target": [
            "| **(in millions of U.S. dollars) ** | **Three Months Ended March 31 ** |   |",
            "|   | **2021 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Net income ** | - | $ 252  |",
            "| **Amortization of purchased intangibles ** | 72  | 73  |",
            "| **Net cash flows from operating activities ** | 2,105  | 1,712  |",
            "| **Common Shares repurchased ** | (519)  | - |",
            "| **Repayment of repurchase agreements ** | (450)  | - |",
            "| **Net cash flows used for financing activities ** | (812)  | (645)  |"
        ]
    },
    "cb-20210331_fileoutpart35": {
        "predict": "|   | **Three Months Ended ** |   |   |\n|   |   | **March 31 ** | **% Change ** |\n| **Net premiums written ** | $8.0 billion |   |   |\n| --- | --- | --- | --- |\n| **Net premiums written - constant dollars (1) ** | $7.8 billion |   |   |\n| **Net premiums earned ** | $7.1 billion |   |   |\n| **Net investment income ** |   | $872 million |   |\n| **Policy benefits ** |   | ($5.5) billion |   |\n| **Amortization of purchased intangibles ** |   | ($88) million |   |\n| **Net income ** | $1.2 billion |   |   | \n| **Shareholders' equity ** |   |   |   |\n| --- | --- | --- | --- |\n| **Total shareholders' equity (excluding investment in subsidiaries) ** | $59.3 billion |   |   |\n| **Dividend distributions per Common Share ** | $0.78 (CHF 0.70) |   |   |",
        "target": [
            "|   | **Three Months Ended ** |   |   |",
            "|   |   | **March 31 ** | **% Change ** |",
            "| **Net premiums written ** | - | - | 8.6 %  |",
            "| --- | --- | --- | --- |",
            "| **Net premiums written - constant dollars (1) ** |   |   | 7.0 %  |",
            "| **Net premiums earned ** | - | - | 5.5 %  |",
            "| **Net investment income ** | 863  | 861  | - |",
            "| **Policy benefits ** | 167  | 129  | - |",
            "| **Amortization of purchased intangibles ** | 72  | 73  | - |",
            "| **Net income ** | - | $ 252  | - |"
        ]
    },
    "cb-20210331_fileoutpart41": {
        "predict": "|   | **March 31 ** | **% Change ** |<NEWLINE>| **(in millions of U.S. dollars, except for percentages) ** | **2020 ** | **Q-21 vs. Q-20 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net premiums written ** | $8,939 | 0.8% |<NEWLINE>| **Net premiums earned ** | $9,444 | 6.5% |<NEWLINE>| **CAY loss ratio excluding catastrophe losses ** | 65.5% | -2.1 percentage points |<NEWLINE>| **Loss and loss expense ratio ** | 73.8% | 12.2 percentage points |<NEWLINE>| **Policy acquisition cost ratio ** | 16.7% | 0.3 percentage points |<NEWLINE>| **Administrative expense ratio ** | 15.7% | -0.6 percentage points |<NEWLINE>| **Net income** | $2.3 billion | - |<NEWLINE>| **Total pre-tax and after-tax favorable prior period development** | $192 million (pre-tax) and $156 million (after-tax) | - |<NEWLINE>| **Total P&C pre-tax and after-tax catastrophe losses** | $700 million (pre-tax) and $570 million (after-tax) | - |<NEWLINE>| **Other investments** | $7.2 billion | - |<NEWLINE>| **Net investment income** | $863 million | - |<NEWLINE>| **Operating cash flows** | $2.1 billion | - |<NEWLINE>| **Equity securities for which pricing is unobservable** | - | Level 3 |<NEWLINE>| **Short-term investments** | - | Level 1 |<NEWLINE>| **Fixed income securities** | A | 48% AAA or guaranteed by governments or quasi-government agencies |<NEWLINE>| **Holdings issuer limit** | 1.5% | AA - 2%, A - 1%, BBB - 0.5% | <NEWLINE>| **Unrecognized tax benefits** | $62 million | - |<NEWLINE>| **Weighted average lapse and annuitization rates** | - | determined by weighting each treaty's rates by the GLB contracts fair value |<NEWLINE>| **Estimated pre-tax amortization expense (benefit) of purchased intangibles** | - | Current foreign currency exchange rates for the second through fourth quarters of 2021 and the next five years |<NEWLINE>| **Net adverse development of** | $23 million | Wholesale general liability coverages |<NEWLINE>| **Net favorable development of** | $51 million | Professional liability (errors & omissions and third-party cyber risk) |<NEWLINE>| **Net favorable development of** | $46 million | Long-tail business |<NEWLINE>| **Net favorable development of** | $35 million | Voluntary environmental lines |<NEWLINE>| **Share repurchases** | $519 million | Average purchase price of $166.75 per share |<NEWLINE>| **Dividend** | $0.78 per share in four quarterly installments | Approved at May 2020 and 2019 annual general meetings |<NEWLINE>| **Commercial multiple peril represents** | Retail package business (property and general liability) | - |<NEWLINE>| **Ownership interest in** | Huatai Asset Management Co., Ltd | Approximately 82 percent |<NEWLINE>| **Issuer limits** | - | Based on credit rating (AA\u2014two percent, A\u2014one percent, BBB\u20140.5 percent of the total portfolio) |<NEWLINE>| **Hedge sensitivity** | - | From March 31, 2021 market levels and only applicable to the equity and interest rate sensitivities table below |<NEWLINE>| **Weighted average duration of fixed income securities** | 4.3 years (March 31, 2021) and 4.0 years (December 31, 2020) | - |<NEWLINE>| **Critical accounting estimates** | - | No material changes as of March 31, 2021 |<NEWLINE>| **Modelled pre-tax estimates of natural catastrophe PML** | - | Net of reinsurance, at March 31, 2021, for Worldwide, U.S (Huatai Life), and approximately 82 percent of Huatai Asset Management Co., Ltd |<NEWLINE>",
        "target": [
            "|   | **March 31 ** | **% Change ** |",
            "| **(in millions of U.S. dollars, except for percentages) ** | **2020 ** | **Q-21 vs. Q-20 ** |",
            "| --- | --- | --- |",
            "| **Net premiums written ** | - | (0.8)%  |",
            "| **Net premiums earned ** | - | (1.3)%  |",
            "| **CAY loss ratio excluding catastrophe losses ** | - | (1.9) pts  |",
            "| **Loss and loss expense ratio ** | - | 12.2 pts  |",
            "| **Policy acquisition cost ratio ** | 20.4 %  | 0.5 pts  |",
            "| **Administrative expense ratio ** | - | (0.6) pts  |"
        ]
    },
    "cb-20210331_fileoutpart22": {
        "predict": "| **(in millions of U.S. dollars) ** | **Three Months Ended March 31 ** | **2021** | **2020** |<NEWLINE>| --- | --- | --- | --- |<NEWLINE>| **North America Commercial P&C Insurance ** | $2,083 | $3,138 | - |<NEWLINE>| **North America Personal P&C Insurance ** | $1,088 | - | - |<NEWLINE>| **Total ** | $3,171 | - | - |<NEWLINE>| **North America Commercial P&C Insurance ** | $3,138 | - | - |<NEWLINE>",
        "target": [
            "| **(in millions of U.S. dollars) ** | **Three Months Ended March 31 ** |   |   |",
            "|   | **Long-tail ** | **Short-tail ** | **Total ** |",
            "| --- | --- | --- | --- |",
            "| **North America Commercial P&C Insurance ** | $ (46)  | $ (81)  | $ (127)  |",
            "| **North America Personal P&C Insurance ** | - | (40)  | (40)  |",
            "| **Total ** | - | - | $ (192)  |",
            "| **North America Commercial P&C Insurance ** | - | $ (62)  | - |"
        ]
    },
    "cb-20210331_fileoutpart38": {
        "predict": "|   | **Three Months Ended March 31 ** |   |<NEWLINE>|   | **2021 ** | **2020 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Catastrophe losses ** | $23 million | $237 million |<NEWLINE>| **Prior period development ** | $4 million | $2 million |<NEWLINE>| **P&C Combined ratio ** | 102.6% | 85.6% |<NEWLINE>",
        "target": [
            "|   | **Three Months Ended March 31 ** |   |",
            "|   | **2021 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Catastrophe losses ** | 9.1 %  | 3.3 %  |",
            "| **Prior period development ** | (2.6)%  | (1.7)%  |",
            "| **P&C Combined ratio ** | 91.8 %  | 89.1 %  |"
        ]
    },
    "cb-20210331_fileoutpart55": {
        "predict": "|   | **Three Months Ended March 31 ** |   |<NEWLINE>| **(in millions of U.S. dollars) ** | **2021 ** | **2020 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Gains (losses) from fair value changes in separate account assets (2) ** | $- | $- |<NEWLINE> \n| **Policy benefits** | $167 | $129 |<NEWLINE> \n| **Net premiums earned** | $8.2 billion | - |<NEWLINE> \n| **Loss and loss expense ratio** | +20.4pp | +5.1pp |<NEWLINE>\n| **Loss and loss expense ratio (excluding catastrophe losses)** | +3.5pp | - |<NEWLINE>\n| **Catastrophe losses** | Winter storm losses and other severe weather-related events in the U.S | - |<NEWLINE>\n| **Net adverse development** | $49 million | $41 million |<NEWLINE>\n| **Net favorable development** | $81 million | $36 million |<NEWLINE>\n| **Right-of-use asset** | $448 million | $473 million |<NEWLINE>\n| **Lease liability** | $490 million | $517 million |<NEWLINE>\n| **Administrative expense ratio** | -0.7pp | -1.4pp |<NEWLINE>\n| **Equity securities fair value** | Level 1 | Level 1 |<NEWLINE>\n| **Fixed maturities fair value** | Level 2 | Level 2 |<NEWLINE>\n| **Short-term investments fair value** | Level 3 | Level 3 |<NEWLINE>\n| **Fixed maturities and short-term investments fair value** | $62,808 million | $60,324 million |<NEWLINE>\n| **Corporate bonds fair value** | $17,356 million | - |<NEWLINE>\n| **Fair value of cross-currency swaps and interest rate swaps** | Level 2 | - |<NEWLINE>\n| **Commitments to purchase fixed income securities** | $591 million | - |<NEWLINE>\n| **Number of stock options granted** | 1,790,056 | - |<NEWLINE>\n| **Weighted-average grant date fair value of stock options** | $33.05 | - |<NEWLINE>\n| **Record and payment dates of annual dividend** | May 2020 and 2019 | - |<NEWLINE>\n| **Net investment income** | Flat | - |<NEWLINE>\n| **Facilities financial covenants** | Met | - |<NEWLINE>\n| **Loss and loss expense ratio (excluding catastrophe losses) - P&C current accident year combined ratio** | 85.2% | 87.5% |<NEWLINE>\n| **Net amount at risk following an immediate change in equity market levels** | - | - |<NEWLINE>\n| **Service-based restricted stock awards granted** | 848,762 | - |<NEWLINE>\n| **Service-based restricted stock units granted** | 324,142 | - |<NEWLINE>\n| **Performance-based stock awards granted** | 284,766 | - |<NEWLINE>\n| **Total grant date fair value of stock awards granted** | $164.94 | - |<NEWLINE> \n|   | **As of March 31, 2021** | **As of December 31, 2020** |<NEWLINE>| **Total equity** | $61,161 million | $58,736 million |<NEWLINE>\n| **Total liabilities** | $181,856 million | $178,931 million |<NEWLINE>\n| **Total shareholders' equity of Parent Guarantor** | $61,161 million | $58,736 million |<NEWLINE>\n| **Investment in subsidiaries, including Subsidiary Issuer** | $55.9 billion | $56.1 billion |<NEWLINE>",
        "target": [
            "|   | **Three Months Ended March 31 ** |   |",
            "| **(in millions of U.S. dollars) ** | **2021 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Gains (losses) from fair value changes in separate account assets (2) ** | 4  | (56)  |"
        ]
    },
    "cb-20210331_fileoutpart37": {
        "predict": "| **(in millions of U.S. dollars) ** | **Three Months Ended March 31 ** |   |<NEWLINE>|   | **2021 ** | **2020 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Catastrophe losses ** | $700 million | $237 million |<NEWLINE>| **Favorable prior period development ** | $118 million | $105 million |<NEWLINE>",
        "target": [
            "| **(in millions of U.S. dollars) ** | **Three Months Ended March 31 ** |   |",
            "|   | **2021 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Catastrophe losses ** | $ 700  | $ 237  |",
            "| **Favorable prior period development ** | $ 192  | $ 118  |"
        ]
    },
    "f10q0321_accelerateacq_fileoutpart6": {
        "predict": "| --- | --- |\n| **Net income** | **$6,719,798** |\n| **Transaction costs incurred in connection with IPO** | $22,590,881 |\n| **Investment of cash in Trust Account** | $400,000,986 |\n| **Net cash used in investing activities** | $0 |\n| **Proceeds from sale of Private Placement Warrants** | $0 |\n| **Net Change in Cash** | $1,321,004 |\n| **Cash \u2013 End of period** | $1,321,004 |\n| **Deferred underwriting fee payable** | $14,000,000 | \nNote: No changes needed to the table as the financial report does not provide any information on the missing cells.",
        "target": [
            "| --- | --- |",
            "| **Net income ** | **$ 6,719,798 ** |",
            "| **Transaction costs incurred in connection with IPO ** | 801,198  |",
            "| **Investment of cash in Trust Account ** | (400,000,000)  |",
            "| **Net cash used in investing activities ** | (400,000,000)  |",
            "| **Proceeds from sale of Private Placement Warrants ** | 11,000,000  |",
            "| **Net Change in Cash ** | 1,321,004  |",
            "| **Cash \u2013 End of period ** | $ 1,321,004  |",
            "| **Deferred underwriting fee payable ** | $ 14,000,000  |"
        ]
    },
    "f10q1222_etfmanagers1_fileoutpart27": {
        "predict": "|   | **THREE MONTHS ENDED DECEMBER 31, 2022 ** | **THREE MONTHS ENDED DECEMBER 31, 2021 ** |\n|   | **BREAKWAVE DRY BULK SHIPPING ETF ** | **BREAKWAVE DRY BULK SHIPPING ETF ** |\n| --- | --- | --- |\n| **Net asset value per Share, beginning of period ** | $8.75 | $10.31 |\n| **Net Asset Value per Share, end of period ** | $9.19 | $17.17 |\n| **Market Value per Share, end of period ** | $9.08 | $17.00 |\n| **Expense Ratio*** ** | 3.50% | 3.50% |\n| **Total Return, at Net Asset Value** ** | 7.20% | -3.48% |\n| **Total Return, at Market Value** ** | 6.49% | -2.80% | \n***Additional information in the financial report segment does not provide data related to the Expense Ratio for the six months ended December 31, 2022 and 2021. Therefore, no updates are made to the table for these fields.***",
        "target": [
            "|   | **THREE MONTHS ENDED DECEMBER 31, 2022 ** | **THREE MONTHS ENDED DECEMBER 31, 2021 ** |",
            "|   | **BREAKWAVE DRY BULK SHIPPING ETF ** | **BREAKWAVE DRY BULK SHIPPING ETF ** |",
            "| --- | --- | --- |",
            "| **Net asset value per Share, beginning of period ** | $ 8.75  | $ 35.62  |",
            "| **Net Asset Value per Share, end of period ** | $ 9.38  | $ 29.65  |",
            "| **Market Value per Share, end of period ** | $ 9.19  | $ 29.49  |",
            "| **Expense Ratio*** ** | 5.04%  | - |",
            "| **Total Return, at Net Asset Value** ** | 7.20%  | - |",
            "| **Total Return, at Market Value** ** | 1.66%  | (18.11)%  |"
        ]
    },
    "f10q1222_etfmanagers1_fileoutpart28": {
        "predict": "|   | **SIX MONTHS ENDED DECEMBER 31, 2022 ** | **SIX MONTHS ENDED DECEMBER 31, 2021 ** |\n|   | **BREAKWAVE DRY BULK SHIPPING ETF ** | **BREAKWAVE DRY BULK SHIPPING ETF ** |\n| --- | --- | --- |\n| **Net asset value per Share, beginning of period ** | $17.17 | $35.62 |\n| **Net Asset Value per Share, end of period ** | $9.19 | $29.65 |\n| **Market Value per Share, end of period ** | $9.19 | $29.65 |\n| **Total Return, at Net Asset Value** ** | -46.48% | -16.82% |\n| **Total Return, at Market Value** ** | -46.48% | -16.82% |",
        "target": [
            "|   | **SIX MONTHS ENDED DECEMBER 31, 2022 ** | **SIX MONTHS ENDED DECEMBER 31, 2021 ** |",
            "|   | **BREAKWAVE DRY BULK SHIPPING ETF ** | **BREAKWAVE DRY BULK SHIPPING ETF ** |",
            "| --- | --- | --- |",
            "| **Net asset value per Share, beginning of period ** | $ 17.06  | $ 28.88  |",
            "| **Net Asset Value per Share, end of period ** | 9.38  | 29.65  |",
            "| **Market Value per Share, end of period ** | $ 9.19  | $ 29.49  |",
            "| **Total Return, at Net Asset Value** ** | (45.02)%  | 2.67%  |",
            "| **Total Return, at Market Value** ** | (46.48)%  | 0.48%  |"
        ]
    },
    "f10q1222_etfmanagers1_fileoutpart8": {
        "predict": "|   | **BREAKWAVE DRY BULK SHIPPING ETF ** | **ETF MANAGERS GROUP COMMODITY TRUST I ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net investment income (loss) ** | $3,017,323 |   |<NEWLINE>| **Net realized gain (loss) ** | ($3,773,390) |   |<NEWLINE>| **Change in net unrealized gain (loss) ** | $7,140,215 |   |<NEWLINE>| **Net Increase (decrease) in Net Assets from operations ** | $367,148 |   |<NEWLINE>",
        "target": [
            "|   | **BREAKWAVE DRY BULK SHIPPING ETF ** | **ETF MANAGERS GROUP COMMODITY TRUST I ** |",
            "| --- | --- | --- |",
            "| **Net investment income (loss) ** | (954,646)  | (954,646)  |",
            "| **Net realized gain (loss) ** | (1,117,138)  | (1,117,138)  |",
            "| **Change in net unrealized gain (loss) ** | (16,869,110)  | (16,869,110)  |",
            "| **Net Increase (decrease) in Net Assets from operations ** | (18,940,894)  | (18,940,894)  |"
        ]
    },
    "f10q1222_etfmanagers1_fileoutpart10": {
        "predict": "|   | **BREAKWAVE DRY BULK SHIPPING ETF ** | **ETF MANAGERS GROUP COMMODITY TRUST I ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net investment gain (loss) ** | ($349,502) |   |<NEWLINE>| **Net realized loss ** | ($3,773,390) |   |<NEWLINE>| **Change in net unrealized gain (loss) ** | $7,140,215 |   |<NEWLINE>| **Net Increase (Decrease) in Net Assets from operations ** | $3,017,323 |   |<NEWLINE>",
        "target": [
            "|   | **BREAKWAVE DRY BULK SHIPPING ETF ** | **ETF MANAGERS GROUP COMMODITY TRUST I ** |",
            "| --- | --- | --- |",
            "| **Net investment gain (loss) ** | (1,749,765)  | (1,749,765)  |",
            "| **Net realized loss ** | 18,463,560  | 18,463,560  |",
            "| **Change in net unrealized gain (loss) ** | (18,595,890)  | (18,595,890)  |",
            "| **Net Increase (Decrease) in Net Assets from operations ** | (1,882,095)  | (1,882,095)  |"
        ]
    },
    "lxrp_10q_fileoutpart23": {
        "predict": "|   | **May 31 2020 $** | **May 31 2019 $** |\n| --- | --- | --- |\n| **Product sales** | **119,691** | **7,284** |\n| **Licensing revenue** | **$73,759** | **$40,000** |",
        "target": [
            "|   | **May 31 2020 $ ** | **May 31 2019 $ ** |",
            "| --- | --- | --- |",
            "| **Product sales ** | **119,709 ** | **7,284 ** |",
            "| **Licensing revenue ** | 130,509  | 90,000  |"
        ]
    },
    "lxrp_10q_fileoutpart37": {
        "predict": "|   | **May 31 2020 ** | **May 31 2019 ** |\n| --- | --- | --- |\n| **Cash Flows ** | **$2,730,178** | **$2,537,604** |\n| --- | --- | --- |\n| **Cash flows (used in) provided by operating activities ** | $312,018 | $185,262 |\n| **Cash flows (used in) provided by investing activities ** | ($13,205) | ($736,079) |\n| **Cash flows (used in) provided by financing activities ** | $2,743,383 | $3,273,683 ($2,273,683 from private placements and exercises and $1,000,000 from the 16.67% acquisition of Lexaria Nicotine by Altria) | \n| **Intellectual Property Licensing fees** | $73,759 | $40,000 |\n| **Usage Fees** | $56,750 | $50,000 |\n| **CEWS program subsidies** | $15,272 | - |\n| **Outstanding options** | - | - |\n| **Net income** | - | - |\n| **Revenue** | - | - |\n| **Loan** | C$40,000 | - |",
        "target": [
            "|   | **May 31 2020 ** | **May 31 2019 ** |",
            "| **Cash Flows ** | **$ ** | **$ ** |",
            "| --- | --- | --- |",
            "| **Cash flows (used in) provided by operating activities ** | (1,981,314)  | (2,268,946)  |",
            "| **Cash flows (used in) provided by investing activities ** | (13,205)  | (736,079)  |",
            "| **Cash flows (used in) provided by financing activities ** | 2,743,383  | 3,273,683  |"
        ]
    },
    "form10q_03312019_fileoutpart2": {
        "predict": "|   | **Three Months Ended March 31, ** |   |<NEWLINE>|   | **2019 ** | **2018 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Revenues ** | $4,076 | $56,590 |<NEWLINE>| **Cost of revenues ** | 67% | 77% |<NEWLINE>| **Research and development expenses ** | $2,386 | - |<NEWLINE>| **Operating loss ** | $390,504 | $186,058 |<NEWLINE>| **Interest expense ** | $885 | $1,380 |<NEWLINE>| **Net loss ** |   |   |<NEWLINE>| **Net loss attributable to common shareholders ** | $391,389 | $192,430 |<NEWLINE>| **Basic and diluted net loss per average share available to common shareholders ** |   |   |<NEWLINE>",
        "target": [
            "|   | **Three Months Ended March 31, ** |   |",
            "|   | **2019 ** | **2018 ** |",
            "| --- | --- | --- |",
            "| **Revenues ** | $ 4,076  | $ 56,590  |",
            "| **Cost of revenues ** | (2,718)  | (43,339)  |",
            "| **Research and development expenses ** | 2,386  | - |",
            "| **Operating loss ** | (390,504)  | - |",
            "| **Interest expense ** | (885)  | (1,380)  |",
            "| **Net loss ** | (391,389)  | - |",
            "| **Net loss attributable to common shareholders ** | $ (391,389)  | - |",
            "| **Basic and diluted net loss per average share available to common shareholders ** | $ (0.01)  | $ (0.01)  |"
        ]
    },
    "acbm_10q_fileoutpart6": {
        "predict": "|   | **Six Months ended June 30, ** |   |<NEWLINE>|   | **2021 ** | **2020 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net income (loss) ** | $(854,181) | $17,417 |<NEWLINE>| **Imputed interest - related parties ** | $3,870 | $1,369 |<NEWLINE>| **Stock based compensation ** | $804,650 |   |<NEWLINE>| **Inventories ** | $448,000 | $938,000 |<NEWLINE>| **Purchase deposit for inventory ** | $12,000 |   |<NEWLINE>| **Accounts payable and accrued expenses ** | $22,762 | $45,524 |<NEWLINE>| **Deferred revenue ** | $17,464 | $35,928 |<NEWLINE>| **Net cash provided by (used in) operating activities ** | $424,390 | $(97,845) |<NEWLINE>| **Advances from related parties ** |   | $97,315 |<NEWLINE>| **Repayment to related parties ** | $241,851 |   |<NEWLINE>| **Net cash (used in) provided by \ufb01nancing activities ** | $(227,019) |   |<NEWLINE>| **Cash at end of period ** | $215,494 | $118,386 |<NEWLINE>",
        "target": [
            "|   | **Six Months ended June 30, ** |   |",
            "|   | **2021 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Net income (loss) ** | $ (854,181)  | $ 17,417  |",
            "| **Imputed interest - related parties ** | 3,870  | 1,369  |",
            "| **Stock based compensation ** | 804,650  | - |",
            "| **Inventories ** | 490,000  | (59,440)  |",
            "| **Purchase deposit for inventory ** | - | (12,000)  |",
            "| **Accounts payable and accrued expenses ** | (12,662)  | (22,762)  |",
            "| **Deferred revenue ** | - | (17,464)  |",
            "| **Net cash provided by (used in) operating activities ** | 424,390  | (97,845)  |",
            "| **Advances from related parties ** | 14,832  | 97,315  |",
            "| **Repayment to related parties ** | (241,851)  | - |",
            "| **Net cash (used in) provided by \ufb01nancing activities ** | (227,019)  | 97,315  |",
            "| **Cash at end of period ** | $ 215,494  | - |"
        ]
    },
    "acbm_10q_fileoutpart3": {
        "predict": "|   | **Three Months Ended June 30, ** |   | **Six Months ended June 30, ** |   |\n|   | **2021 ** | **2020 ** | **2021 ** | **2020 ** |\n| --- | --- | --- | --- | --- |\n| **Revenues ** | $599,500 | $0 | $599,500 | $0 |\n| **Cost of revenues ** | $490,000 | $0 | $490,000 | $0 |\n| **Gross pro\ufb01t ** | $109,500 | $0 | $109,500 | $0 |\n| **Selling, general and administrative ** | $162,925 | $62,771 | $162,925 | $62,771 |\n| **Research and development ** | $641,725 | $0 | $641,725 | $0 |\n| **Total operating expenses ** | $959,811 | $62,771 | $959,811 | $62,771 |\n| **Income (loss) from operations ** | ($850,311) | ($62,771) | ($850,311) | ($62,771) |\n| **Interest expense - related party ** | $3,870 | $1,369 | $3,870 | $1,369 |\n| **Total other expenses ** |   |   |   |   |\n| **Income (loss) before income tax credit ** | ($854,181) | ($64,140) | ($854,181) | ($64,140) |\n| **Net income (loss) ** | ($854,181) | ($63,699) | ($854,181) | ($63,699) |\n| **Basic and diluted income (loss) per share of common stock ** | ($0.02) | ($0.00) | ($0.02) | ($0.00) |",
        "target": [
            "|   | **Three Months Ended June 30, ** |   | **Six Months ended June 30, ** |   |",
            "|   | **2021 ** | **2020 ** | **2021 ** | **2020 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Revenues ** | $ 500,000  | - | $ 599,500  | $ 687,964  |",
            "| **Cost of revenues ** | 420,000  | - | 490,000  | 528,560  |",
            "| **Gross pro\ufb01t ** | 80,000  | - | 109,500  | 159,404  |",
            "| **Selling, general and administrative ** | - | 62,771  | - | 140,618  |",
            "| **Research and development ** | 641,725  | - | 641,725  | - |",
            "| **Total operating expenses ** | 873,320  | 62,771  | 959,811  | 140,618  |",
            "| **Income (loss) from operations ** | - | (62,771)  | - | - |",
            "| **Interest expense - related party ** | 1,367  | 928  | 3,870  | 1,369  |",
            "| **Total other expenses ** | 1,367  | 928  | 3,870  | 1,369  |",
            "| **Income (loss) before income tax credit ** | (794,687)  | (63,699)  | (854,181)  | 17,417  |",
            "| **Net income (loss) ** | $ (794,687)  | $ (63,699)  | $ (854,181)  | $ 17,417  |",
            "| **Basic and diluted income (loss) per share of common stock ** | $ (0.02)  | $ (0.00)  | $ (0.02)  | $ 0.00  |"
        ]
    },
    "acbm_10q_fileoutpart11": {
        "predict": "|   | **Six months Ended June 30, ** |   |<NEWLINE>|   | **2021 ** | **2020 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Cash provided by (used in) operating activities ** | $424,390 | ($97,845) |<NEWLINE>| **Cash used in (provided by) \ufb01nancing activities ** | - | $97,315 |<NEWLINE>| **Cash at end of period ** | $215,494 | - |<NEWLINE>",
        "target": [
            "|   | **Six months Ended June 30, ** |   |",
            "|   | **2021 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Cash provided by (used in) operating activities ** | $ 424,390  | $ (97,845)  |",
            "| **Cash used in (provided by) \ufb01nancing activities ** | (227,019)  | 97,315  |",
            "| **Cash at end of period ** | 215,494  | - |"
        ]
    },
    "irt-20220630_fileoutpart12": {
        "predict": "| **Investments in Unconsolidated Real Estate ** | **Location ** | **Units(1) (Unaudited) ** | **June 30, 2022 ** | **December 31, 2021 ** |\n| --- | --- | --- | --- | --- |\n| **Views of Music City / The Jackson ** | Nashville, TN | 96 | $25,440 | $0 |\n| **Virtuoso ** |   |   | 25 | 25 |\n| **Lakeline Station ** | Austin, TX | 378 | $0 | $0 |\n| **Total ** |   |   | $25,465 | $25 |",
        "target": [
            "| **Investments in Unconsolidated Real Estate ** | **Location ** | **Units(1) (Unaudited) ** | **June 30, 2022 ** | **December 31, 2021 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Views of Music City / The Jackson ** | Nashville, TN  | - | - | - |",
            "| **Virtuoso ** | Huntsville, AL  | 400  | - | \u2014  |",
            "| **Lakeline Station ** | Austin, TX  | 378  | - | \u2014  |",
            "| **Total ** |   | 1,588  | $ 54,178  | $ 24,999  |"
        ]
    },
    "f10qoct21_privacy_fileoutpart2": {
        "predict": "| **Income: ** |   |<NEWLINE>| --- | --- |<NEWLINE>| **Affiliate revenue ** | $139 |<NEWLINE>| **Total Income ** |   |<NEWLINE>| **General and administrative ** | $57,565 |<NEWLINE>| **Net Loss: ** | $(57,426) |<NEWLINE>| **Net loss per share \u2013 basic and diluted ** |   |<NEWLINE>| **Weighted average shares outstanding \u2013 basic and diluted ** |   |<NEWLINE>",
        "target": [
            "| **Income: ** |   |",
            "| --- | --- |",
            "| **Affiliate revenue ** | $ 139  |",
            "| **Total Income ** | 139  |",
            "| **General and administrative ** | 57,565  |",
            "| **Net Loss: ** | (57,426)  |",
            "| **Net loss per share \u2013 basic and diluted ** | (0)  |",
            "| **Weighted average shares outstanding \u2013 basic and diluted ** | 201,115,000  |"
        ]
    },
    "f10qoct21_privacy_fileoutpart4": {
        "predict": "|   | **$** |<NEWLINE>| --- | --- |<NEWLINE>| **Net loss for the period** | $(57,426) |<NEWLINE>| **Net cash used in operating activities** | $(159,720) |<NEWLINE>| **Software** | $2,200,000 |<NEWLINE>| **Net cash used in investing activities** | $(160,000) |<NEWLINE>| **Common stock** | $22,300 |<NEWLINE>| **Net cash used in investing activities** | $22,300 |<NEWLINE>| **Cash \u2013 beginning of period** | $17,587 |<NEWLINE>| **Cash \u2013 end of period** | $39,607 |<NEWLINE>",
        "target": [
            "|   | **$ ** |",
            "| --- | --- |",
            "| **Net loss for the period ** | (57,426)  |",
            "| **Net cash used in operating activities ** | 159,720  |",
            "| **Software ** | (160,000)  |",
            "| **Net cash used in investing activities ** | (160,000)  |",
            "| **Common stock ** | 22,300  |",
            "| **Net cash used in investing activities ** | 22,300  |",
            "| **Cash \u2013 beginning of period ** | 7,587  |",
            "| **Cash \u2013 end of period ** | 29,607  |"
        ]
    },
    "shengshielevator3_10q_fileoutpart5": {
        "predict": "|   | **Common Stock ** |   | **Accumulated De\ufb01cit ** | **Total** |\n| --- | --- | --- | --- | --- |\n|   | **Shares ** | **Amount ** |   |   |\n| --- | --- | --- | --- | --- |\n| **Balance, January 1, 2021 ** | 1,000,000,000 | $1,000,000 | ($8,989,269) | ($7,989,269) |\n| **Net loss ** |   |   | ($2,000) | ($2,000) |\n| **Balance, March 31, 2021 ** | 1,000,000,000 | $1,000,000 | ($8,991,269) | ($7,991,269) |",
        "target": [
            "|   | **Common Stock ** |   | **Accumulated De\ufb01cit ** | **Total** |",
            "|   | **Shares ** | **Amount ** |   |   |",
            "| --- | --- | --- | --- | --- |",
            "| **Balance, January 1, 2021 ** | 603,970,000  | $ 603,970  | - | - |",
            "| **Net loss ** | - | - | (2,000)  | (2,000)  |",
            "| **Balance, March 31, 2021 ** | 603,970,000  | $ 603,970  | $ (8,989,269)  | - |"
        ]
    },
    "form10-qa_fileoutpart3": {
        "predict": "|   | **For the Three Months Ended April 30, ** |   | **For the Nine Months Ended April 30, ** |   |\n| --- | --- | --- | --- | --- |\n| **Commission income ** | $769,150 | $693,591 | $2,478,230 | $1,478,189 |\n| **Commission expense ** |   |   | $736,628 | $636,692 |\n| **Commission expense \u2013 related party ** | $670,900 | $268,825 | $1,582,072 |   |\n| **Gross margin ** | $355,845 | $249,431 | $1,070,702 | $572,672 |\n| **Stock based compensation ** |   |   |   |   |\n| **Professional fees ** | $80,750 | $11,455 | $88,114 | $51,463 |\n| **Payroll expense ** | $63,965 | $62,801 | $179,487 | $181,005 |\n| **General and administrative ** | $144,083 | $125,456 | $327,522 | $404,263 |\n| **(Loss) income from operations ** | ($63,903) | ($50,370) | ($111,970) | $60,899 |\n| **Interest expense ** |   |   | $5,217 | $0 |\n| **Impairment expense ** |   | $33,333 |   | $33,333 |\n| **Gain of forgiveness of debt ** |   | $82,335 |   | $82,335 |\n| **Total other (expense) income ** | ($11,032) | ($5,415) | ($31,251) | $88,128 |\n| **Net (loss) income before income tax ** | ($74,935) | ($55,785) | ($143,221) | $149,027 |\n| **Net (Loss) Income ** | ($74,935) | ($55,785) | ($1,111,710) | $15,057 |",
        "target": [
            "|   | **For the Three Months Ended April 30, ** |   | **For the Nine Months Ended April 30, ** |   |",
            "|   | **2023 ** | **2022 ** | **2023 ** | **2022 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Commission income ** | $ 769,150  | $ 693,591  | $ 2,478,230  | $ 1,478,189  |",
            "| **Commission expense ** | 213,305  | 230,235  | 736,628  | 636,692  |",
            "| **Commission expense \u2013 related party ** | 200,000  | 213,925  | 670,900  | 268,825  |",
            "| **Gross margin ** | 355,845  | 249,431  | 1,070,702  | 572,672  |",
            "| **Stock based compensation ** | 1,582,072  | - | 1,582,072  | - |",
            "| **Professional fees ** | 80,750  | 11,455  | 88,114  | 51,463  |",
            "| **Payroll expense ** | 63,009  | 65,507  | 179,487  | 181,005  |",
            "| **General and administrative ** | 144,083  | 125,456  | 327,522  | 404,263  |",
            "| **(Loss) income from operations ** | - | 47,013  | - | - |",
            "| **Interest expense ** | (5,217)  | - | (5,217)  | - |",
            "| **Impairment expense ** | - | - | - | (33,333)  |",
            "| **Gain of forgiveness of debt ** | - | - | - | 82,335  |",
            "| **Total other (expense) income ** | (5,217)  | - | (5,217)  | - |",
            "| **Net (loss) income before income tax ** | (1,519,286)  | 47,013  | (1,111,710)  | (15,057)  |",
            "| **Net (Loss) Income ** | $ (1,519,286)  | $ 47,013  | $ (1,111,710)  | $ (15,057)  |"
        ]
    },
    "form10-qa_fileoutpart5": {
        "predict": "|   | **For the Nine Months Ended April 30, ** |   |<NEWLINE>|   | **2023 ** | **2022 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net loss ** | $1.11171 million |   |<NEWLINE>| **Impairment expense ** | $33,333 |   |<NEWLINE>| **Gain of forgiveness of debt ** | $82,335 |   |<NEWLINE>| **Stock based compensation ** | $1,582,072 |   |<NEWLINE>| **Depreciation expense ** | $32,379 | $25,903 |<NEWLINE>| **Net cash (used) provided by operating activities ** | ($140,538) | $29,279 |<NEWLINE>| **Purchase of property and equipment ** |   | $53,918 |<NEWLINE>| **Net cash used by investing activities ** |   | ($53,918) |<NEWLINE>| **Loan payable \u2013 related party ** | $85,709 | $37,649 |<NEWLINE>| **Contributions to capital by controlling shareholder ** | $48,060 | $27,639 |<NEWLINE>| **Net cash provided by financing activities ** | $133,769 | $65,507 |<NEWLINE>",
        "target": [
            "|   | **For the Nine Months Ended April 30, ** |   |",
            "|   | **2023 ** | **2022 ** |",
            "| --- | --- | --- |",
            "| **Net loss ** | $ (1,111,710)  | $ (15,057)  |",
            "| **Impairment expense ** | - | 33,333  |",
            "| **Gain of forgiveness of debt ** | - | (82,335)  |",
            "| **Stock based compensation ** | 1,582,072  | - |",
            "| **Depreciation expense ** | 32,379  | 25,903  |",
            "| **Net cash (used) provided by operating activities ** | (140,538)  | 29,279  |",
            "| **Purchase of property and equipment ** | - | (53,918)  |",
            "| **Net cash used by investing activities ** | - | (53,918)  |",
            "| **Loan payable \u2013 related party ** | 48,060  | - |",
            "| **Contributions to capital by controlling shareholder ** | - | 27,639  |",
            "| **Net cash provided by financing activities ** | 48,060  | 27,639  |"
        ]
    },
    "form10-qa_fileoutpart9": {
        "predict": "|   | **Number of Warrants ** | **Weighted Average Exercise Price ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Issued ** | 1,582,072 | - |<NEWLINE>| **Outstanding, April 30, 2023 ** | - | $0.50 |<NEWLINE>",
        "target": [
            "|   | **Number of Warrants ** | **Weighted Average Exercise Price ** |",
            "| --- | --- | --- |",
            "| **Issued ** | 5,000,000  | $ 0.50  |",
            "| **Outstanding, April 30, 2023 ** | 5,000,000  | $ 0.50  |"
        ]
    },
    "form10-qa_fileoutpart6": {
        "predict": "|   | **Nine months Ended September 30, 2021 ** | **For the Period from August 21, 2020 (Inception) Through September 30, 2020 ** |\n| --- | --- | --- |\n| **Net loss ** | $1,111,710 |   |\n| **Interest earned on investments held in Trust Account ** |   |   |\n| **Net cash used in operating activities ** | $140,538 |   |\n| **Cash \u2013 End of period ** | $164,000 |   |",
        "target": [
            "|   | **Nine months Ended September 30, 2021 ** | **For the Period from August 21, 2020 (Inception) Through September 30, 2020 ** |",
            "| --- | --- | --- |",
            "| **Net loss ** | $ (1,601,809)  | $ (1,000)  |",
            "| **Interest earned on investments held in Trust Account ** | (5,627)  | - |",
            "| **Net cash used in operating activities ** | (893,655)  | - |",
            "| **Cash \u2013 End of period ** | $ 8,413  | - |"
        ]
    },
    "kss-20221029_fileoutpart23": {
        "predict": "| **(Dollars in Millions) ** |   |   |<NEWLINE>| --- | --- | --- |<NEWLINE>| **SG&A ** | $1,300 million | $46 million decrease |<NEWLINE>| **As a percent of total revenue ** | 3.3% | 120 basis points decrease |<NEWLINE>",
        "target": [
            "| **(Dollars in Millions) ** |   |   |",
            "|   | **Change ** | **Change ** |",
            "| --- | --- | --- |",
            "| **SG&A ** | $(46)  | $119  |",
            "| **As a percent of total revenue ** | 120 bps  | 306 bps  |"
        ]
    },
    "kss-20221029_fileoutpart26": {
        "predict": "| **(Dollars in Millions) ** | **Three Months Ended ** |   | **Nine Months Ended ** |   |\n|   | **October 29, 2022 ** | **October 30, 2021 ** | **October 29, 2022 ** | **October 30, 2021 ** |\n| --- | --- | --- | --- | --- |\n| **Effective tax rate ** | 18.3% | 24.3% | 21.1% | 23.4% |",
        "target": [
            "| **(Dollars in Millions) ** | **Three Months Ended ** |   | **Nine Months Ended ** |   |",
            "|   | **October 29, 2022 ** | **October 30, 2021 ** | **October 29, 2022 ** | **October 30, 2021 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Effective tax rate ** | 18.3%  | 24.3%  | 21.1%  | 23.4%  |"
        ]
    },
    "kss-20221029_fileoutpart29": {
        "predict": "|   | **Nine Months Ended ** |   |<NEWLINE>| **(Dollars in Millions) ** | **October 29, 2022 ** | **October 30, 2021 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Operating activities ** |  |  |<NEWLINE>| Net sales | $135 | $132 |<NEWLINE>| SG&A expenses | $3.9 billion | $3.8 billion |<NEWLINE>| Gross margin | 38.4% | 40.5% |<NEWLINE>| Comparable sales | -6.9% | -0.8% |<NEWLINE>| **Investing activities ** |  |  |<NEWLINE>| Investing activities | -$702 | -$391 |<NEWLINE>| Capital expenditures | $1.1 billion | $848 million |<NEWLINE>| Gift card breakage income | $135 | $132 |<NEWLINE>| **Financing activities ** |  |  |<NEWLINE>| Borrowings under revolving credit facility | $668 million | $1.2 billion |<NEWLINE>| Common stock repurchases | $658 million | $807 million |<NEWLINE>| Senior unsecured debt tender offer | $1.0 billion | - |<NEWLINE>| ASR program | $500 million | - |<NEWLINE>| Cash dividends | $0.50 per share | $0.50 per share |<NEWLINE>",
        "target": [
            "|   | **Nine Months Ended ** |   |",
            "| **(Dollars in Millions) ** | **October 29, 2022 ** | **October 30, 2021 ** |",
            "| --- | --- | --- |",
            "| **Operating activities ** | $(425)  | - |",
            "| **Investing activities ** | (702)  | (391)  |",
            "| **Financing activities ** | (266)  | - |"
        ]
    },
    "kss-20221029_fileoutpart4": {
        "predict": "|   | **Nine Months Ended ** |   |\n| **(Dollars in Millions) ** | **October 29, 2022 ** | **October 30, 2021 ** |\n| --- | --- | --- |\n| **Loss on extinguishment of debt ** | $201 | - |\n| **Net cash (used in) provided by operating activities ** | $1,171 | $1,123 |\n| **Net cash used in investing activities ** | $702 | $391 |\n| **Net borrowings under revolving credit facility ** | $668 | - |\n| **Treasury stock purchases ** | $658 | $807 |\n| **Dividends paid ** | $184 | $114 |\n| **Premium paid on redemption of debt ** | $- | $54 |\n| **Net cash used in financing activities ** | $266 | $1,849 |\n| **Cash and cash equivalents at end of period ** | $194 | $1,871 |",
        "target": [
            "|   | **Nine Months Ended ** |   |",
            "| **(Dollars in Millions) ** | **October 29, 2022 ** | **October 30, 2021 ** |",
            "| --- | --- | --- |",
            "| **Loss on extinguishment of debt ** | - | 201  |",
            "| **Net cash (used in) provided by operating activities ** | (425)  | - |",
            "| **Net cash used in investing activities ** | (702)  | (391)  |",
            "| **Net borrowings under revolving credit facility ** | 668  | - |",
            "| **Treasury stock purchases ** | (658)  | (807)  |",
            "| **Dividends paid ** | (184)  | (114)  |",
            "| **Premium paid on redemption of debt ** | - | (192)  |",
            "| **Net cash used in financing activities ** | (266)  | - |",
            "| **Cash and cash equivalents at end of period ** | $194  | - |"
        ]
    },
    "kss-20221029_fileoutpart22": {
        "predict": "| **(Dollars in Millions) ** | **Three Months Ended ** |   | **Nine Months Ended ** |   |\n|   | **October 29, 2022 ** | **Change ** | **October 29, 2022 ** | **Change ** |\n| --- | --- | --- | --- | --- |\n| **Gross margin as a percent of net sales ** |   | 37.3% |   | 38.4% | -215 basis points |",
        "target": [
            "| **(Dollars in Millions) ** | **Three Months Ended ** |   | **Nine Months Ended ** |   |",
            "|   | **October 29, 2022 ** | **Change ** | **October 29, 2022 ** | **Change ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Gross margin as a percent of net sales ** | 37.3%  | (263) bps  | 38.4%  | (215) bps  |"
        ]
    },
    "msgentertainmentcorp10_fileoutpart50": {
        "predict": "|   | **Three Months Ended March 31, ** |   | **Change ** |\n| --- | --- | --- | --- |\n| **Operating loss ** | $145,541 | N/A | N/A |\n| **Share-based compensation ** | N/A | N/A | N/A |\n| **Depreciation and amortization (a) ** | $26,196 | N/A | N/A |\n| **Impairment of intangibles, long-lived assets and goodwill (b) ** | $80,698 | N/A | N/A |\n| **Adjusted operating income (loss) ** | ($7,230) | N/A | N/A |",
        "target": [
            "|   | **Three Months Ended March 31, ** |   | **Change ** |",
            "|   | **2020 ** | **2019 ** | **Amount ** |",
            "| --- | --- | --- | --- |",
            "| **Operating loss ** | $ (145,541)  | - | $ (126,922)  |",
            "| **Share-based compensation ** | 8,836  | 8,726  |   |",
            "| **Depreciation and amortization (a) ** | 26,196  | - |   |",
            "| **Impairment of intangibles, long-lived assets and goodwill (b) ** | 102,211  | - |   |",
            "| **Adjusted operating income (loss) ** | $ (7,230)  | $ 17,944  | - |"
        ]
    },
    "msgentertainmentcorp10_fileoutpart11": {
        "predict": "|   | **Madison Square Garden Sports Corp. Investment ** | **Total Company Divisional Equity ** | **Non -redeemable Noncontrolling Interests ** | **Total Divisional Equity ** | **Redeemable Noncontrolling Interests ** |\n| --- | --- | --- | --- | --- | --- |\n| **Net income (loss) ** | $-102,211 | $-45,176 | $2,997 | $-144,580 | $-3,303 |\n| **Comprehensive income (loss) ** | $(19,863) | $(19,863) |   | $(19,863) |   |\n| **Noncontrolling interest non-cash acquisition ** | $6,333 |   |   |   |   |\n| **Redeemable noncontrolling interest adjustment to redemption fair value ** | $22,997 |   |   |   | $-22,997 |\n| **Balance as of March 31, 2020 ** | $3,208 shares of the common stock of Townsquare Media, Inc | $-102,211 | $60,032 | $-45,176 | $-3,303 | \n| **Revenues** | $1,182,491 |   | $509 | $1,182,999 |   |\n| **Operating income** | $-62,220 | $-52,726 |   | $-115,946 | $-1,909 |\n| **Adjusted operating income** | $-62,220 | $-52,726 |   | $-115,946 | $-1,909 |\n| **Savings Plans and Union Savings Plan expenses** | $4,166 |   |   | $4,166 |   | \n| **Weighted-average fair value per share at grant date of RSUs granted during the nine months ended March 31, 2019** |   |   |   |   |   | \n| **Capitalized share-based compensation expense for the three months ended March 31, 2020** |   |   |   |   |   | \n| **Capitalized share-based compensation expense for the nine months ended March 31, 2020** |   |   |   |   |   |\n| **Lease liability as of March 31, 2020** |   | $1,134,987 |   | $1,134,987 |   | \n| **Property and equipment as of March 31, 2020** |   | $1,870,234 |   | $1,870,234 |   |\n| **Investments and loans to nonconsolidated affiliates as of March 31, 2020** |   | $10,050 |   | $10,050 |   |\n| **Revenues from Obscura\u2019s third-party production business for the three and nine months ended March 31, 2020** | $1,386 |   |   | $1,386 |   |\n| **Dolan and Sterling2k LLC as of March 31, 2020** | $3,200 |   |   | $3,200 |   |\n| **MSG Networks\u2019 charges from the Company for the three and nine months ended March 31, 2020 and 2019** | $(6,333) |   |   | $(6,333) |   |\n| **Christmas Spectacular performances for the three months ended March 31, 2020 and 2019** | $1,182 |   |   | $1,182 |   |\n| **Venue-related signage and sponsorship revenues for the three and nine months ended March 31, 2020** | $10,050 |   |   | $10,050 |   |\n| **Effects of COVID-19 on the Company\u2019s revenues** | $(3,355) |   |   | $(3,355) |   |\n| **Disposition of the Forum** | $104,781 |   |   | $104,781 | $-104,781 |\n| **Financial covenants for TAOIH as of March 31, 2020** |   |   |   |   |   |\n| **Quantitative impairment test results for Tao Group Hospitality reporting unit as of March 31, 2020** | $37,715 |   |   | $37,715 | $-37,715 |\n| **COVID-19 pandemic impact on the Company\u2019s operating results** | $(19,863) |   |   | $(19,863) |   |\n| **Lease accounting impact on the Company** | $(87,463) |   |   | $(87,463) |   |\n| **Related party arrangements with 605, LLC** | $(32,074) |   |   | $(32,074) |   |\n| **Possible future impacts of COVID-19 on the Company** |   |   |   |   |   |\n| **Temporary suspension of construction for MSG Sphere development** | $(75,000) |   |   | $(75,000) |   |\n| **2018-18 guidance on collaborative arrangements** |   |   |   |   |   |\n| **Changes in the Company\u2019s CODM resulting in two segments after the Entertainment Distribution** |   |   |   |   |   |\n| **Adoption impact of ASU No. 2018-13 on the Company** |   |   |   |   |   | \n| **Nine months ended March 31, 2020 Revenues** | $767,038 |   |   | $767,038 |   |\n| **Nine months ended March 31, 2020 Net Income (Loss)** | $-145,996 |   |   | $-145,996 |   |\n| **Nine months ended March 31, 2020 Loss in Equity Method Investments** | $3,739 |   |   | $3,739 |   |\n| **Intangibles - Goodwill and Other (Topic 350): Simplifying the Accounting for Goodwill Impairment** | $6,399 |   |   | $6,399 |   |\n| **Depreciation and Amortization on Property and Equipment for the three months ended March 31, 2020** | $23,187 |   |   | $23,187 |   |\n| **Depreciation and Amortization on Property and Equipment for the nine months ended March 31, 2020** | $23,617 |   |   | $23,617 |   |\n| **Loss in Equity Method Investments for the nine months ended March 31, 2019** | $1,571 |   |   | $1,571 |   |\n| **Earnings in Equity Method Investments for the nine months ended March 31, 2019** | $20,415 |   |   | $20,415 |   |\n| **Outstanding principal balance of each term loan due upon draws down on one or both DDTL Facilities** |   |   |   |   |   |\n| **Contractual Obligations** |   |   |   |   |   | \n| **Market risk resulting from foreign currency fluctuations** |   |   |   |   |   |\n| **Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes** |   |   |   |   |   |\n| **National Basketball Association (the \u201cNBA\u201d) and the National Hockey League (the \u201cNHL\u201d) have also suspended their 2019-20 seasons** |   |   |   |   |   |\n| **Share repurchase program to repurchase up to $350 million of the Company\u2019s Class A Common Stock** |   |   |   |   |   |\n| **Tao Senior Credit Agreement** | $25,000 revolving credit facility |   |   |   |   |\n| **Reconciliation of the non-GAAP financial measure of Adjusted Operating Income to Operating Income for the nine months ended March 31, 2020** | $(62,220) | $(52,726) |   | $(115,946) | $(1,909) |\n| **Other live sporting events for the nine months ended March 31, 2020** |   |   |   |   |   |\n| **Defined Benefit Plans \u2014 General (Subtopic 715-20): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans** |   |   |   |   |   |\n| **Outbreak of a novel strain of coronavirus, COVID-19** |   |   |   |   |   |\n| **Purchase of land in Stratford, London** |   |   |   |   |   |\n| **Intangibles - Goodwill and Other (Topic 350): Simplifying the Accounting for Goodwill Impairment in the third quarter of fiscal year 2020 in connection with its interim goodwill impairment test performed as of March 31, 2020, as discussed further below** |   |   |   |   |   |\n| **Cancellation of college basketball events as a result of the temporary closure of venues since March 12, 2020 due to COVID-19** |   |   |   |   |   |\n| **Wind down Obscura\u2019s third-party production business to focus on MSG Sphere development** |   |   |   |   |   |\n| **Possible closure of certain venues due to COVID-19** |   |   |   |   |   |\n| **MSG Sphere** |   |   |   |   |   | \n| **Loss of equity method investments for the nine months ended March 31, 2020** | $3,739 |   |   | $3,739 |   |\n| **IRS audit of the federal income tax return for the year ended June 30, 2016** |   |   |   |   |   |\n| **Membership Interest Purchase Agreement (the \u201cMIPA\u201d) with CAPSS LLC** | $400,000 |   |   | $400,000 |   |\n| **Delay in achieving goal of opening the venue in calendar year 2021** |   |   |   |   |   |\n| **Possible impacts of COVID-19 on the Company** |   |   |   |   |   |\n| **Uniform hypothetical 8% fluctuation in the GBP/USD exchange rate** | $23,700 |   |   | $23,700 |   |",
        "target": [
            "|   | **Madison Square Garden Sports Corp. Investment ** | **Total Company Divisional Equity ** | **Non -redeemable Noncontrolling Interests ** | **Total Divisional Equity ** | **Redeemable Noncontrolling Interests ** |",
            "| --- | --- | --- | --- | --- | --- |",
            "| **Net income (loss) ** | - | - | 38  | - | (23,851)  |",
            "| **Comprehensive income (loss) ** | - | - | 38  | - | (23,851)  |",
            "| **Noncontrolling interest non-cash acquisition ** | 37,715  | 37,715  | - | 37,715  | (37,715)  |",
            "| **Redeemable noncontrolling interest adjustment to redemption fair value ** | (16,939)  | (16,939)  | - | (16,939)  | 16,939  |",
            "| **Balance as of March 31, 2020 ** | - | - | - | - | $ 23,000  |"
        ]
    },
    "msgentertainmentcorp10_fileoutpart5": {
        "predict": "|   | **Three Months Ended March 31, ** |   |<NEWLINE>|   | **2020 ** | **2019 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Revenues (a) ** | $767,038 | $832,384 |<NEWLINE>| **Direct operating expenses (b) ** | $\u2014 | $\u2014 |<NEWLINE>| **Selling, general and administrative expenses (c) ** | $257,970 | $231,038 |<NEWLINE>| **Impairment for intangibles, long-lived assets, and goodwill ** | $21,513 | $\u2014 |<NEWLINE>| **Operating income (loss) ** | $(145,996) | $12,491 |<NEWLINE>| **Net income (loss) ** | $(178,903) | $(22,194) |<NEWLINE>| **Less: Net income (loss) attributable to nonredeemable noncontrolling interests ** | $\u2014 | $\u2014 |<NEWLINE>| **Net income (loss) attributable to the Company ** | $(178,903) | $(22,194) |<NEWLINE>| **Basic and diluted earnings (loss) per common share attributable to the Company (f) ** | $(7.64) | $(0.92) |<NEWLINE>| **Depreciation and amortization expense on property and equipment ** | $23,187 | $23,617 |<NEWLINE>| **Amortization expense for intangible assets, excluding the amortization of favorable lease assets ** | $11,031 | $9,451 |<NEWLINE>| **Cash, cash equivalents and restricted cash ** | $1,021,848 | $1,092,065 |<NEWLINE>| **Identifiable indefinite-lived intangible assets ** | $28,000 | $\u2014 |<NEWLINE>| **Notes payable due to noncontrolling interest holder ** | $637 | $\u2014 |<NEWLINE>",
        "target": [
            "|   | **Three Months Ended March 31, ** |   |",
            "|   | **2020 ** | **2019 ** |",
            "| --- | --- | --- |",
            "| **Revenues (a) ** | $ 199,861  | $ 250,018  |",
            "| **Direct operating expenses (b) ** | - | 158,710  |",
            "| **Selling, general and administrative expenses (c) ** | 84,186  | - |",
            "| **Impairment for intangibles, long-lived assets, and goodwill ** | 102,211  | \u2014  |",
            "| **Operating income (loss) ** | (145,541)  | (18,619)  |",
            "| **Net income (loss) ** | (150,838)  | (12,616)  |",
            "| **Less: Net income (loss) attributable to nonredeemable noncontrolling interests ** | 195  | - |",
            "| **Net income (loss) attributable to the Company ** | $ (128,586)  | - |",
            "| **Basic and diluted earnings (loss) per common share attributable to the Company (f) ** | $ (5.36)  | - |"
        ]
    },
    "msgentertainmentcorp10_fileoutpart14": {
        "predict": "| --- | --- |\n| **Property and equipment, net of accumulated depreciation and amortization ** | - |\n| **Indefinite-lived intangible assets ** | - |\n| **Goodwill ** | $102,211 | \n| **Short-term investments** | $331,000 | \n| **Cash and cash equivalents** | $1,004,000 | $1,021,848 | \n| **Event-related revenues** | $767,038 | - |\n| **Net income (loss)** | - | $145,996 | \n| **Revenues** | - | $65,346 decrease to $767,038 | \n| **Depreciation and amortization expense on property and equipment** | $23,187 (Q1 2020) | $23,617 (Q1 2019) | \n| **Loss (earnings) in equity method investments** | ($3,739) | $17,131 (Q1 2019) |",
        "target": [
            "| --- | --- |",
            "| **Property and equipment, net of accumulated depreciation and amortization ** | 104,781  |",
            "| **Indefinite-lived intangible assets ** | 540  |",
            "| **Goodwill ** | 2,864  |"
        ]
    },
    "msgentertainmentcorp10_fileoutpart9": {
        "predict": "|   | **Madison Square Garden Sports Corp. Investment ** | **Total Company Divisional Equity ** | **Non -redeemable Noncontrolling Interests ** | **Total Divisional Equity ** | **Redeemable Noncontrolling Interests ** |\n| --- | --- | --- | --- | --- | --- |\n| **Net income (loss) ** | $-102.211 million | $80.698 million | $0.195 million | $-21.318 million | $0.195 million |\n| **Comprehensive income (loss) ** | $(19,526) | $12,258 | $0.029 million | $(7,269) | $0.029 million |\n| **Noncontrolling interests non-cash acquisition ** |   |   | $37.715 million | $38.063 million |   |\n| **Redeemable noncontrolling interest adjustment to redemption fair value ** |   |   | $(0.046) million | $0.178 million | $(0.046) million |\n| **Balance as of March 31, 2020 ** | $36.142 million | $93.956 million | $38.063 million | $206.019 million | $0.132 million | \n| **Net charges to related parties (3 months ended March 31, 2020)** | $(32,074) |   |   |   |   |\n| **Net charges to related parties (3 months ended March 31, 2019)** | $(30,293) |   |   |   |   |\n| **Net charges to related parties (9 months ended March 31, 2020)** | $(97,832) |   |   |   |   |\n| **Net charges to related parties (9 months ended March 31, 2019)** | $(84,956) |   |   |   |   |\n| **Cash flow activities (9 months ended March 31, 2020)** |   |   |   |   |   |\n| Net cash provided by operating activities | $2,947 |   |   |   |   |\n| Net cash used in investing activities | $(1,336) |   |   |   |   |\n| Net cash used in financing activities | $(77,480) |   |   |   |   |\n| **Revenue (3 months ended March 31, 2020)** | $215.934 million | $215.934 million |   | $215.934 million |   |\n| Large accelerated filer |   | X |   |   |   |\n| Accelerated filer |   |   |   | X |   |\n| Smaller reporting company | X |   |   |   |   |\n| Emerging growth company | X |   |   |   |   |\n| **Net interest income (3 months ended March 31, 2020)** | $3,054 |   |   |   |   |\n| **Services provided to MSG Networks** | $2,732 |   |   |   |   |\n| **Cash flow activities (9 months ended March 31, 2019)** |   |   |   |   |   |\n| Net cash provided by operating activities | $19,453 |   |   |   |   |\n| Net cash used in investing activities | $(1,013) |   |   |   |   |\n| Net cash used in financing activities | $(21,710) |   |   |   |   |\n| **Cash flow activities (9 months ended March 31, 2020)** |   |   |   |   |   |\n| Net cash provided by operating activities | $63,540 |   |   |   |   |\n| Net cash used in investing activities | $(1,224) |   |   |   |   |\n| Net cash used in financing activities | $(61,313) |   |   |   |   | \n----",
        "target": [
            "|   | **Madison Square Garden Sports Corp. Investment ** | **Total Company Divisional Equity ** | **Non -redeemable Noncontrolling Interests ** | **Total Divisional Equity ** | **Redeemable Noncontrolling Interests ** |",
            "| --- | --- | --- | --- | --- | --- |",
            "| **Net income (loss) ** | - | - | 195  | - | (22,447)  |",
            "| **Comprehensive income (loss) ** | - | - | 195  | - | (22,447)  |",
            "| **Noncontrolling interests non-cash acquisition ** | 37,715  | 37,715  | - | 37,715  | (37,715)  |",
            "| **Redeemable noncontrolling interest adjustment to redemption fair value ** | (16,939)  | (16,939)  | - | (16,939)  | 16,939  |",
            "| **Balance as of March 31, 2020 ** | - | - | - | - | $ 23,000  |"
        ]
    },
    "msgentertainmentcorp10_fileoutpart47": {
        "predict": "|   | **Three Months Ended March 31, ** |   | **Change (a) ** |   |\n|   | **2020 ** | **2019** | **Amount** | **Percentage** |\n| --- | --- | --- | --- | --- |\n| **Revenues ** | $278,982 | $315,278 | ($36,296) | (12%) |\n| **Direct operating expenses ** | $132,809 | $158,710 | ($25,901) | (16%) |\n| **Selling, general and administrative expenses ** | $11,573 | - | - | - |\n| **Depreciation and amortization ** | $26,196 | $26,768 | ($572) | (2%) |\n| **Impairment of intangibles, long-lived assets and goodwill ** | $80,698 | $6,399 | $74,299 | N/A |\n| **Operating income (loss) ** | $6,594 | $25,242 | ($18,648) | (74%) |\n| **Loss in equity method investments ** | $1,096 | - | - | - |\n| **Interest income, net ** | $15,388 | $11,944 | $3,444 | 29% |\n| **Miscellaneous income (expense), net ** | ($17,381) | $4,613 | ($22,994) | N/A |\n| **Income tax benefit (expense) ** | ($22,043) | $469 | ($22,512) | N/A |\n| **Less: Net loss attributable to redeemable noncontrolling interests ** | ($1,812) | ($2,662) | $850 | (32%) |\n| **Less: Net income (loss) attributable to nonredeemable noncontrolling interests ** | $5,001 | - | - | - | \n| **GBP/USD exchange rate** | 1.1491 | 1.3357 | ($0.1866) | (14%) |\n| **Net income** | - | ($2,193) | - | - |\n| **Revenue** | $767,038 | $832,384 | ($65,346) | (8%) |",
        "target": [
            "|   | **Three Months Ended March 31, ** |   | **Change (a) ** |   |",
            "|   | **2020 ** | **2019 ** | **Amount ** | **Percentage ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Revenues ** | 199,861  | - | (50,157)  | (20)%  |",
            "| **Direct operating expenses ** | 132,809  | - | (25,901)  | (16)%  |",
            "| **Selling, general and administrative expenses ** | 84,186  | - | 1,027  | 1%  |",
            "| **Depreciation and amortization ** | 26,196  | - | (572)  | (2)%  |",
            "| **Impairment of intangibles, long-lived assets and goodwill ** | 102,211  | - | 102,211  | - |",
            "| **Operating loss ** | (145,541)  | - | (126,922)  | - |",
            "| **Loss in equity method investments ** | (1,096)  | - | 1,785  | 62 %  |",
            "| **Interest income, net ** | 3,054  | - | (1,686)  | (36)%  |",
            "| **Miscellaneous income (expense), net ** | (17,381)  | 4,613  | - | - |",
            "| **Income tax benefit (expense) ** | 10,126  | (469)  | - | - |",
            "| **Less: Net loss attributable to redeemable noncontrolling interests ** | (22,447)  | (7)  | - | - |",
            "| **Less: Net income (loss) attributable to nonredeemable noncontrolling interests ** | 195  | (680)  | - | - |",
            "| **Revenues ** | $ 767,038  | - | $ (65,346)  | (8)%  |",
            "| **Direct operating expenses ** | 472,582  | - | (34,667)  | (7)%  |",
            "| **Selling, general and administrative expenses ** | 257,970  | - | 26,932  | 12 %  |",
            "| **Depreciation and amortization ** | 80,271  | - | (1,335)  | (2)%  |",
            "| **Impairment of intangibles, long-lived assets and goodwill ** | 102,211  | - | 102,211  | - |",
            "| **Operating income (loss) ** | (145,996)  | 12,491  | - | - |",
            "| **Earnings (loss) in equity method investments ** | (3,739)  | 17,131  | - | - |",
            "| **Interest income, net ** | 15,388  | - | 3,444  | 29 %  |",
            "| **Miscellaneous expense, net ** | (2,893)  | - | 1,225  | 30 %  |",
            "| **Income tax benefit (expense) ** | 8,686  | (1,253)  | - | - |",
            "| **Less: Net loss attributable to redeemable noncontrolling interests ** | (23,851)  | (3,662)  | - | - |",
            "| **Less: Net income (loss) attributable to nonredeemable noncontrolling interests ** | 38  | (3,121)  | - | - |"
        ]
    },
    "msgentertainmentcorp10_fileoutpart51": {
        "predict": "|   | **Nine Months Ended March 31, ** |   | **Change ** |   |<NEWLINE>|   | **2020 ** | **2019 ** | **Amount ** | **Percentage ** |<NEWLINE>| --- | --- | --- | --- | --- |<NEWLINE>| **Operating income (loss) ** | $(294,399) | $174,649 | $(469,048) | (269)% |<NEWLINE>| **Share-based compensation ** | $29,294 | $27,929 | $1,365 | 5% |<NEWLINE>| **Depreciation and amortization (a) ** | $87,736 | $75,917 | $11,819 | 16% |<NEWLINE>| **Impairment of intangibles, long-lived assets and goodwill (b) ** | $95,613 | $17,809 | $77,804 | 437% |<NEWLINE>| **Adjusted operating income ** | $(81,756) | $296,304 | $(378,060) | (128)% |<NEWLINE>",
        "target": [
            "|   | **Nine Months Ended March 31, ** |   | **Change ** |   |",
            "|   | **2020 ** | **2019 ** | **Amount ** | **Percentage ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Operating income (loss) ** | $ (145,996)  | $ 12,491  | - | - |",
            "| **Share-based compensation ** | 29,294  | 27,929  |   |   |",
            "| **Depreciation and amortization (a) ** | 80,271  | - |   |   |",
            "| **Impairment of intangibles, long-lived assets and goodwill (b) ** | 102,211  | - |   |   |",
            "| **Adjusted operating income ** | $ 70,244  | - | $ (55,499)  | (44)%  |"
        ]
    },
    "rivn-20210930_fileoutpart19": {
        "predict": "|   | **2021 ** | **2021 ** |<NEWLINE>| **Revenues ** | $1 million | N/A |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Cost of revenues ** | $83 million | N/A |<NEWLINE>| **Gross profit ** | $(82) million | N/A |<NEWLINE>| **Interest expense ** | $7 million | N/A |<NEWLINE>| Net proceeds | $13.5 billion | N/A |<NEWLINE>| ABL Facility | $750 million | May 20, 2025 |<NEWLINE>| SG&A expenses | $403 million | N/A |<NEWLINE>| California Privacy Rights Act | N/A | January 1, 2023 |<NEWLINE>| Convertible Notes | July 23, 2026 | $25 million original issue discount |<NEWLINE>| Fair value hierarchy | Level 3 | N/A |<NEWLINE>| Financing activities | $5.1 billion | N/A |<NEWLINE>| Common stock | 101,518,666 shares | No shares issued in 2020 |<NEWLINE>| COVID-19 impact | N/A | Adverse impact possible |<NEWLINE>| Risks and uncertainties | N/A | Described in Part II, Item 1A |<NEWLINE>| RSUs | $322 million | Performance condition not satisfied |<NEWLINE>| Securities Act | N/A | Federal and state court jurisdiction |<NEWLINE>| Vehicle production | September 2021 | N/A |<NEWLINE>| Safe harbor provisions | N/A | Sections 27A and 21E |<NEWLINE>| Standard Contractual Clauses | N/A | 18 month implementation period |<NEWLINE>| Term Facility Agreement | $79 million drawn as of December 31, 2020 | N/A |<NEWLINE>| Remote work | N/A | Significant percentage of personnel working remotely |<NEWLINE>| Lock-up agreements | N/A | Investors cannot waive compliance with federal securities laws |<NEWLINE>| Workforce impact | N/A | Adverse impact possible |<NEWLINE>| Convertible Notes conversion | $66.30 per share or IPO price | N/A |<NEWLINE>| Internal control over financial reporting | N/A | Time consuming and costly |<NEWLINE>| Registration Statement | N/A | Declared effective on November 9, 2021 |<NEWLINE>| Preorders | $1,000 cancellable and fully refundable deposit | N/A |<NEWLINE>| Evaluation of disclosure controls and procedures | N/A | Conducted by management and executives |<NEWLINE>| Fair value hierarchy transfers | N/A | No transfers in 2021 |<NEWLINE>| Shares reserved for issuance | 22,197,528 | 1% annual increase on the first day of each year beginning on January 1, 2022 and ending on January 1, 2031 |<NEWLINE>",
        "target": [
            "|   | **2021 ** | **2021 ** |",
            "| **Revenues ** | $ 1  | $ 1  |",
            "| --- | --- | --- |",
            "| **Cost of revenues ** | 83  | 83  |",
            "| **Gross profit ** | (82)  | (82)  |",
            "| **Interest expense ** | (1)  | (7)  |"
        ]
    },
    "rivn-20210930_fileoutpart23": {
        "predict": "| **Three months ended September 30, Nine months ended September 30, 2020 2021 $ Change % Change 2020 2021 $ Change % Change (in millions) (unaudited) (in millions) (unaudited) ** |   |   |   |   |\n| --- | --- | --- | --- | --- |\n| **Selling, general, and administrative ** | $1 million | $7 million | +$6 million | +600% | $3 million | $17 million | +$14 million | +466.7% |",
        "target": [
            "| **Three months ended September 30, Nine months ended September 30, 2020 2021 $ Change % Change 2020 2021 $ Change % Change (in millions) (unaudited) (in millions) (unaudited) ** |   |   |   |   |",
            "| --- | --- | --- | --- | --- |",
            "| **Selling, general, and administrative ** | $ 185  | 272 %  | $ 403  | 257 %  |"
        ]
    },
    "rivn-20210930_fileoutpart4": {
        "predict": "|   | **2021 Q3** | **2023 Q4** |<NEWLINE>| **Revenues ** | $1 million | - |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Cost of revenues ** | $83 million | - |<NEWLINE>| **Gross profit ** | $(82) million | - |<NEWLINE>| **Interest expense ** | $7 million | - |<NEWLINE>| **Net income** | - | - |<NEWLINE>| **Cash used in investing activities** | $1.3 billion | - |<NEWLINE>| **Issuance of senior secured floating rate notes due 2026** | $1,250 million | - | <NEWLINE> | **Unrecognized compensation cost related to stock-based compensation arrangements** | $1,389 million | - | <NEWLINE> | **Fair value of the 2021 Convertible Notes recorded** | $2,958 million | - | <NEWLINE> | **Depreciation and amortization expense** | $17 million | $84 million | <NEWLINE>",
        "target": [
            "|   | **2021 ** | **2021 ** |",
            "| **Revenues ** | $ 1  | $ 1  |",
            "| --- | --- | --- |",
            "| **Cost of revenues ** | 83  | 83  |",
            "| **Gross profit ** | (82)  | (82)  |",
            "| **Interest expense ** | - | (7)  |"
        ]
    },
    "rivn-20210930_fileoutpart10": {
        "predict": "|   | **2021 Convertible Notes ** |\n| --- | --- |\n| **Loss on issuance ** | $643 million |\n| **Issue-date estimated fair value ** | $3,049 million |\n| **Gain on change in fair value ** | $91 million |\n| **Fair value as of September 30, 2021 ** | $66.30 per share |<NEWLINE>",
        "target": [
            "|   | **2021 Convertible Notes ** |",
            "| --- | --- |",
            "| **Loss on issuance ** | 549  |",
            "| **Issue-date estimated fair value ** | 3,049  |",
            "| **Gain on change in fair value ** | (91)  |",
            "| **Fair value as of September 30, 2021 ** | $ 2,958  |"
        ]
    },
    "tgt-20211030_fileoutpart23": {
        "predict": "| **RedCard Penetration ** |   | **Nine Months Ended ** |<NEWLINE>|   | **October 31, 2020 ** | **October 30, 2021 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Total RedCard Penetration ** |   | 24.7% |",
        "target": [
            "| **RedCard Penetration ** |   | **Nine Months Ended ** |",
            "|   | **October 31, 2020 ** | **October 30, 2021 ** |",
            "| --- | --- | --- |",
            "| **Total RedCard Penetration ** | 21.5 %  | 20.5 %  |"
        ]
    },
    "tgt-20211030_fileoutpart17": {
        "predict": "| **Rate Analysis ** | **Three Months Ended ** |   | **Nine Months Ended ** |   |\n|   | **October 30, 2021 ** | **October 31, 2020 ** | **October 30, 2021 ** | **October 31, 2020 ** |\n| --- | --- | --- | --- | --- |\n| **Gross margin rate ** | 28.0 percent | 30.6 percent |   |   |\n| **SG&A expense rate ** | 18.9 percent | 20.5 percent | 19.0 percent | 20.2 percent |",
        "target": [
            "| **Rate Analysis ** | **Three Months Ended ** |   | **Nine Months Ended ** |   |",
            "|   | **October 30, 2021 ** | **October 31, 2020 ** | **October 30, 2021 ** | **October 31, 2020 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Gross margin rate ** | 28.0 %  | 30.6 %  | 29.5 %  | 29.1 %  |",
            "| **SG&A expense rate ** | 18.9  | 20.5  | 19.0  | 20.2  |"
        ]
    },
    "tdy-20210704_fileoutpart40": {
        "predict": "| **(dollars in millions) ** | **Second Quarter ** | **Six Months ** |\n| --- | --- | --- |\n| **Selling, general and administrative expenses ** | $88.3 | $157.5 | \n| **Cost of sales as a % of net sales ** | 65.6% | 82.8% | \n| **Selling, general and administrative expenses as a % of net sales ** | 6.1% | 28.6% | \n| **Operating income** | $223.1 | $394.4 | \n| **Net income** | $69.9 | $172.9 | \n| **Net income per diluted share** | $1.77 | $4.37 | \n| **Total debt** | $4,742.0 | $778.5 | \n| **Operating lease expense** | $7.9 | $14.3 | \n| **Goodwill** | $7,515.9 | $2,150.0 | \n| **Net sales** | $1,102.0 | $2,167.9 | \n| **Operating income for second quarter** | $70.5 | $70.5 | \n| **Operating income for six months** | $123.5 | $123.5 | \n| **Acquisition-related costs** | $70.2 | $70.2 | \n| **Acquired intangible asset amortization expense** | $22.8 | $42.6 | \n| **Inventory step-up expense** | $23.4 | $23.4 | \n| **Net cash used by investing activities** | $3,761.8 | $65.7 | \n| **Effective tax rate for first six months** | 23.9% | 22.8% |",
        "target": [
            "| **(dollars in millions) ** | **Second Quarter ** |   | **Six Months ** |   |",
            "|   | **2021 ** | **2020 ** | **2021 ** | **2020 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Selling, general and administrative expenses ** | $ 5.9  | $ 7.8  | $ 12.5  | $ 14.4  |",
            "| **Cost of sales as a % of net sales ** | 82.8 %  | 81.3 %  | 81.1 %  | 81.3 %  |",
            "| **Selling, general and administrative expenses as a % of net sales ** | 6.0 %  | 7.8 %  | 6.1 %  | 7.4 %  |"
        ]
    },
    "tdy-20210704_fileoutpart27": {
        "predict": "|   | **Second Quarter ** |   | **Six Months ** |   |<NEWLINE>|   | **2021 ** | **2020 ** | **2021 ** | **2020 ** |<NEWLINE>| --- | --- | --- | --- | --- |<NEWLINE>| **Service cost \u2014 benefits earned during the period (in millions) ** | $2.7 million | $2.6 million | $5.4 million | $5.2 million |<NEWLINE>| **Pension non-service income ** | $- | $- | $- | $- |<NEWLINE>| **Interest expense, net of interest income (in millions)** | $56.9 million | $7.8 million | $82.8 million | $14.8 million |<NEWLINE>| **Selling, general and administrative expenses (in millions)** | $301.1 million | $153.8 million | $550.4 million | $305.6 million |<NEWLINE>| **Stock option compensation expense (in millions)** | $3.6 million | $5.7 million | $6.7 million | $10.4 million |<NEWLINE>| **Cost of sales as a percentage of net sales** | 52.7% | 56.1% | 51.3% | 54.5% |<NEWLINE>| **Inventories at cost (in millions)** | $843.1 million | $324.8 million | - | - |<NEWLINE>| **Deferred tax assets (in millions)** | $209.7 million | $142.2 million | - | - |<NEWLINE>| **Non-service retirement benefit income (in millions)** | $2.8 million | $3.2 million | $5.5 million | $6.3 million |<NEWLINE>| **Net discrete tax benefits (in millions)** | $12.6 million | $9.8 million | $22.8 million | $14.5 million |<NEWLINE>| **Operating income (in millions)** | $259.8 million | $195.2 million | $489.2 million | $342.8 million |<NEWLINE>| **Net income attributable to Teledyne (in millions)** | $168.8 million | $123.1 million | $318.2 million | $225.8 million |<NEWLINE>| **Earnings per common share attributable to Teledyne** | $4.38 | $3.22 | $8.27 | $5.91 |<NEWLINE>| **Weighted average diluted common shares outstanding (in millions)** | 38.5 | 38.2 | 38.4 | 38.2 |<NEWLINE>",
        "target": [
            "|   | **Second Quarter ** |   | **Six Months ** |   |",
            "|   | **2021 ** | **2020 ** | **2021 ** | **2020 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Service cost \u2014 benefits earned during the period (in millions) ** | $ 2.7  | $ 2.6  | $ 5.4  | $ 5.2  |",
            "| **Pension non-service income ** | - | $ (3.2)  | - | - |"
        ]
    },
    "tdy-20210704_fileoutpart6": {
        "predict": "|   | **Six Months ** |   |\n|   | **2021 ** | **2020 ** |\n| --- | --- | --- |\n| **Net cash provided by operating activities ** | $336.2 million | $232.2 million |\n| **Purchases of property, plant and equipment ** | $47.6 million | $37.8 million |\n| **Net cash used in investing activities ** | $3,761.8 million | $65.7 million |\n| **Proceeds from exercise of stock options ** | $0.6 million | $0.2 million |\n| **Net cash provided by financing activities ** | $1,957.4 million | $30.4 million | \n| **Net income per diluted share** | $3.66 | $4.65 | \n| **Interest expense, net of interest income** | $56.9 million | - |",
        "target": [
            "|   | **Six Months ** |   |",
            "|   | **2021 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Net cash provided by operating activities ** | 336.2  | 232.2  |",
            "| **Purchases of property, plant and equipment ** | (38.4)  | (36.8)  |",
            "| **Net cash used in investing activities ** | (3,761.8)  | (65.7)  |",
            "| **Proceeds from exercise of stock options ** | 15.9  | 28.2  |",
            "| **Net cash provided by financing activities ** | 3,451.4  | 27.8  |"
        ]
    },
    "tdy-20210704_fileoutpart35": {
        "predict": "| **(dollars in millions)** | **Second Quarter** | **Six Months** | **% Change** | **% Change** |\n| --- | --- | --- | --- | --- |\n| **Digital Imaging (b)** | $661.7 | $1,221.4 | 74.8% | 68.4% |\n| **Instrumentation** | $267.1 | $499.5 | 7.8% | 9.3% |\n| **Aerospace and Defense Electronics** | $241.5 | $443.6 | 19.1% | 15.0% |\n| **Engineered Systems** | $70.3 | $128.6 | 40.7% | 28.4% |\n| **Total net sales** | $1,240.6 | $2,293.1 | 41.1% | 37.4% |\n| **Digital Imaging (b)** | $142.9 | $255.3 | 69.4% | 79.5% |\n| **Instrumentation** | $52.6 | $101.1 | 10.3% | 4.1% |\n| **Aerospace and Defense Electronics** | $44.7 | $77.8 | 36.2% | 25.4% |\n| **Engineered Systems** | $12.5 | $21.1 | 43.7% | 26.4% |\n| **Corporate expense (c)** | ($58.2) | ($107.4) | (26.0%) | (10.6%) |\n| **Total operating income** | $194.5 | $348.0 | 52.9% | 56.9% |\n| **Net sales by segment** | - | - | <NEWLINE> | - | - | <NEWLINE> | Digital Imaging (b) | $661.7 | $1,221.4 | - | - |\n| - | - | <NEWLINE> | Instrumentation | $267.1 | $499.5 | - | - |\n| - | - | <NEWLINE> | Aerospace and Defense Electronics | $241.5 | $443.6 | - | - |\n| - | - | <NEWLINE> | Engineered Systems | $70.3 | $128.6 | - | - |\n| - | - | <NEWLINE> | **Total net sales** | $1,240.6 | $2,293.1 | - | - |\n| **Operating income by segment** | - | - | <NEWLINE> | - | - | <NEWLINE> | Digital Imaging (b) | $142.9 | $255.3 | - | - |\n| - | - | <NEWLINE> | Instrumentation | $52.6 | $101.1 | - | - |\n| - | - | <NEWLINE> | Aerospace and Defense Electronics | $44.7 | $77.8 | - | - |\n| - | - | <NEWLINE> | Engineered Systems | $12.5 | $21.1 | - | - |\n| - | - | <NEWLINE> | **Total operating income** | $194.5 | $348.0 | - | - |\n| **Other financial data** | - | - | <NEWLINE> | - | - | <NEWLINE> | Cost of sales as a percentage of net sales | 82.8% | - | - | - |\n| - | - | <NEWLINE> | Net income | - | $50.1245 million | - | - |\n| - | - | <NEWLINE> | Revenue | - | $1.2345 billion | - | - |\n| - | - | <NEWLINE> | Corporate expense | - | $84.2 million | - | - |\n| - | - | <NEWLINE> | Acquired intangible asset amortization | $32.8 million | $42.6 million | - | - |\n| - | - | <NEWLINE> | Capital expenditures | $38.4 million | $36.8 million | - | - |\n| - | - | <NEWLINE> | Foreign currency forward contracts | - | - | - | Maturities ranging from September 2021 to December 2022 |\n| - | - | <NEWLINE> | Inventory balance | - | - | - | Increase in 2021 reflects inventory acquired in connection with the FLIR acquisition |\n| - | - | <NEWLINE> | Other income and expense | Income of $6.1 million for the second quarter of 2021, compared with expense of $1.4 million | - | - | - |\n| - | - | <NEWLINE> | Pretax charges | $177.2 million for the first six months of 2021 related to the acquisition of FLIR | - | - | - |\n| - | - | <NEWLINE> | Cash equivalents | $160.1 million at July 4, 2021 and $471.0 million at January 3, 2021 | - | - | - |\n| - | - | <NEWLINE> | Interest rate swap | - | - | - | Notional amount of $125.0 million and matures in March 2023 |\n| - | - | <NEWLINE> | Proceeds from the exercise of stock options | $15.9 million for the first six months of 2021 compared with $28.2 million for the first six months of 2020 | - | - | - |\n| - | - | <NEWLINE> | Cash provided by financing activities | $3,451.4 million for the first six months of 2021, compared with cash provided by financing activities of $27.8 million | - | - | - |\n| - | - | <NEWLINE> | Effective tax rates | 25.3% for the second quarter of 2021 and 23.9% for the first six months of 2021 (excluding discrete tax items) | - | - | - | \n| **Consolidated Leverage Ratio** | - | - | <NEWLINE> | - | - | <NEWLINE> | Net Debt/EBITDA | 3.95x | - | - | $1.150 billion credit agreement |\n| **SECURITIES** | - | - | <NEWLINE> | - | - | <NEWLINE> | Securities registered pursuant to Section 12(b) of the Act | - | - | - | - |\n| **Forward Contracts** | - | - | <NEWLINE> | - | - | <NEWLINE> | Foreign currency forward contracts | \u20ac113.0 million and $125.0 million, and \u20ac135.0 million and $150.0 million | - | - | - | Maturities ranging from September 2021 to December 2022 |\n| - | - | <NEWLINE> | Interest rate swap | - | - | - | Notional amount of $125.0 million and matures in March 2023 |\n| **Form 10-Q** | - | - | <NEWLINE> | - | - | <NEWLINE> | Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | - | - | - | - |\n| **Risk Factors** | - | - | <NEWLINE> | - | - | <NEWLINE> | Risk factors | - | - | - | Previously disclosed in our 2020 Form 10-K |\n| **Shell Company** | - | - | <NEWLINE> | - | - | <NEWLINE> | Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) | - | - | - | - |",
        "target": [
            "| **(dollars in millions) ** | **Second Quarter ** |   | **% Change ** | **Six Months ** |   | **% Change** |",
            "|   | **2021 ** | **2020 ** |   | **2021 ** | **2020 ** |   |",
            "| --- | --- | --- | --- | --- | --- | --- |",
            "| **Digital Imaging (b) ** | - | - | 143.9 %  | - | - | 74.0 %  |",
            "| **Instrumentation ** | - | - | 10.6 %  | - | - | 5.4 %  |",
            "| **Aerospace and Defense Electronics ** | - | - | 6.5 %  | - | - | 1.4 %  |",
            "| **Engineered Systems ** | - | - | (1.5)%  | - | - | 3.4 %  |",
            "| **Total net sales ** | - | - | 50.8 %  | - | - | 26.1 %  |",
            "| **Digital Imaging (b) ** | - | - | 80.8 %  | - | - | 50.8 %  |",
            "| **Instrumentation ** | - | - | 33.2 %  | - | - | 24.9 %  |",
            "| **Aerospace and Defense Electronics ** | - | - | 62.3 %  | - | - | 83.5 %  |",
            "| **Engineered Systems ** | - | 10.8  | 1.9 %  | - | - | 16.7 %  |",
            "| **Corporate expense (c) ** | (84.2)  | (13.8)  | - | (103.6)  | (29.2)  | - |",
            "| **Total operating income ** | - | - | (4.9)%  | - | - | 12.1 %  |"
        ]
    },
    "tdy-20210704_fileoutpart39": {
        "predict": "| **(dollars in millions) ** | **Second Quarter ** |   | **Six Months ** |   |\n|   | **2021 ** | **2020 ** | **2021 ** | **2019 ** |\n| --- | --- | --- | --- | --- |\n| **Selling, general and administrative expenses ** | $140.7 | $N/A | $88.3 | $N/A |\n| **Acquired intangible asset amortization ** | $10.0 | $N/A | $22.8 | $N/A |\n| **Operating income ** | $219.6 | $N/A | $358.4 | $N/A |\n| **Cost of sales as a % of net sales ** | 57.3% | 58.1% | 60.0 | $N/A |\n| **Selling, general and administrative expenses as a % of net sales ** | 28.6% | 22.0% | 23.3 | $N/A | \n| **Interest expense, net of interest income ** | $56.9 | $7.8 | $91.3 | $24.6 | \n| **Non-service retirement benefit income ** | $2.8 | $3.2 | $5.4 | $6.5 |\n| **Net discrete tax items** | $(5.1) | $9.8 | $(8.7) | $14.5 |\n| **Inventories at cost** | $843.1 | $N/A | $843.1 | $N/A |\n| **Acquisition-related transaction and purchase accounting expenses** | $70.5 | $N/A | $76.4 | $N/A |\n| **Acquired inventory step-up expense** | $N/A | $N/A | $23.4 | $N/A |\n| **Acquisition-related debt extinguishment fees** | $N/A | $N/A | $30.6 | $N/A |\n| **Acquired intangible assets and weighted average useful life in years** | $N/A | $N/A | $N/A | $N/A |\n| **Restricted stock activity** | $N/A | $N/A | $N/A | $N/A |\n| **Forward contracts designated as fair value hedges** | $N/A | $N/A | $N/A | $N/A |\n| **Remaining performance obligations** | $N/A | $N/A | $2,979.4 | $N/A |\n| **Stock option compensation expense** | $3.6 | $5.7 | $6.2 | $10.3 | \n| **Capital expenditures** | $38.4 | $49.3 | $74.0 | $90.5 | \n| **Reserves for environmental remediation obligations** | $6.5 | $N/A | $6.5 | $N/A | \n| **Expense related to facility consolidation** | $24.2 | $7.7 | $25.1 | $11.4 |",
        "target": [
            "| **(dollars in millions) ** | **Second Quarter ** |   | **Six Months ** |   |",
            "|   | **2021 ** | **2020 ** | **2021 ** | **2019 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Selling, general and administrative expenses ** | $ 23.9  | $ 29.0  | $ 47.0  | $ 60.9  |",
            "| **Acquired intangible asset amortization ** | $ 0.2  | $ 0.2  | $ 0.4  | $ 0.4  |",
            "| **Operating income ** | - | - | $ 56.7  | $ 30.9  |",
            "| **Cost of sales as a % of net sales ** | 65.6 %  | 67.4 %  | 65.7 %  | 69.2 %  |",
            "| **Selling, general and administrative expenses as a % of net sales ** | 15.7 %  | 20.3 %  | 15.5 %  | 20.4 %  |"
        ]
    },
    "tdy-20210704_fileoutpart38": {
        "predict": "| **(dollars in millions) ** | **Second Quarter ** |   | **Six Months ** |   |\n|   | **2021 ** | **2020 ** | **2021 ** | **2020 ** |\n| --- | --- | --- | --- | --- |\n| **Acquired intangible asset amortization ** | $32.8 million | $9.7 million | $42.6 million | $19.3 million |\n| **Cost of sales as a % of net sales ** | 52.7% | 56.1% | 51.5% | 57.2% |\n| **Selling, general and administrative expenses as a % of net sales ** | 24.0% | 21.3% | 23.2% | 24.4% | \n| **Operating income ** | $186.5 million | $103.0 million | $343.1 million | $274.4 million |\n| **Net income ** | $95.6 million | $138.1 million | $190.2 million | $249.6 million |\n| **Net income per diluted share ** | $2.31 | $3.29 | $4.57 | $6.05 |\n| **Net sales ** | $834.2 million | $708.6 million | $1,550.4 million | $1,399.5 million | \n| **Interest expense, net of interest income** | $56.9 million | - | $56.9 million | - |\n| **Acquisition-related transaction and purchase accounting expenses related to the FLIR acquisition** | $70.5 million | - | $76.4 million | - |\n| **Pretax expenses of FLIR acquisition** | $177.2 million | - | $177.2 million | - |\n| **Stock option compensation expense** | $3.6 million | $5.7 million | - | - |\n| **Forward contracts designated as fair value hedges** | - | - | - | - |\n| **Remaining performance obligations** | $2,979.4 million | - | - | - |\n| **Reserves for environmental remediation obligations** | - | - | $6.5 million | - |\n| **Facility consolidation expense** | $24.2 million | $7.7 million | $25.1 million | $11.4 million |\n| **Letter of credit to the Swedish Tax Authority** | - | - | $260.0 million | - |\n| **Net discrete income tax amounts** | $6.2 million | $11.5 million | $12.3 million | $14.5 million |",
        "target": [
            "| **(dollars in millions) ** | **Second Quarter ** |   | **Six Months ** |   |",
            "|   | **2021 ** | **2020 ** | **2021 ** | **2020 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Acquired intangible asset amortization ** | $ 5.2  | $ 5.1  | - | - |",
            "| **Cost of sales as a % of net sales ** | 52.7 %  | 56.1 %  | 53.5 %  | 55.7 %  |",
            "| **Selling, general and administrative expenses as a % of net sales ** | 23.3 %  | 23.6 %  | 23.2 %  | 24.4 %  |"
        ]
    },
    "f10q0321_victoryoil_fileoutpart11": {
        "predict": "|   | **Three Months Ended March 31, ** |   |<NEWLINE> |   | **2021 ** | **2020 ** |<NEWLINE> | --- | --- | --- |<NEWLINE> | **Net cash used in operating activities ** | $-1,582,986 | $-2,222,737 |<NEWLINE> | **Net cash used in investing activities ** | $-32,998 | $-19,622 |<NEWLINE> | **Net cash provided by financing activities ** | $4,130,245 | $1,438,071 |<NEWLINE> | **Depreciation expense ** | $33,561 | $32,937 |<NEWLINE> | **Net loss adjusted for non-cash items ** | $94,681 | $6,797 |<NEWLINE> | **Total revenue ** | - | Decreased |<NEWLINE> | **Net income ** | - | - |<NEWLINE> | **Interest expense ** | - | Decreased |<NEWLINE> | **Remaining performance obligations ** | Not disclosed | Not disclosed |<NEWLINE> | **Impact of ASU 2020-04 on operating results, financial position and disclosures ** | Currently evaluating | - |<NEWLINE> | **Loan amount ** | $4,000,000 | - |<NEWLINE> | **Bad debt losses ** | None | None |<NEWLINE> | **PPP loan proceeds ** | $168,800 | $168,800 |<NEWLINE> | **Shares of common stock issued ** | 0 | 0 |<NEWLINE> | **Amortization of intangible assets ** | $4,313 | $4,313 |<NEWLINE> | **Allowance ** | $0 | $13,056 |<NEWLINE> | **Goodwill balances ** | $145,149 | $145,149 |<NEWLINE>",
        "target": [
            "|   | **Three Months Ended March 31, ** |   |",
            "|   | **2021 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Net cash used in operating activities ** | $ (152,243)  | $ (2,162)  |",
            "| **Net cash used in investing activities ** | (32,998)  | (6,797)  |",
            "| **Net cash provided by financing activities ** | - | 207,869  |"
        ]
    },
    "f10q0321_victoryoil_fileoutpart9": {
        "predict": "|   | **Three months ended March 31, ** |   |<NEWLINE>|   | **2021 ** | **2020 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net loss ** | $(144,654) | $(273,049) |<NEWLINE>| **Basic weighted average common shares outstanding ** | 28,037,713 | 28,037,713 |<NEWLINE>| **Diluted weighted average common shares outstanding ** | 28,037,713 | 28,037,713 |<NEWLINE>| **Basic ** | $(0.01) | $(0.01) |<NEWLINE>| **Diluted ** | $(0.01) | $(0.01) |<NEWLINE> \n(Note: No updates needed as the financial report segment does not contain any relevant information for this table)",
        "target": [
            "|   | **Three months ended March 31, ** |   |",
            "|   | **2021 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Net loss ** | $ (144,654)  | $ (273,049)  |",
            "| **Basic weighted average common shares outstanding ** | 28,037,713  | 28,037,713  |",
            "| **Diluted weighted average common shares outstanding ** | 28,037,713  | 28,037,713  |",
            "| **Basic ** | $ (0.01)  | $ (0.01)  |",
            "| **Diluted ** | $ (0.01)  | $ (0.01)  |"
        ]
    },
    "f10q0622_eaststoneacq_fileoutpart2": {
        "predict": "| **For the Three Months Ended For the Six Months Ended June 30, June 30, 2022 2021 2022 2021 ** | - | - | - | - |\n| --- | --- | --- | --- | --- |\n| **Operating costs ** | $553,983 | $966,456 | $1.1 million | $1.9 million |\n| **Loss from operations ** | $(1.5) million | $(0.9) million | $(2.4) million | $(1.4) million |\n| **Change in fair value of derivative warrant liabilities ** | $1.0 million | $18,900 | $0.6 million | $2.8 million |\n| **Extension incentive paid by Founder Shares transferred ** | - | - | - | Yes |\n| **Change in fair value of Forward Purchase Agreement ** | $0 | $3,723,000 | $0 | $3,723,000 |\n| **Interest earned on investments held in the trust account ** | $38,374 | $3,479 | $38,374 | $3,479 |\n| **Net loss ** | $(1.5) million | $(0.9) million | $(2.4) million | $(1.4) million |\n| **Weighted average shares outstanding of redeemable ordinary shares ** | 3,264,744 | 3,264,744 | 3,264,744 | 3,264,744 |\n| **Basic and diluted net loss per redeemable ordinary share ** | $(0.45) | $(0.27) | $(0.73) | $(0.43) |\n| **Weighted average shares outstanding of non-redeemable ordinary shares ** | 639,756 | 639,756 | 639,756 | 639,756 |\n| **Basic and diluted net loss per non-redeemable ordinary share ** | $(0.29) | $(0.29) | $(0.21) | $(0.21) |",
        "target": [
            "| **For the Three Months Ended For the Six Months Ended June 30, June 30, 2022 2021 2022 2021 ** |   |   |   |   |",
            "| --- | --- | --- | --- | --- |",
            "| **Operating costs ** | $ 553,983  | $ 966,456  | $ 956,470  | $ 1,076,393  |",
            "| **Loss from operations ** | (553,983)  | (966,456)  | (956,470)  | (1,076,393)  |",
            "| **Change in fair value of derivative warrant liabilities ** | (1,019,000)  | 18,900  | (570,000)  | 35,600  |",
            "| **Extension incentive paid by Founder Shares transferred ** | - | - | (1,900,800)  | - |",
            "| **Change in fair value of Forward Purchase Agreement ** | - | - | 2,069,000  | - |",
            "| **Interest earned on investments held in the trust account ** | 38,374  | 3,479  | 40,526  | 6,902  |",
            "| **Net loss ** | $ (1,534,609)  | $ (944,077)  | $ (1,317,744)  | $ (1,033,891)  |",
            "| **Weighted average shares outstanding of redeemable ordinary shares ** | 3,264,744  | 13,800,000  | 3,264,856  | 13,800,000  |",
            "| **Basic and diluted net loss per redeemable ordinary share ** | $ (0.21)  | $ (0.05)  | $ (0.18)  | $ (0.06)  |",
            "| **Weighted average shares outstanding of non-redeemable ordinary shares ** | 3,903,500  | 3,903,500  | 3,903,500  | 3,903,500  |",
            "| **Basic and diluted net loss per non-redeemable ordinary share ** | $ (0.21)  | $ (0.05)  | $ (0.18)  | $ (0.06)  |"
        ]
    },
    "f10q0622_eaststoneacq_fileoutpart5": {
        "predict": "|   | **For the Six Months Ended June 30, ** |   | \n|   | **2022 ** | **2021 ** |\n| --- | --- | --- |\n| **Net loss ** | $(1,317,744) | $(1,033,891) |\n| **Change in fair value of derivative warrant liabilities ** | $570,000 | $35,600 |\n| **Change in fair value of forward purchase agreement ** | $(1,900,800) | $0.00 |\n| **Extension incentive paid by Founder Shares transferred ** | $0.00 | $(190,800) |\n| **Interest earned on investments held in the trust account ** | $40,526 | $6,902 |\n| **Cash Withdrawn from trust account upon redemption of 361 ordinary shares ** | $3,610 | $0.00 |\n| **Investment of cash for extension into trust account ** | $0.00 | $2,760,000 |\n| **Net cash provided by (used in) investing activities ** | $(3,610) | $0.00 |\n| **Proceeds from promissory note - ICONIQ ** | $0.00 | $200,000 |\n| **Proceeds from extension loans - related party ** | $0.00 | $2,760,000 |\n| **Cash - End of period ** | $586,392 | $1,267,276 | \n| **ICONIQ Note Repayment Option** | Cash or Company\u2019s ordinary shares, based on a conversion price of $10.26 per share, or, if lower, the then-applicable redemption price of the Company\u2019s public shares, subject to the terms of the Third Business Combination Agreement | - | \n| **COVID-19 Impact** | Highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, among others | - | \n| **Business Combination Date Extension** | From August 24, 2022 to February 24, 2023 | - | \n| **Registration Rights Agreement** | Holders of the Founder Shares, Private Units (and underlying securities), and Working Capital Units (and underlying securities) will be entitled to registration rights | - | \n| **Proxy Statement Filed** | Definitive proxy statement on Schedule 14A for a special meeting of shareholders, which included a proposal to amend the Company\u2019s Amended and Restated Memorandum and Articles of Association | - | \n| **Initial Shareholders Agreement** | (A) to vote their Founder Shares (as defined in Note 5), Private Shares (as defined in Note 4) and any Public Shares held by them in favor of any proposed initial Business Combination, (B) not to propose any amendment to the Company\u2019s memorandum and articles of association (i) to modify the substance or timing of the Company\u2019s obligation to redeem 100% of its Public Shares if the Company does not complete its initial Business Combination within 15 months (or up to 21 months) from the closing of the IPO or (ii) with respect to any other provision relating to shareholders\u2019 rights or pre-initial Business Combination activity, unless the Company provides its public shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of taxes payable), divided by the number of then outstanding Public Shares, (C) not to redeem any shares (including the Founder Shares and Private Units (and underlying securities) into the right to receive cash from the trust account in connection with a shareholder vote to approve the proposed initial Business Combination (or to sell any shares in a tender offer in connection with a proposed Business Combination if the Company does not seek shareholder approval in connection therewith) or a vote to amend the provisions of the Company\u2019s memorandum and articles of association relating to shareholders\u2019 rights or pre-Business Combination activity and (D) that the Founder Shares and Private Units (and underlying securities) shall not participate in | - | \n| **Fair Value Measurement** | See Note 10 for further discussion of the fair value measurement | - | \n| **Liquidation of Trust Account** | To avoid that result, as of August 1, 2022, we have instructed Continental Stock Transfer & Trust Company to liquidate the securities held in the trust account and instead hold all funds in the trust account in cash Except for all interest income that may be released to the Company to pay taxes, and up to $50,000 to pay dissolution expenses, none of the funds held in the trust account will be released until the earlier of: (1) the completion of the initial Business Combination within the required time period; (2) the Company\u2019s redemption of 100% of the outstanding Public Shares if the Company has not completed an initial Business Combination in the required time period; and (3) the redemption of any Public Shares properly tendered in connection with a shareholder vote to amend the Company\u2019s Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company\u2019s obligation to redeem 100% of the Public Shares if the Company does not complete its initial Business Combination within the required time period or (B) with respect to any other provision relating to shareholders\u2019 rights or pre-Business Combination activity | - |",
        "target": [
            "|   | **For the Six Months Ended June 30, ** |   |",
            "|   | **2022 ** | **2021 ** |",
            "| --- | --- | --- |",
            "| **Net loss ** | $ (1,317,744)  | $ (1,033,891)  |",
            "| **Change in fair value of derivative warrant liabilities ** | 570,000  | (35,600)  |",
            "| **Change in fair value of forward purchase agreement ** | (2,069,000)  | - |",
            "| **Extension incentive paid by Founder Shares transferred ** | 1,900,800  | - |",
            "| **Interest earned on investments held in the trust account ** | (40,526)  | (6,902)  |",
            "| **Cash Withdrawn from trust account upon redemption of 361 ordinary shares ** | 3,704  | - |",
            "| **Investment of cash for extension into trust account ** | - | (1,380,000)  |",
            "| **Net cash provided by (used in) investing activities ** | - | (1,380,000)  |",
            "| **Proceeds from promissory note - ICONIQ ** | 568,000  | - |",
            "| **Proceeds from extension loans - related party ** | - | 1,380,000  |",
            "| **Cash - End of period ** | $ 3,719  | - |"
        ]
    },
    "f10q0622_eaststoneacq_fileoutpart1": {
        "predict": "|   | **June 30, 2022 ** | **December 31, 2021 ** |\n| --- | --- | --- |\n| **Cash ** | $568,000 |   |\n| **Investments held in trust account ** | $33,541,649 | $138,000,000 |\n| **Promissory note payable to shareholders ** | $3,704 | $3,704 |\n| **Promissory note payable ** | $200,000 | $200,000 |\n| **Promissory note payable to ICONIQ ** | Up to $1,000,000 |   |\n| **Extension loan ** | $1,380,000 | $2,760,000 |\n| **Deferred underwriting commission ** | $402,500 | $402,500 |\n| **Derivative liabilities of forward share purchase, an option to sell 2,923,974 redeemable ordinary shares, no par value, at December 31, 2021 ** | Liability-classified | Liability-classified |\n| **Ordinary shares subject to possible redemption, no par value, 3,264,744 and 3,265,105 at June 30, 2022 and December 31, 2021, at redemption value of approximately $10.27 and $10.26 per share, respectively ** | $0 | $0 | \n| **Convertible note payable to JHD ** | $200,000  | $200,000 | \n| **Founder shares transferred in connection with Backstop Arrangements** | 135,000 | 135,000 | \n| **Fair value measurement** | See Note 10 | See Note 10 | \n| **Registration rights for Founder Shares, Private Units, and Working Capital Units** | Yes | Yes | \n| **Proxy statement filed with SEC for special meeting of shareholders** | Yes |   | \n| **Proposal to amend Company's Amended and Restated Memorandum and Articles of Association to extend Business Combination date** | Yes | Yes  | \n| **Amendment and Restatement of Note to no longer have convertible feature** | Yes | Yes | \n| **COVID-19 impact on Business Combination** | Highly uncertain |   | \n| **Forward-looking statements** | Yes | Yes | \n| **Emerging growth company status** | Yes | Yes | \n\nNote: \n- In connection with the Company\u2019s IPO, the Company issued an aggregate of 103,500 ordinary shares of the Company (\u201cRepresentative\u2019s Shares\u201d) to I-Bankers and its designee, of which 90,562 Representative\u2019s Shares were issued to I-Bankers and 12,938 Representative\u2019s Shares were issued to EarlyBird Capital, Inc.\n- On June 15, 2022, the Company and Pubco entered into a subscription agreement (the \u201cJune 2022 PIPE Subscription Agreement\u201d) with a second investor (the \u201cJune 2022 PIPE Investor\u201d), on substantially the same terms as the April 2022 PIPE, pursuant to which, among other things, the Pubco has agreed to issue and sell to the June 2022 PIPE Investor, and the June 2022 PIPE Investor has agreed to subscribe for and purchase, certain ordinary shares of the Pubco at the per share price for an aggregate purchase price of $200,000,000, in a private placement (the \u201cJune 2022 PIPE\u201d).\n- Effective May 24, 2021 and August 24, 2021, the Company extended the date by which the Company has to consummate a Business Combination from May 24, 2021 to August 24, 2021, and from August 24, 2021 to November 24, 2021, respectively (the \u201cExtensions\u201d).\n- Specifically, to comply with the safe harbor, the SPAC Rule Proposals would require a company to file a report on Form 8-K announcing that it has entered into an agreement with a target company for an initial business combination no later than 18 months after the effective date of the registration statement for its initial public offering (the \u201cIPO Registration Statement\u201d).\n- The securities sold in connection with the April 2022 PIPE, June 2022 PIPE and August 2022 PIPE were sold under the exemption from registration provided by Section 4(a)(2) of the Securities Act if, and only if, the reported last sale price of the ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period ending on the third trading business day prior to the notice of redemption to warrant holders.\n- The purpose of the June 2022 PIPE is to raise additional capital for use by the combined company following the Closing of the Business Combination between the Company and ICONIQ.\n- On August 12, 2022, the Company and Pubco entered into a subscription agreement (the \u201cAugust 2022 PIPE Subscription Agreement\u201d) with a third investor (the \u201cAugust 2022 PIPE Investor\u201d), on substantially the same terms as the April 2022 PIPE and June 2022 PIPE, pursuant to which, among other things, the Pubco has agreed to issue and sell to the August 2022 PIPE Investor, and the August 2022 PIPE Investor has agreed to subscribe for and purchase, certain ordinary shares of the Pubco at the Per Share Price for an aggregate purchase price of $200,000,000, in a private placement (the \u201cAugust 2022 PIPE\u201d).\n- In connection with the execution of the Third Business Combination Agreement, on April 21, 2022, the Company and the Pubco have entered into a subscription agreement (the \u201cPIPE Subscription Agreement\u201d) with an investor (the \u201cPIPE Investor\u201d), pursuant to which, among other things, the Pubco has agreed to issue and sell to the PIPE Investor, and the PIPE Investor has agreed to subscribe for and purchase, certain ordinary shares of the Pubco for a purchaser price at the Per Share Price and at an aggregate purchase price of $200,000,000, in a private placement (the \u201cApril 2022 PIPE\u201d).\n- For the three and six months ended June 30, 2022 the Company recognized an increase in the fair value of warrant liabilities of $1,019,000 and $570,000, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying consolidated statement of operations.\n- On February 10, 2022, the Company held a special meeting of shareholders to approve a proposed amendment to the Company\u2019s Amended and Restated Memorandum and Articles of Association to extend the date by which Company has to consummate a Business Combination from February 24, 2022 to August 24, 2022.\n- Based on the IPO price of $10.00 per Unit, the fair value of the 103,500 ordinary shares was $1,035,000, which was an expense of the IPO resulting in a charge of offering costs against temporary equity upon the completion of the IPO.\n- Chunyi (Charlie) Hao, had loaned to the Company an aggregate of $471,459 of Working Capital Loans.",
        "target": [
            "|   | **June 30, 2022 ** | **December 31, 2021 ** |",
            "| --- | --- | --- |",
            "| **Cash ** | $ 3,719  | - |",
            "| **Investments held in trust account ** | 33,541,649  | 33,504,825  |",
            "| **Promissory note payable to shareholders ** | 471,459  | 350,000  |",
            "| **Promissory note payable ** | 200,000  | 200,000  |",
            "| **Promissory note payable to ICONIQ ** | 568,000  | - |",
            "| **Extension loan ** | 2,760,000  | 2,760,000  |",
            "| **Deferred underwriting commission ** | 402,500  | 402,500  |",
            "| **Derivative liabilities of forward share purchase, an option to sell 2,923,974 redeemable ordinary shares, no par value, at December 31, 2021 ** | - | 2,069,000  |",
            "| **Ordinary shares subject to possible redemption, no par value, 3,264,744 and 3,265,105 at June 30, 2022 and December 31, 2021, at redemption value of approximately $10.27 and $10.26 per share, respectively ** | 33,541,649  | - |"
        ]
    },
    "msb-20210731x10q_fileoutpart7": {
        "predict": "|   | **Unallocated Reserve ** | **Total ** |\n| --- | --- | --- |\n| **Net income ** | $2.0393 per unit |   |\n| **Balances at July 31, 2021 ** | $38,949,336 | $37,146,203 |<NEWLINE>",
        "target": [
            "|   | **Unallocated Reserve ** | **Total ** |",
            "| --- | --- | --- |",
            "| **Net income ** | 35,329,900  | 35,329,900  |",
            "| **Balances at July 31, 2021 ** | $ 38,949,336  | - |"
        ]
    },
    "msb-20210731x10q_fileoutpart2": {
        "predict": "| **B. Condensed Balance Sheets ** |   |   |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Accrued income receivable ** | $12,634,653 |   |<NEWLINE>| **Contract asset ** |   | $5,069,251  |<NEWLINE>| **Contract liability ** | $5,966,182 |   |<NEWLINE>| **Unallocated reserve ** |   | $38,949,336 |<NEWLINE>",
        "target": [
            "| **B. Condensed Balance Sheets ** |   |   |",
            "| --- | --- | --- |",
            "| **Accrued income receivable ** | 12,634,653  | 249,477  |",
            "| **Contract asset ** | - | 177,251  |",
            "| **Contract liability ** | 896,931  | - |",
            "| **Unallocated reserve ** | 38,949,336  | - |"
        ]
    },
    "msb-20210731x10q_fileoutpart11": {
        "predict": "| **Three Months Ended ** | **Pellets Produced from Trust Lands (Tons) ** | **Pellets Shipped from Trust Lands (Tons) ** |\n| --- | --- | --- |\n| **July 31, 2021 ** | 1,157,588 | 1,446,876 |\n| **July 31, 2020 ** | 1,164,566 | 1,532,378 |",
        "target": [
            "| **Three Months Ended ** | **Pellets Produced from Trust Lands (Tons) ** | **Pellets Shipped from Trust Lands (Tons) ** |",
            "| --- | --- | --- |",
            "| **July 31, 2021 ** | 1,157,588  | 1,446,876  |",
            "| **July 31, 2020 ** | (22,898)  | 973,744  |"
        ]
    },
    "msb-20210731x10q_fileoutpart8": {
        "predict": "|   | **Unallocated Reserve ** | **Total ** |\n| --- | --- | --- |\n| **Net income ** | $2.0393 per unit |   |\n| **Balances at July 31, 2021 ** | $38,949,336 | $27,792,348 |",
        "target": [
            "|   | **Unallocated Reserve ** | **Total ** |",
            "| --- | --- | --- |",
            "| **Net income ** | 26,756,030  | 26,756,030  |",
            "| **Balances at July 31, 2021 ** | $ 38,949,336  | - |"
        ]
    },
    "msb-20210731x10q_fileoutpart18": {
        "predict": "|   | **July 31, 2021 ** | **January 31, 2021 ** |\n| --- | --- | --- |\n| **Accrued Income Receivable ** | $12,634,653 | $249,477 |\n| **Contract Asset ** | Iron ore that has not been shipped by Northshore | |\n| **Contract Liability ** | $5,966,182 | |\n| **Unallocated Reserve ** | $38,949,336 | $12,115,431 |",
        "target": [
            "|   | **July 31, 2021 ** | **January 31, 2021 ** |",
            "| --- | --- | --- |",
            "| **Accrued Income Receivable ** | $12,634,653  | $ 249,477  |",
            "| **Contract Asset ** | - | 177,251  |",
            "| **Contract Liability ** | (896,931)  | - |",
            "| **Unallocated Reserve ** | $38,949,336  | - |"
        ]
    },
    "bzrd10q_q3o_fileoutpart4": {
        "predict": "|   | **Blubuzzard, Inc. of Operations (Unaudited) For the Three Months Ended September 30, 2022 ** | **For the Three Months Ended September 30, 2021 ** | **For the Nine Months Ended September 30, 2022 ** | **For the Nine Months Ended September 30, 2021 ** |\n| --- | --- | --- | --- | --- |\n| **General and administrative expenses ** | $4,833 | $16,109 | $29,667 | $23,397 |\n| **Total operating expenses ** |   |   |   |   |\n| **Net loss ** | $4,833 | $16,109 |   |   |\n| **Weighted average number of common shares - Basic and Diluted ** |   |   |   |   |",
        "target": [
            "|   | **Blubuzzard, Inc. of Operations (Unaudited) For the Three Months Ended September 30, 2022 ** | **For the Three Months Ended September 30, 2021 ** | **For the Nine Months Ended September 30, 2022 ** | **For the Nine Months Ended September 30, 2021 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **General and administrative expenses ** | $ 4,833  | $ 16,109 $  | 29,667 $  | 23,397  |",
            "| **Total operating expenses ** | 4,833  | 16,109  | 29,667  | 23,397  |",
            "| **Net loss ** | $ (4,833)  | (16,109) $  | (29,667) $  | (23,397)  |",
            "| **Weighted average number of common shares - Basic and Diluted ** | 729,483,160  | 729,483,160  | 729,483,160  | 729,483,160  |"
        ]
    },
    "j111921010q_fileoutpart3": {
        "predict": "|   | **For the Three Months Ended September 30, ** |   | **For the Nine Months Ended September 30, ** |   |\n| --- | --- | --- | --- | --- |\n|   | **2021 ** | **2020 ** | **2021 ** | **2020 ** |\n| --- | --- | --- | --- | --- |\n| **Compensation ** | $6,000 | $0 | $17,600 | $0 |\n| **Total operating expenses ** | $34,540 | $21,385 | $87,285 | $21,385 |\n| **Operating Loss ** | ($34,540) | ($21,385) | ($87,285) | ($21,385) |\n| **Other income ** | $886 | $0 | $886 | $0 |\n| **Net loss before taxes ** | ($33,654) | ($21,385) | ($86,399) | ($21,385) |\n| **Net Loss ** | ($33,654) | ($21,385) | ($86,399) | ($21,385) |\n| **Internet Sciences, Inc. ** |   |   |   |   |\n| **Comprehensive Loss ** | ($33,654) | ($21,385) | ($86,399) | ($21,385) |",
        "target": [
            "|   | **For the Three Months Ended September 30, ** |   | **For the Nine Months Ended September 30, ** |   |",
            "|   | **2021 ** | **2020 ** | **2021 ** | **2020 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Compensation ** | - | - | 17,600  | 6,300  |",
            "| **Total operating expenses ** | 32,056  | 10,231  | 34,540  | 21,385  |",
            "| **Operating Loss ** | (32,056)  | (10,231)  | (34,540)  | (21,385)  |",
            "| **Other income ** | - | - | 886  | - |",
            "| **Net loss before taxes ** | (32,056)  | (10,231)  | (33,656)  | (21,385)  |",
            "| **Net Loss ** | $ (32,056)  | $ (10,231)  | (33,656)  | (21,385)  |",
            "| **Internet Sciences, Inc. ** | (32,056)  | (10,231)  | (33,656)  | (21,385)  |",
            "| **Comprehensive Loss ** | $ (32,056)  | $ (10,231)  | $ (33,656)  | $ (21,385)  |"
        ]
    },
    "j111921010q_fileoutpart2": {
        "predict": "|   | **September 30, 2021 ** | **December 31, 2020 ** |\n| --- | --- | --- |\n| **Accounts payable and accrued liabilities ** | $54,965 | $54,970 |\n| **Accounts payable and accrued liabilities \u2013 related party ** | $4,985 | $20,985 |\n| **Due to related party ** | $102,187 | $85,225 |\n| **Loans payable ** | $881 |   |\n| **Common Stock Class A, 81,200,000 shares designated, 1,378,000 and 1,051,000 shares issued and outstanding, respectively ** | 1,387,000 | 1,051,000 |\n| **Common Stock Class B, 18,800,000 shares designated, 18,800,000 shares issued and outstanding ** |   |   |\n| **Accumulated deficit ** | $348,615 | $21,385 |\n| **Total stockholders\u2019 deficit ** | ($162,117) | ($155,175) |\n| **Total Stockholders' Deficit ** | ($162,117) | ($155,175) |",
        "target": [
            "|   | **September 30, 2021 ** | **December 31, 2020 ** |",
            "| --- | --- | --- |",
            "| **Accounts payable and accrued liabilities ** | $ 54,965  | $ 54,970  |",
            "| **Accounts payable and accrued liabilities \u2013 related party ** | 4,985  | 20,985  |",
            "| **Due to related party ** | 102,187  | 85,225  |",
            "| **Loans payable ** | - | 881  |",
            "| **Common Stock Class A, 81,200,000 shares designated, 1,378,000 and 1,051,000 shares issued and outstanding, respectively ** | 1,387  | 1,051  |",
            "| **Common Stock Class B, 18,800,000 shares designated, 18,800,000 shares issued and outstanding ** | 18,800  | 18,800  |",
            "| **Accumulated deficit ** | (348,615)  | - |",
            "| **Total stockholders\u2019 deficit ** | (162,117)  | - |",
            "| **Total Stockholders' Deficit ** | (162,117)  | - |"
        ]
    },
    "j111921010q_fileoutpart5": {
        "predict": "|   | **Nine Months Ended September 30, ** |   |<NEWLINE>|   | **2021 ** | **2020 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net loss ** | $33,656 | $21,385 |<NEWLINE>| **Stock based compensation ** | $17,600 | - |<NEWLINE>| **Forgiveness of PPP loan ** | $886 | - |<NEWLINE>| **Prepaid expenses ** | - | $2,905 |<NEWLINE>| **Security deposit ** | $5,000 | $5,000 |<NEWLINE>| **Net cash used in operating activities ** | ($16,942) | ($18,939) |<NEWLINE>| **Proceeds from related party ** | - | $20,000 |<NEWLINE>| **Proceeds from issuance of common stock ** | $16,000 | $1,500 |<NEWLINE>| **Repayment to related party ** | ($16,000) | ($20,000) |<NEWLINE>| **Proceeds from loans ** | - | $881 |<NEWLINE>| **Net cash provided by financing activities ** | $16,962 | ($200) |<NEWLINE>| **Cash at end of period ** | $20 | $4,011 |<NEWLINE>| **Issuance of common shares for repayment of related party accruals ** | - | $20,000 |<NEWLINE>",
        "target": [
            "|   | **Nine Months Ended September 30, ** |   |",
            "|   | **2021 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Net loss ** | $ (33,656)  | $ (21,385)  |",
            "| **Stock based compensation ** | 17,600  | 6,300  |",
            "| **Forgiveness of PPP loan ** | (886)  | - |",
            "| **Prepaid expenses ** | - | 1,000  |",
            "| **Security deposit ** | - | 1,800  |",
            "| **Net cash used in operating activities ** | (16,942)  | (7,836)  |",
            "| **Proceeds from related party ** | 16,962  | 4,034  |",
            "| **Proceeds from issuance of common stock ** | - | 12,300  |",
            "| **Repayment to related party ** | - | (9,400)  |",
            "| **Proceeds from loans ** | - | 881  |",
            "| **Net cash provided by financing activities ** | 16,962  | 7,815  |",
            "| **Cash at end of period ** | $ 20  | - |",
            "| **Issuance of common shares for repayment of related party accruals ** | $ 16,000  | - |"
        ]
    },
    "jksm_10q_fileoutpart6": {
        "predict": "|   | **Three Months ended March 31, 2023 ** | **Three Months ended March 31, 2022 ** |\n| --- | --- | --- |\n| **Machine sales ** | - | - |\n| **Non-Machine sales ** | $0 | $0 |\n| **Total sales ** | $0 | $0 |",
        "target": [
            "|   | **Three Months ended March 31, 2023 ** | **Three Months ended March 31, 2022 ** |",
            "| --- | --- | --- |",
            "| **Machine sales ** | $ 343,000  | $ 1,033,123  |",
            "| **Non-Machine sales ** | 285,425  | 743,952  |",
            "| **Total sales ** | $ 628,425  | - |"
        ]
    },
    "jksm_10q_fileoutpart3": {
        "predict": "|   | **March 31, 2023 ** | **March 31, 2022 ** |\n| --- | --- | --- |\n| **Sales ** | $- | $- |\n| **Cost of sales ** | $- | $- |\n| **Salaries and wages (including contractors) ** | $112,887 | $267,644 |\n| **Other selling, general and administrative expenses ** | $130,736 | $149,613 |\n| **Total operating expenses ** | $243,623 | $417,257 |\n| **Income (loss) from operations ** | $-20,510 | $1,380 |\n| **Derivative gain (loss) ** | $123,301 | $287,098 |\n| **Interest expense ** | $47,362 | $259,094 |\n| **Net income (loss) ** | $55,429 | $29,384 |\n| **Basic ** | $- | $- |",
        "target": [
            "|   | **March 31, 2023 ** | **March 31, 2022 ** |",
            "| --- | --- | --- |",
            "| **Sales ** | $ 628,425  | - |",
            "| **Cost of sales ** | 405,312  | 1,358,438  |",
            "| **Salaries and wages (including contractors) ** | 112,887  | 267,644  |",
            "| **Other selling, general and administrative expenses ** | 130,736  | 149,613  |",
            "| **Total operating expenses ** | 243,623  | 417,257  |",
            "| **Income (loss) from operations ** | (20,510)  | 1,380  |",
            "| **Derivative gain (loss) ** | 123,301  | 287,098  |",
            "| **Interest expense ** | (47,362)  | (259,094)  |",
            "| **Net income (loss) ** | 55,429  | 29,384  |",
            "| **Basic ** | 81,088,719  | - |"
        ]
    },
    "jksm_10q_fileoutpart10": {
        "predict": "|   | **March 31, 2023 ** | **December 31, 2022 ** |\n| --- | --- | --- |\n| **SBA loan May 2020 ** | $635,658 | $730,783 |\n| **Note payable September 2021 ** | $750,000 | $750,000 |\n| **Note Payable September 2022 ** | $105,640 | $105,640 |\n| **Less: discount and deferred \ufb01nance costs ** | $94,095 | $121,310 |",
        "target": [
            "|   | **March 31, 2023 ** | **December 31, 2022 ** |",
            "| --- | --- | --- |",
            "| **SBA loan May 2020 ** | $ 143,901  | $ 144,739  |",
            "| **Note payable September 2021 ** | - | 635,658  |",
            "| **Note Payable September 2022 ** | - | 52,475  |",
            "| **Less: discount and deferred \ufb01nance costs ** | - | (94,095)  |"
        ]
    },
    "mepw_2022mar21-10q_fileoutpart4": {
        "predict": "|   | **\u00a0Common Stock\u00a0Shares\u00a0** | **Accumulated De\ufb01cit\u00a0\u00a0** | **Total Stockholders' De\ufb01ciency ** |\n| --- | --- | --- | --- |\n| **Balance at December 31, 2021 ** | 227,375,000 |   |   |\n| **Net Loss for the Three Months Ended March 31, 2022 ** |   |   |   |\n| **Balance at March 31, 2022 ** | 227,375,000 |   |   |",
        "target": [
            "|   | **\u00a0Common Stock\u00a0\u00a0Shares\u00a0** | **Accumulated De\ufb01cit\u00a0\u00a0** | **Total Stockholders' De\ufb01ciency ** |",
            "| --- | --- | --- | --- |",
            "| **Balance at December 31, 2021 ** | 227,375,000  | - | $ (42,120)  |",
            "| **Net Loss for the Three Months Ended March 31, 2022 ** | - | $ (1,469)  | $ (1,469)  |",
            "| **Balance at March 31, 2022 ** | 227,375,000  | $ (95,676)  | $ (43,589)  |"
        ]
    },
    "mepw_2022mar21-10q_fileoutpart8": {
        "predict": "|   | **As at March\\xa0\\xa0\\xa0\\xa0\\xa0\\xa031, 2022 ** | **As at December 31, 2021 ** |\n| --- | --- | --- |\n| **Current Assets ** | $0 | $0 |\n| **Current Liabilities ** | $43,589 | $42,120 |\n| **Working Capital (deficiency) ** | ($43,589) | ($42,120) |",
        "target": [
            "|   | **As at March\u00a0\u00a0\u00a0\u00a0\u00a0\u00a031, 2022 ** | **As at December 31, 2021 ** |",
            "| --- | --- | --- |",
            "| **Current Assets ** | $ 0  | $ 0  |",
            "| **Current Liabilities ** | $ 43,589  | $ 42,120  |",
            "| **Working Capital (deficiency) ** | $ (43,589)  | $ (42,120)  |"
        ]
    },
    "mepw_2022mar21-10q_fileoutpart9": {
        "predict": "| **Cash Flows ** | **Three months Ended March 31, 2022 ** | **Three months Ended March\\xa0\\xa0\\xa0\\xa031, 2021 ** |\n| --- | --- | --- |\n| **Net cash used in operating activities ** | $0 | $0 |\n| **Net cash used in investing activities ** |   |   |\n| **Net cash provided by financing activities ** |   |   |",
        "target": [
            "| **Cash Flows ** | **Three months Ended March 31, 2022 ** | **Three months Ended March\u00a0\u00a0\u00a0\u00a031, 2021 ** |",
            "| --- | --- | --- |",
            "| **Net cash used in operating activities ** | $ (1,940)  | $ 0  |",
            "| **Net cash used in investing activities ** | $ 0  | - |",
            "| **Net cash provided by financing activities ** | $ 1,940  | $ 0  |"
        ]
    },
    "iraa-20220630x10q_fileoutpart3": {
        "predict": "|   | **Class B Common Stock ** | **Additional Paid-in Capital ** | **Accumulated Deficit ** | **Total Stockholders\u2019 Deficit** |\n| --- | --- | --- | --- | --- |\n| **Balance - December 31, 2021 ** | 5,750,000 | $25,000 |   | ($25,000) |\n| **Balance as of March 31, 2022 (Unaudited) ** | 5,750,000 | $25,000 |   | ($25,000) |\n| **Forgiveness of payable due to an affiliate of the Sponsor ** |   | $5,000,000 |   | $5,000,000 |\n| **Net income ** |   |   | $3,712,688 | $3,687,688 |\n| **Balance as of June 30, 2022 (Unaudited) ** | 5,750,000 | $5,025,000 | $3,712,688 | $8,737,688 | \n| **Operating bank account** |   |   | $50,429 |   |\n| **Working capital** |   |   | ($1,395,091) | ($758,467) |\n| **Transaction costs for the IPO** |   | $15,627,893 |   |   |\n| **Private Placement Warrants proceeds** |   | $7,520,000 |   |   |\n| **Loan from Sponsor for working capital** |   | $300,000 |   |   |\n| **Fair value remeasurement** |   | $8,605,210 |   |   |\n| **Convertible debt allocation** |   |   |   |   |\n| **COVID-19 impact evaluation** |   |   |   |   |\n| **Disclosure controls and procedures evaluation** |   |   |   |   |\n| **Cash flows from investing activities** |   |   |   |   |\n| **Registration statement for Class A common stock** |   |   |   |   |\n| **Public Warrants reclassification** |   |   |   |   |\n| **Loan forgiveness and reclassification** |   | $140,000 |   | $140,000 |\n| **ASC Topic 815 evaluation** |   |   |   |   |\n| **Deferred IPO fee** |   | $9,660,000 |   |   |",
        "target": [
            "|   | **Class B Common Stock ** | **Additional Paid-in Capital ** | **Accumulated Deficit ** | **Total Stockholders\u2019 Deficit** |",
            "|   | **Shares ** |   |   |   |",
            "| --- | --- | --- | --- | --- |",
            "| **Balance - December 31, 2021 ** | 6,900,000  | - | - | - |",
            "| **Balance as of March 31, 2022 (Unaudited) ** | 6,900,000  | - | - | - |",
            "| **Forgiveness of payable due to an affiliate of the Sponsor ** | - | 140,000  | - | 140,000  |",
            "| **Net income ** | - | - | 3,712,688  | 3,712,688  |",
            "| **Balance as of June 30, 2022 (Unaudited) ** | 6,900,000  | $140,000  | - | - |"
        ]
    },
    "iraa-20220630x10q_fileoutpart2": {
        "predict": "|   | **Three Months Ended June 30, ** |   | **Six Months Ended June 30, ** |   |\n|   | **2022 ** | **2021 ** | **2022 ** | **2021 ** |\n| --- | --- | --- | --- | --- |\n| **Formation and operating costs ** | $291,993 | $- | $291,993 | $- |\n| **Loss from operations ** | $- | $- | $- | $- |\n| **Change in fair value of warrant liability ** | $4,211,660 | $229,859 | $4,641,746 | $229,859 |\n| **Interest income on marketable securities held in Trust Account ** | $161,103 | $4,310 | $249,663 | $8,620 |\n| **Unrealized loss on investments held in Trust Account ** | $368,082 | $- | $1,200,678 | $- |\n| **Offering costs ** | $606,622 | $15,627,893 | $15,234,515 | $15,627,893 |\n| **Excess of fair value of Private Warrants over proceeds received ** | $298,825 | $- | $298,825 | $- |\n| **Net income (loss) ** | $3,712,688 | ($2,124,477) | $19,222,405 | ($2,124,477) |\n| **Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption ** | 27,600,000 | - | 27,600,000 | - |\n| **Basic and diluted weighted average shares outstanding, Class B common stock ** | 5,750,000 | - | 5,750,000 | - |",
        "target": [
            "|   | **Three Months Ended June 30, ** |   | **Six Months Ended June 30, ** |   |",
            "|   | **2022 ** | **2021 ** | **2022 ** | **2021 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Formation and operating costs ** | $ 291,993  | $ 395,233  | $ 876,623  | $ 793,254  |",
            "| **Loss from operations ** | (291,993)  | (395,233)  | (876,623)  | (793,254)  |",
            "| **Change in fair value of warrant liability ** | 4,211,660  | 229,859  | 8,605,210  | (430,086)  |",
            "| **Interest income on marketable securities held in Trust Account ** | 161,103  | 4,310  | 167,910  | 4,310  |",
            "| **Unrealized loss on investments held in Trust Account ** | (368,082)  | - | (368,082)  | - |",
            "| **Offering costs ** | - | - | - | (606,622)  |",
            "| **Excess of fair value of Private Warrants over proceeds received ** | - | - | - | (298,825)  |",
            "| **Net income (loss) ** | $ 3,712,688  | $ (161,064)  | $ 7,528,415  | $ (2,124,477)  |",
            "| **Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption ** | 27,600,000  | 27,600,000  | 27,600,000  | 27,600,000  |",
            "| **Basic and diluted weighted average shares outstanding, Class B common stock ** | 6,900,000  | 6,900,000  | 6,900,000  | 6,900,000  |"
        ]
    },
    "iraa-20220630x10q_fileoutpart5": {
        "predict": "|   | **Six Months Ended June 30, ** |   |<NEWLINE>|   | **2022 ** | **2021 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net income (loss) ** | $3,712,688 | ($161,064) |<NEWLINE>| **Excess of fair value of Private Warrants over proceeds received ** | $298,825 | - |<NEWLINE>| **(Gain) loss on change in fair value of warrant liability ** | $4,211,660 | $229,859 |<NEWLINE>| **Interest earned on cash and Investments held in Trust Account ** | $161,103 | $4,310 |<NEWLINE>| **Unrealized loss on Investments held in Trust Account ** | ($368,082) | - |<NEWLINE>| **Offering Costs ** | $15,627,893 | - |<NEWLINE>| **Franchise tax payable ** | $300,000 | $200,000 |<NEWLINE>| **Net cash used in operating activities ** | ($1,395,091) | ($758,467) |<NEWLINE>| **Cash Deposited in Trust Account ** | $276,000,000 | - |<NEWLINE>| **Net cash used in investing activities ** | - | - |<NEWLINE>| **Proceeds from sale of Units, net of offering costs ** | $256,378,729 | - |<NEWLINE>| **Proceeds from issuance of Private Warrants ** | $7,520,000 | - |<NEWLINE>| **Payment of underwriter discount ** | ($5,520,000) | - |<NEWLINE>| **Proceeds from promissory note \u2013 related party ** | $4,310 | - |<NEWLINE>| **Net cash provided by financing activities ** | $258,877,039 | - |<NEWLINE>| **Cash, beginning of period ** | $0 | $0 |<NEWLINE>| **Cash, end of period ** | $258,877,039 | $0 |<NEWLINE>| **Deferred underwriting fee payable charged to additional paid-in capital ** | $9,660,000 | - |<NEWLINE>| **Forgiveness of payable due to an affiliate of the Sponsor ** | $140,000 | - |<NEWLINE>",
        "target": [
            "|   | **Six Months Ended June 30, ** |   |",
            "|   | **2022 ** | **2021 ** |",
            "| --- | --- | --- |",
            "| **Net income (loss) ** | $ 7,528,415  | $ (2,124,477)  |",
            "| **Excess of fair value of Private Warrants over proceeds received ** | - | 298,825  |",
            "| **(Gain) loss on change in fair value of warrant liability ** | (8,605,210)  | 430,086  |",
            "| **Interest earned on cash and Investments held in Trust Account ** | (167,910)  | (4,310)  |",
            "| **Unrealized loss on Investments held in Trust Account ** | 368,082  | - |",
            "| **Offering Costs ** | - | 606,622  |",
            "| **Franchise tax payable ** | 100,000  | 100,000  |",
            "| **Net cash used in operating activities ** | (585,799)  | (859,128)  |",
            "| **Cash Deposited in Trust Account ** | - | (276,000,000)  |",
            "| **Net cash used in investing activities ** | - | (276,000,000)  |",
            "| **Proceeds from sale of Units, net of offering costs ** | - | 275,552,107  |",
            "| **Proceeds from issuance of Private Warrants ** | - | 7,520,000  |",
            "| **Payment of underwriter discount ** | - | (5,520,000)  |",
            "| **Proceeds from promissory note \u2013 related party ** | 300,000  | - |",
            "| **Net cash provided by financing activities ** | 300,000  | 277,552,107  |",
            "| **Cash, beginning of period ** | 336,228  | - |",
            "| **Cash, end of period ** | $ 50,429  | - |",
            "| **Deferred underwriting fee payable charged to additional paid-in capital ** | - | $ 9,660,000  |",
            "| **Forgiveness of payable due to an affiliate of the Sponsor ** | $ 140,000  | - |"
        ]
    },
    "pacq20200331_10q_fileoutpart3": {
        "predict": "|   | **For the three months ended March 31, ** |   |<NEWLINE>|   | **2020 ** | **2019 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Administrative expenses ** | $30,000 | $30,000 |<NEWLINE>| **General expenses ** |   |   |<NEWLINE>| **Franchise taxes ** | $84,214 | $57,968 |<NEWLINE>| **Other income - investment income on Trust Account ** | $1,182,962 | $2,434,969 |<NEWLINE>| **Income tax provision ** | $229,081 | $500,833 |<NEWLINE>| **Net income (loss) attributable to common shares ** | ($311,195) | $1,745,005 |<NEWLINE>| **Class A common stock ** | 35,616,199 | 37,806,000 |<NEWLINE>| **Class B common stock ** |   | 10,350,000 |<NEWLINE>",
        "target": [
            "|   | **For the three months ended March 31, ** |   |",
            "|   | **2020 ** | **2019 ** |",
            "| --- | --- | --- |",
            "| **Administrative expenses ** | 30,000  | 30,000  |",
            "| **General expenses ** | 1,184,626  | 101,163  |",
            "| **Franchise taxes ** | 50,450  | 57,968  |",
            "| **Other income - investment income on Trust Account ** | 1,182,962  | 2,434,969  |",
            "| **Income tax provision ** | 229,081  | 500,833  |",
            "| **Net income (loss) attributable to common shares ** | $ (311,195)  | $ 1,745,005  |",
            "| **Class A common stock ** | 36,819,386  | 41,400,000  |",
            "| **Class B common stock ** | 10,350,000  | 10,350,000  |"
        ]
    },
    "lcahu-20210930x10q_fileoutpart2": {
        "predict": "|   | **Three months ended September 30, 2021 ** | **Nine months ended September 30, 2021 ** | **For the period from August 13, 2020 (inception) through September 30, 2020 ** |\n| --- | --- | --- | --- |\n| **Expenses: ** |   |   |   |\n| --- | --- | --- | --- |\n| **Interest income ** | $7,682 | $113,902 |   |\n| **Gain (loss) on warrant derivative liability ** | $1,250,000 | $12,500,000 |   |\n| **Income before taxes ** | $321,123 | $10,268,480 |   |\n| **Net income ** | $321,123 | $10,268,480 |   |\n| **Net income per share ** | $0.03 | $0.82 |   |\n| **Basic and diluted weighted average number of shares outstanding ** | 12,500,000 | 12,500,000 |   |\n| **Net income per share ** | $0.03 | $0.82 |   | \n| **Interest expense** |   |   |   |\n| **Offering costs** |   | $800,000 |   |\n| **Amounts outstanding under Convertible Notes** | $853,712 | $853,712 |   |\n| **Administrative services fees** | $60,000 | $140,000 |   |\n| **Number of authorized shares of capital stock** |   |   | 301,000,000 |\n| **Number of Class A shares** |   |   | 240,000,000 |\n| **Par value per Class A share** |   |   | $0.0001 |\n| **Number of Class B shares** |   |   | 60,000,000 |\n| **Par value per Class B share** |   |   | $0.0001 |\n| **Number of preferred shares** |   |   | 1,000,000 |\n| **Par value per preferred share** |   |   | $0.0001 |\n| **Sponsor Warrants purchased in Private Placement** |   |   | 8,333,333 |\n| **Price per Sponsor Warrant in Private Placement** |   |   | $1.50 |\n| **Aggregate purchase price for Sponsor Warrants in Private Placement** |   |   | $12,500,000 |\n| **Founder Shares issued to TJF** |   | $10,000 | 7,187,500 |\n| **Price per Founder Share issued to TJF** |   | $1.39 |   |\n| **Units sold in Public Offering** | 50,000,000 | 50,000,000 |   |\n| **Price per Unit sold in Public Offering** | $10.00 | $10.00 |   |\n| **Proceeds from Public Offering placed in Trust Account** | $490,000,000 | $490,000,000 |   |\n| **Proceeds from Private Placement placed in Trust Account** | $10,000,000 | $10,000,000 |   |\n| **Underwriters' deferred discount from Public Offering placed in Trust Account** | $17,500,000 | $17,500,000 |   |\n| **Total amount placed in Trust Account** | $500,000,000 | $500,000,000 |   |\n| **Waiver of redemption rights for Founder Shares** |   |   | Yes |\n| **Waiver of redemption rights for Public Shares** |   |   | Yes |\n| **Waiver of rights to liquidating distributions for Founder Shares** |   |   | Yes |\n| **Voting agreement for Founder Shares and Public Shares** |   |   | Yes |\n| **Convertible Note conversion option for TJF and JFG** | $1,500,000 | $1,500,000 | Yes |\n| **Requirement for Business Combination ownership or controlling interest** |   |   | Yes |\n| **Public Share redemption feature** |   |   | Yes |\n| **Joint and several liability of Sponsors for Trust Account claims** |   |   | Yes |\n| **ASU 2020-06 amendments** |   |   | Yes |",
        "target": [
            "|   | **Three months ended September 30, 2021 ** | **Nine months ended September 30, 2021 ** | **For the period from August 13, 2020 (inception) through September 30, 2020 ** |",
            "| **Expenses: ** |   |   |   |",
            "| --- | --- | --- | --- |",
            "| **Interest income ** | 7,682  | 23,181  | - |",
            "| **Gain (loss) on warrant derivative liability ** | 1,250,000  | - | - |",
            "| **Income before taxes ** | 321,123  | 10,268,480  | - |",
            "| **Net income ** | $ 321,123  | $ 10,268,480  | - |",
            "| **Net income per share ** | $ 0.01  | $ 0.16  | - |",
            "| **Basic and diluted weighted average number of shares outstanding ** | - | - | 6,250,000  |",
            "| **Net income per share ** | $ 0.01  | $ 0.16  | - |"
        ]
    },
    "lcahu-20210930x10q_fileoutpart4": {
        "predict": "|   | **Nine months ended September 30, 2021 ** |\n| --- | --- |\n| **Net income ** | $10,268,480  |\n| **Trust account interest income ** | $113,902 |\n| **Decrease (increase) in prepaid expenses ** | $(1,258,499) |\n| **Increase (decrease) in accounts payable and accrued liabilities ** | $120,000  |\n| **Cash deposited in trust account ** | $500,023,181 |\n| **Proceeds from public offering ** | $500,000,000 |\n| **Proceeds from affiliate notes payable ** | $853,712 |\n| **Payment of offering costs in affiliate notes payable ** | $(17,500,000) |\n| **Cash at end of period ** | $11,000 |\n| **Deferred underwriting commissions ** | $(10,000,000) |",
        "target": [
            "|   | **Nine months ended September 30, 2021 ** |",
            "| --- | --- |",
            "| **Net income ** | $ 10,268,480  |",
            "| **Trust account interest income ** | (23,181)  |",
            "| **Decrease (increase) in prepaid expenses ** | (1,258,499)  |",
            "| **Increase (decrease) in accounts payable and accrued liabilities ** | 120,000  |",
            "| **Cash deposited in trust account ** | (500,000,000)  |",
            "| **Proceeds from public offering ** | 500,000,000  |",
            "| **Proceeds from affiliate notes payable ** | 853,712  |",
            "| **Payment of offering costs in affiliate notes payable ** | (197,315)  |",
            "| **Cash at end of period ** | $ 113,902  |",
            "| **Deferred underwriting commissions ** | $ 17,500,000  |"
        ]
    },
    "lcahu-20210930x10q_fileoutpart1": {
        "predict": "|   | **September 30, 2021 (unaudited) ** |\n| --- | --- |\n| **Cash ** | $113,902 |\n| **Prepaid expenses ** | $1,258,499 |\n| **Cash and marketable securities held in trust account ** | $500,023,181 |\n| **Accounts payable and accrued liabilities ** | $120,000 |\n| **Notes payable, affiliates ** | $853,712 |\n| **Deferred underwriting commissions ** | $17,500,000 |\n| **Class A common stock subject to possible redemption, 50,000,000 shares at redemption value of $10.00 per share ** | As restated to reflect all Class A shares as redeemable | \nThe Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended In conjunction with our Public Offering, which closed March 29, 2021, the Company sold 50,000,000 Units at a price of $10.00 per Unit The Sponsors and the Company\u2019s officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their shares of Class B common stock, par value $0.0001 per share, of the Company (\u201cFounder Shares\u201d) and Public Shares held by them in connection with the completion of the Business Combination, (ii) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a stockholder vote to approve an amendment to the Charter to modify the substance or timing of the Company\u2019s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination by March 29, 2023, or to provide for redemption in connection with a Business Combination and (iii) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete a Business Combination by March 29, 2023, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete a Business Combination within the prescribed time frame; and (iv) vote any Founder Shares held by them and any Public Shares purchased during or after the Public Offering (including in open market and privately-negotiated transactions) in favor of the Business Combination The Sponsors have agreed that they will be jointly and severally liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share or (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company\u2019s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act",
        "target": [
            "|   | **September 30, 2021 (unaudited) ** |",
            "| --- | --- |",
            "| **Cash ** | $ 113,902  |",
            "| **Prepaid expenses ** | 1,258,499  |",
            "| **Cash and marketable securities held in trust account ** | 500,023,181  |",
            "| **Accounts payable and accrued liabilities ** | $ 120,000  |",
            "| **Notes payable, affiliates ** | 853,712  |",
            "| **Deferred underwriting commissions ** | 17,500,000  |",
            "| **Class A common stock subject to possible redemption, 50,000,000 shares at redemption value of $10.00 per share ** | $ 500,000,000  |"
        ]
    },
    "brhc10025986_10q_fileoutpart7": {
        "predict": "|   | **Three Months Ended March 31, 2021 ** |\n| --- | --- |\n| **Interest Income ** | N/A |\n| **Class A Ordinary Shares, Basic and Diluted ** | 5,322,492 |\n| **Net Income ** | $5,572,126 |\n| **Class B Ordinary Shares, Basic and Diluted ** | 6,900,000 | \n| **Assets** | $278,773,543 in U.S. Treasury securities and $1,103 in cash |\n| **Liabilities** | U.S. Derivative liabilities |\n| **Share Authorization** | 20,000,000 Class B ordinary shares, with a par value of $0.0001 per share |\n| **Warrant Conversion** | Up to $2,000,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant, at the option of the lender |\n| **Deferred Fee** | $0.35 per Unit, or $9,660,000 in the aggregate |\n| **Public Share Redemption** | Anticipated to be $10.10 per Public Share |\n| **Private Placement Warrants** | 13,040,000 outstanding |\n| **Trust Account Assets** | $278,799,845 in U.S. Derivative liabilities |\n| **Going Concern Considerations** | The Company has until November 27, 2021 to consummate a Business Combination | \n| **Fair Value Hierarchy** | Level 1: $278,773,543 in U.S. Treasury securities <br> Level 3: $1,103 in cash |\n| **Concentrations of Credit Risk** | Cash account in a financial institution may exceed the Federal Depository Insurance Coverage of $250,000 |\n| **Accounting for Warrants and FPA** | Recorded as liabilities in accordance with guidance contained in ASC 815-40 |\n| **Long-term Liabilities** | No long-term debt, capital lease obligations, operating lease obligations, or long-term liabilities, other than an agreement to pay an affiliate of the Sponsor a monthly fee of $10,000 for overhead expenses and related services provided to the Company |\n| **Financial Accounting Standards** | Exempt from being required to comply with new or revised financial accounting standards until private companies are required to comply |\n| **Level 3 Fair Value Measurement Inputs** | See Fair Value Hierarchy |\n| **Indemnity of Underwriters** | Liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company\u2019s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended |\n| **Income Taxes** | Accounts for income taxes under ASC Topic 740, \u201cIncome Taxes,\u201d which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return at a price of $0.01 per warrant |\n| **Ordinary Shares Subject to Possible Redemption** | Accounts for ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (\u201cASC\u201d) Topic 480 \u201cDistinguishing Liabilities from Equity.\u201d |\n| **Redemption Trigger Price** | $10.00 and $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively |\n| **Listing Rules** | Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (excluding the amount of any deferred underwriting discount held in the Trust Account and taxes payable on the income earned on the Trust Account) |\n| **Post-Business Combination Company** | Will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act |\n| **Emerging Growth Company** | The Company is an \u201cemerging growth company,\u201d as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the \u201cJOBS Act\u201d), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved |\n| **Diluted Income (Loss) Per Share** | The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase 24,080,000 shares of Class A common stock in the calculation of diluted income (loss) per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive under the treasury stock method |\n| **Shareholder Approval** | If the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a \u201cgroup\u201d (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the \u201cExchange Act\u201d)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company\u2019s prior written consent |\n| **Business Combination Period** | The Company has until November 27, 2021 to consummate a Business Combination. If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company\u2019s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company\u2019s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law |",
        "target": [
            "|   | **Three Months Ended March 31, 2021 ** |",
            "| --- | --- |",
            "| **Interest Income ** | $ 31,721  |",
            "| **Class A Ordinary Shares, Basic and Diluted ** | 27,600,000  |",
            "| **Net Income ** | $ 5,572,126  |",
            "| **Class B Ordinary Shares, Basic and Diluted ** | 6,900,000  |"
        ]
    },
    "brhc10025986_10q_fileoutpart4": {
        "predict": "| **Operating costs** | **$184,784** |<NEWLINE> | --- | --- | <NEWLINE> | **Loss from operations** | - |<NEWLINE> | **Interest earned on marketable securities held in Trust Account** | $31,721 |<NEWLINE> | **Change in fair value of warrant liability** | $7,328,958 |<NEWLINE> | **Change in fair value of FPA liability** | ($1,603,769) |<NEWLINE> | **Net Income** | $5,572,126 |<NEWLINE> | **Weighted average shares outstanding of Class A ordinary shares** | 5,597,059 |<NEWLINE> | **Weighted average shares outstanding of Class B ordinary shares** | 6,900,000 |<NEWLINE>",
        "target": [
            "| **Operating costs ** | **$ 184,784 ** |",
            "| --- | --- |",
            "| **Loss from operations ** | (184,784)  |",
            "| **Interest earned on marketable securities held in Trust Account ** | 31,721  |",
            "| **Change in fair value of warrant liability ** | 7,328,958  |",
            "| **Change in fair value of FPA liability ** | (1,603,769)  |",
            "| **Net Income ** | $ 5,572,126  |",
            "| **Weighted average shares outstanding of Class A ordinary shares ** | 27,600,000  |",
            "| **Weighted average shares outstanding of Class B ordinary shares ** | 6,900,000  |"
        ]
    },
    "f-20220630_fileoutpart58": {
        "predict": "|   | **June 30, 2022 ** |\n| --- | --- |\n| **Company Cash ** | $28.7 billion |\n| **Liquidity ** | $45.1 billion |\n| **Debt ** | $1.75 billion (364-day revolving credit facility) |",
        "target": [
            "|   | **June 30, 2022 ** |",
            "| --- | --- |",
            "| **Company Cash ** | $ 28.7  |",
            "| **Liquidity ** | 45.1  |",
            "| **Debt ** | (19.4)  |"
        ]
    },
    "f-20220630_fileoutpart73": {
        "predict": "|   | **Second Quarter ** |   |<NEWLINE>|   | **Company excluding Ford Credit ** | **Consolidated ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Interest expense on Company debt excluding Ford Credit ** | $312 million |   |<NEWLINE>| **Provision for/(Benefit from) income taxes ** | $153 million (provision) / $576 million (benefit) |   |<NEWLINE>| **Net income/(loss) attributable to Ford Motor Company ** | $667 million |   |<NEWLINE>| **Issuances for full year 2020** |  $11.3 billion |  $14.1 billion |<NEWLINE>| **Issuances for full year 2021** |  $15.7 billion |  $18.4 billion |<NEWLINE>| **Planned issuances for full year 2022** |  $24 billion |  - |<NEWLINE>| **Global public term funding issuances through July 26, 2022** |  $7.2 billion |  - |<NEWLINE>",
        "target": [
            "|   | **Second Quarter ** |   |",
            "|   | **Company excluding Ford Credit ** | **Consolidated ** |",
            "| --- | --- | --- |",
            "| **Interest expense on Company debt excluding Ford Credit ** | 312  | 312  |",
            "| **Provision for/(Benefit from) income taxes ** | - | 153  |",
            "| **Net income/(loss) attributable to Ford Motor Company ** | - | $ 667  |"
        ]
    },
    "f-20220630_fileoutpart42": {
        "predict": "|   |   |   | **First Half ** |   |\n|   | **2022 ** | **H / (L) ** | **2021 ** | **H / (L) ** |\n| --- | --- | --- | --- | --- |\n| **Cash Flows from Operating Activities ($B) ** | $2.9 | +$2.2 | $0.7 | -$1.1 |\n| **Net Income/(Loss) ($M) ** | $576 | +$654 | ($1,356) | -$1,434 |\n| **Net Income/(Loss) Margin (%) ** | 4.1% | +6.5pts | -3.6% | -8.3pts |\n| **Company Adj. Free Cash Flow ($B) ** | $1.8 | +$2.0 | ($0.2) | -$1.5 |\n| **Company Adj. EBIT ($M) ** | $3,895 | +$5,574 | ($1,679) | -$4,167 |\n| **Company Adj. EBIT Margin (%) ** | 4.9% | +7.1pts | -1.8% | -5.5pts |\n| **Adjusted EPS (Diluted) ** | $0.41 | +$0.53 | ($0.84) | -$0.88 | \n| **Total balance sheet cash, cash equivalents, marketable securities, and restricted cash** | $37.3 billion | - | $29.6 billion | - |\n| **Ford Credit\u2019s liquidity sources including cash, committed asset-backed facilities, and unsecured credit facilities** | $44.6 billion | -$7.6 billion | $33.6 billion | - |\n| **Commodity headwinds** | $4 billion | - | - | - |\n| **Credit facility with a syndicate of banks** | \u00a3750 million | - | - | - | \n| **EBIT by Business Unit (in millions)** | - | <NEWLINE> | - | <NEWLINE> |\n| **Automotive** | $3,297 | +$3,381 | ($97) | -$2,420 |\n| **North America** | $2,563 | +$3,197 | $634 | -$1,247 |\n| **South America** | $11 | +$106 | ($95) | -$130 |\n| **Europe** | $69 | +$242 | ($173) | -$774 |\n| **China (including Taiwan)** | $357 | +$398 | $41 | -$86 |\n| **International Markets Group** | $297 | +$438 | ($504) | -$283 | \n| **Revenue by Major Source (in millions)** | - | <NEWLINE> | - | <NEWLINE> |\n| **Automotive** | $79,210 | +$1,870 | $77,340 | - |\n| **Sales to External Customers** | $76,050 | +$2,350 | $73,700 | - |\n| **Intersegment Sales** | $3,160 | -$480 | $3,640 | - |\n| **Mobility** | $125 | +$26 | $99 | - | \n| **Net Income/(Loss) Margin (%)** | - | <NEWLINE> | - | <NEWLINE> |\n| **Automotive** | 3.1% | +2.3pts | -1.0% | -4.1pts |\n| **North America** | 3.4% | +3.3pts | 0.1% | -2.9pts |\n| **South America** | 0.1% | +3.4pts | -3.3% | -7.4pts |\n| **Europe** | 0.1% | +0.6pts | -0.5% | -1.5pts |\n| **China (including Taiwan)** | 1.5% | +0.8pts | 0.7% | -0.4pts |\n| **International Markets Group** | 0.2% | +3.3pts | -3.1% | -6.4pts | \n| **Ford Credit Debt Extinguishment** | $3 billion | - | - | - |\n| **Net liquidity available for use** | $25 billion | -$7 billion | - | - |\n| **2022Q2 EBIT** | - | <NEWLINE> | - | <NEWLINE> |\n| **South America** | $104 million | +$190 million | $nil | $nil |",
        "target": [
            "|   |   |   | **First Half ** |   |",
            "|   | **2022 ** | **H / (L) ** | **2021 ** | **H / (L) ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Cash Flows from Operating Activities ($B) ** | $ 2.9  | $ 2.2  | - | - |",
            "| **Net Income/(Loss) ($M) ** | 667  | $ 106  | - | - |",
            "| **Net Income/(Loss) Margin (%) ** | 1.7 %  | (0.4) ppts  | - | - |",
            "| **Company Adj. Free Cash Flow ($B) ** | $ 3.6  | $ 8.7  | $ (5.5)  | - |",
            "| **Company Adj. EBIT ($M) ** | 3,722  | - | - | - |",
            "| **Company Adj. EBIT Margin (%) ** | 9.3 %  | 5.4 ppts  | - | 0.2 ppts  |",
            "| **Adjusted EPS (Diluted) ** | $ 0.68  | - | - | - |"
        ]
    },
    "ctlt-20230331_fileoutpart45": {
        "predict": "| **Year-Over-Year Change ** | **2023 vs. 2022 ** |   | \n| --- | --- | --- |\n| **Organic ** | -19% |   | \n| **Constant-currency change ** | N/A |   | \n|   | **Three Months Ended March 31, ** |   | \n| Net revenue | Decreased | Decreased primarily due to a significant decline in demand for COVID-19 related programs as well as inventory write-offs and operational challenges that meaningfully impacted the Biologics segment | \n| Other income, net | $4 million | - | \n| Interest expense, net | $51 million | - | \n| Depreciation expense | $207 million | $66 million for 2022 | \n| Research and development costs | $4 million | - | \n| Segment EBITDA | -46% (excluding impact of acquisitions) | Decreased primarily driven by a significant decline in demand for COVID-19 related programs, inventory write-offs, lower levels of utilization across the Biologics network, as well as an unfavorable impact from remediation-related activities at our Brussels facility, which were partially offset by strong growth in our gene therapy offerings | \n| Provision for income taxes | $63 million | - |",
        "target": [
            "| **Year-Over-Year Change ** | **2023 vs. 2022 ** |   |",
            "|   | **Three Months Ended March 31, ** |   |",
            "| --- | --- | --- |",
            "| **Organic ** | (32)%  | - |",
            "| **Constant-currency change ** | (32)%  | (98)%  |"
        ]
    },
    "ctlt-20230331_fileoutpart3": {
        "predict": "| **Three Months Ended ** |   |   |   |   |\n|   | **March 31, 2023** |   | **Nine Months Ended March 31, 2023** |   |\n|   | **2023** | **2022** | **2023** | **2022** |\n| --- | --- | --- | --- | --- |\n| **Goodwill impairment charges** | >$200 million |   | >$200 million |   |\n| **Other operating expense, net** | $40 million |   | $115 million | $76 million |\n| **Interest expense, net** | >$69 million |   | $105 million | $295 million |\n| **Other (income) expense, net** | $2 million | ($20 million) | $5 million | $20 million |\n| **(Loss) earnings before income taxes** | ($282 million) | $394 million | ($165 million) | $1.37 billion |\n| **Income tax (bene\ufb01t) expense** | $55 million | $63 million | ($19 million) | $300 million |",
        "target": [
            "| **Three Months Ended ** |   |   |   |   |",
            "|   | **March 31, ** |   | **Nine Months Ended March 31, ** |   |",
            "|   | **2023 ** | **2022 ** | **2023 ** | **2022 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Goodwill impairment charges ** | 210  | - | 210  | - |",
            "| **Other operating expense, net ** | - | - | 40  | - |",
            "| **Interest expense, net ** | 51  | - | 130  | - |",
            "| **Other (income) expense, net ** | - | - | - | 25  |",
            "| **(Loss) earnings before income taxes ** | (282)  | 176  | (165)  | 394  |",
            "| **Income tax (bene\ufb01t) expense ** | (55)  | 35  | - | 63  |"
        ]
    },
    "ctlt-20230331_fileoutpart44": {
        "predict": "| **(Dollars in millions) ** | **Three Months Ended March 31, ** |   |<NEWLINE>|   | **2023 ** | **2022 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Interest expense, net ** | $- | $- |<NEWLINE>| **Income tax (bene\ufb01t) expense ** | $55 | $63 |<NEWLINE>",
        "target": [
            "| **(Dollars in millions) ** | **Three Months Ended March 31, ** |   |",
            "|   | **2023 ** | **2022 ** |",
            "| --- | --- | --- |",
            "| **Interest expense, net ** | 51  | - |",
            "| **Income tax (bene\ufb01t) expense ** | (55)  | 35  |"
        ]
    },
    "ctlt-20230331_fileoutpart48": {
        "predict": "|   | **2023 vs. 2022 ** |<NEWLINE>|   | **Nine Months Ended ** |<NEWLINE>| --- | --- |<NEWLINE>| **Organic ** | (9)% |<NEWLINE>| **Impact of acquisitions ** | -  |<NEWLINE>| **Constant-currency change ** |  (9)% |<NEWLINE>| **Total % change ** | (9)% |<NEWLINE>",
        "target": [
            "|   | **2023 vs. 2022 ** |",
            "|   | **Nine Months Ended ** |",
            "| --- | --- |",
            "| **Organic ** | (9)%  |",
            "| **Impact of acquisitions ** | 3%  |",
            "| **Constant-currency change ** | (6)%  |",
            "| **Total % change ** | (9)%  |"
        ]
    },
    "ctlt-20230331_fileoutpart52": {
        "predict": "| **Year-Over-Year Change ** | -46%  |<NEWLINE> | **Segment EBITDA ** | - |<NEWLINE> | **Organic ** | -46% |<NEWLINE> | --- | --- |<NEWLINE> | **Constant-currency change ** | -48% | - |<NEWLINE>",
        "target": [
            "| **Year-Over-Year Change ** |   |",
            "|   | **Segment EBITDA ** |",
            "| **Organic ** | (46)%  |",
            "| --- | --- |",
            "| **Constant-currency change ** | (48)%  |"
        ]
    },
    "ctlt-20230331_fileoutpart47": {
        "predict": "| **(Dollars in millions) ** | **Nine Months Ended March 31, ** |   | **FX Impact ** | **Constant Currency Increase (Decrease) ** |   |\n| --- | --- | --- | --- | --- | --- |\n| **Net revenue ** | $-197 million | $-6 million | $-191 million | $279 million |   |\n| **Gross margin ** | -$298 million | $-9 million | $-289 million | -$238 million |   |\n| **Selling, general, and administrative expenses ** | $14 million |   |   |   |   |\n| **Goodwill impairment charges ** | $200 million | $-210 million |   |   |   |\n| **Other operating expense ** | $40 million |   |   |   |   |\n| **Interest expense, net ** | $51 million | $-3 million | $48 million |   |   |\n| **Other (income) expense, net ** | $2 million |   |   |   |   |\n| **(Loss) earnings before income taxes ** | -$165 million |   |   |   |   |\n| **Income tax (bene\ufb01t) expense ** | -$19 million |   |   |   |   |",
        "target": [
            "| **(Dollars in millions) ** | **Nine Months Ended March 31, ** |   | **FX Impact ** | **Constant Currency Increase (Decrease) ** |   |",
            "|   | **2023 ** | **2022 ** |   | **Change $ ** | **Change % ** |",
            "| --- | --- | --- | --- | --- | --- |",
            "| **Net revenue ** | - | - | - | $ (197)  | (6)%  |",
            "| **Gross margin ** | - | - | (29)  | (298)  | (26)%  |",
            "| **Selling, general, and administrative expenses ** | - | - | - | 7  | - |",
            "| **Goodwill impairment charges ** | 210  | - | - | 210  | - |",
            "| **Other operating expense ** | 40  | 25  | - | - | 50 %  |",
            "| **Interest expense, net ** | 130  | - | - | 41  | 44 %  |",
            "| **Other (income) expense, net ** | - | 25  | - | - | - |",
            "| **(Loss) earnings before income taxes ** | (165)  | 394  | - | - | - |",
            "| **Income tax (bene\ufb01t) expense ** | - | 63  | - | - | - |"
        ]
    },
    "ctlt-20230331_fileoutpart42": {
        "predict": "| **(Dollars in millions) ** | **Three Months Ended March 31, ** | **FX Impact ** | **Constant Currency Increase (Decrease) ** |   |\n| --- | --- | --- | --- | --- |\n| **Net revenue ** | $-197 | $0 | $6 |   |\n| **Segment EBITDA ** | $-15 |   |   |   |\n| **Net revenue ** | $-216 | $0 | $4 |   |\n| **Net revenue ** | $-400 | $0 |   | 2% |\n| **Inventory cost adjustment** | $1 |   |   |   |\n| **Selling, general, and administrative expense** | $-21 |   |   |   |\n| **Goodwill impairment charges** |   |   |   | $210 |\n| **Contract assets** | $9 |   | $64 |   |",
        "target": [
            "| **(Dollars in millions) ** | **Three Months Ended March 31, ** | **FX Impact ** | **Constant Currency Increase (Decrease) ** |   |",
            "|   | **2023 ** |   | **Change $ ** | **Change % ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Net revenue ** | - | - | $ (222)  | (32)%  |",
            "| **Segment EBITDA ** | 6  | - | (214)  | (98)%  |",
            "| **Net revenue ** | - | (17)  | 6  | 1%  |",
            "| **Net revenue ** | - | - | $ (216)  | (17)%  |"
        ]
    },
    "ctlt-20230331_fileoutpart17": {
        "predict": "| **(Dollars in millions) ** | **Preliminary Purchase Price Allocation ** |<NEWLINE> | --- | --- |<NEWLINE> | **Other intangibles, net ** | $52 million |<NEWLINE> | **Goodwill ** | $200 million |<NEWLINE> | **Total assets acquired and liabilities assumed ** | $1 billion |<NEWLINE> | Net revenue | Decreased 9% organically on a constant-currency basis |<NEWLINE> | Research and development costs | $13 million (2023), $18 million (2022) |<NEWLINE> | Gain on sale of subsidiary | Due to divestiture of former facility in Woodstock, Illinois and associated business |<NEWLINE> | President and Chief Financial Officer | Ricky Hopson, effective April 14, 2023 |<NEWLINE> | Impairment charge | $210 million (Consumer Health reporting unit) |<NEWLINE> | Foreign currency remeasurement gains/losses | Included in other income (expense), net |<NEWLINE> | Interest-rate swap agreement | $500 million of term loan effectively fixed at 0.9985% as of February 2021 |<NEWLINE>",
        "target": [
            "| **(Dollars in millions) ** | **Preliminary Purchase Price Allocation ** |",
            "| --- | --- |",
            "| **Other intangibles, net ** | 52  |",
            "| **Goodwill ** | 216  |",
            "| **Total assets acquired and liabilities assumed ** | $ 474  |"
        ]
    },
    "medies_i10q-053123_fileoutpart4": {
        "predict": "|   | **For the period ended May 31, 2023 ** | **For the period ended May 31, 2022 ** |<NEWLINE>| **CASH FLOWS FROM OPERATING ACTIVITIES ** | ($1,012) | ($3,500) |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Net loss ** | ($6,336) | ($9,939) |<NEWLINE>| **Amortization ** | $3,265 | $2,223 |<NEWLINE>| **Depreciation ** | $1,947 | - |<NEWLINE>| **Net cash provided by (used in) Operating activities ** |   |   |<NEWLINE>| **Increase (decrease) in cash and equivalents ** |   |   |<NEWLINE>| **Cash and equivalents at end of the period ** |   |   |",
        "target": [
            "|   | **For the period ended May 31, 2023 ** | **For the period ended May 31, 2022 ** |",
            "| **CASH FLOWS FROM OPERATING ACTIVITIES ** |   |   |",
            "| --- | --- | --- |",
            "| **Net loss ** | $ (6,336)  | $ (9,939)  |",
            "| **Amortization ** | 3,265  | 2,223  |",
            "| **Depreciation ** | 1,947  | 1,947  |",
            "| **Net cash provided by (used in) Operating activities ** | (1,012)  | (3,500)  |",
            "| **Increase (decrease) in cash and equivalents ** | (1,012)  | - |",
            "| **Cash and equivalents at end of the period ** | $ 850  | $ 400  |"
        ]
    },
    "medies_i10q-053123_fileoutpart1": {
        "predict": "|   | **MAY 31, 2023 (Unaudited) ** | **FEBRUARY 28, 2023 (Audited) ** |\n| --- | --- | --- |\n| **Cash & cash equivalents ** | $0 | $0 |\n| **Intangibles (net) ** | $26,680 | $27,860 |\n| **Equipment (net) ** | $38,930 | $38,930 |\n| **TOTAL ASSETS ** | $65,610 | $66,790 |\n| **Total current liabilities ** | $56,580 | $18,000 |\n| **Note Payable - RP ** | $12,500 | $0 |\n| **Accounts Payable ** | $25,500 | $18,000 |\n| **Total non-current liabilities ** | $38,000 | $20,000 |\n| **Total Liabilities ** | $94,580 | $38,000 |\n| **Accumulated Deficit ** | $67,600 | $61,264 |",
        "target": [
            "|   | **MAY 31, 2023 (Unaudited) ** | **FEBRUARY 28, 2023 (Audited) ** |",
            "| --- | --- | --- |",
            "| **Cash & cash equivalents ** | $ 850  | - |",
            "| **Intangibles (net) ** | 24,918  | - |",
            "| **Equipment (net) ** | 28,778  | - |",
            "| **TOTAL ASSETS ** | $ 54,546  | - |",
            "| **Total current liabilities ** | 56,580  | - |",
            "| **Note Payable - RP ** | 12,500  | 12,500  |",
            "| **Accounts Payable ** | 25,500  | 25,500  |",
            "| **Total non-current liabilities ** | 38,000  | 38,000  |",
            "| **Total Liabilities ** | 94,580  | - |",
            "| **Accumulated Deficit ** | (67,600)  | - |"
        ]
    },
    "form10-q_fileoutpart30": {
        "predict": "|   | **Nine Months Ended July 31, ** | **Increase (Decrease) ** |   |\n|   | **2022 ** | **$ ** | **% ** |\n| --- | --- | --- | --- |\n| **Hotspot/Off-the-Shelf therapies ** | $3,076,000 | 22% | - |\n| **Prostate cancer ** | ($122,000) | (59%) | - |\n| **HPV-associated cancers ** | $0 | - | - |\n| **Personalized neoantigen-directed therapies ** | ($392,000) | (98%) | - |\n| **Other expenses ** | $1,271,000 | 133% | $1,743,000 |",
        "target": [
            "|   | **Nine Months Ended July 31, ** | **Increase (Decrease) ** |   |",
            "|   | **2022 ** | **$ ** | **% ** |",
            "| --- | --- | --- | --- |",
            "| **Hotspot/Off-the-Shelf therapies ** | $ 3,076  | - | 22%  |",
            "| **Prostate cancer ** | - | (122)  | (59)%  |",
            "| **HPV-associated cancers ** | - | (1,533)  | (82)%  |",
            "| **Personalized neoantigen-directed therapies ** | - | (392)  | (98)%  |",
            "| **Other expenses ** | - | (1,743)  | (48)%  |"
        ]
    },
    "form10-q_fileoutpart27": {
        "predict": "|   | **Preferred Stock Redemption Liability** | **Warrant Liabilities** | **Total** |\n| --- | --- | --- | --- |\n| **Fair value at October 31, 2021** | $87,000 | $8,758,000 | $8,845,000 |\n| **Additions** |   | $72,000 | $72,000 |\n| **Change in fair value** | ($43,000) | ($4,642,000) | ($4,685,000) |\n| **Redemption** | ($5,250,000) |   | ($5,250,000) |\n| **Fair value at July 31, 2022** | $38,000 | $4,188,000 | $4,226,000 |",
        "target": [
            "|   | **Preferred Stock Redemption Liability ** | **Warrant Liabilities ** | **Total ** |",
            "| --- | --- | --- | --- |",
            "| **Fair value at October 31, 2021 ** | - | $ 4,929  | $ 4,929  |",
            "| **Additions ** | 87  | - | 87  |",
            "| **Change in fair value ** | - | (4,642)  | (4,685)  |",
            "| **Redemption ** | (44)  | - | (44)  |",
            "| **Fair value at July 31, 2022 ** | - | $ 287  | $ 287  |"
        ]
    },
    "form10-q_fileoutpart28": {
        "predict": "|   | **Three Months Ended July 31, ** |   | **Increase (Decrease) ** |   |\n|   | **2022 ** | **2021 ** | **$1,000 ** | **% ** |\n| --- | --- | --- | --- | --- |\n| **Hotspot/Off-the-Shelf therapies ** | $1,271 | $548 | $723 | 133% |\n| **Prostate cancer ** | $- | $205 | ($205) | (100%) |\n| **HPV-associated cancers ** | $- | $173 | ($173) | (100%) |\n| **Personalized neoantigen-directed therapies ** | $- | $392 | ($392) | (100%) |\n| **Other expenses ** | $- | $1,743 | ($1,743) | (100%) |\n| **Stock-based compensation expense included in research and development expense ** | $47 | $56 | ($9) | (16%) |",
        "target": [
            "|   | **Three Months Ended July 31, ** |   | **Increase (Decrease) ** |   |",
            "|   | **2022 ** | **2021 ** | **$ ** | **% ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Hotspot/Off-the-Shelf therapies ** | $ 1,271  | - | - | 133%  |",
            "| **Prostate cancer ** | 32  | - | - | (72)%  |",
            "| **HPV-associated cancers ** | - | - | (173)  | (41)%  |",
            "| **Personalized neoantigen-directed therapies ** | - | 7  | (7)  | - |",
            "| **Other expenses ** | - | - | 66  | 11%  |",
            "| **Stock-based compensation expense included in research and development expense ** | - | $ 29  | - | (59)%  |"
        ]
    },
    "form10-q_fileoutpart4": {
        "predict": "|   | **Nine Months Ended July 31, ** |   |\n|   | **2022 ** | **2021 ** |\n| --- | --- | --- |\n| **Gain on change in value of warrants ** | $4,685,000 | - |\n| **Loss on disposal of property and equipment ** | - | Prior period losses |\n| **Abandonment of intangible assets ** | $159,000 | $90,000 |\n| **Impairment charges on intangible assets ** | $3,005,000 | - |\n| **Depreciation expense ** | $13,000 | $50,000 |\n| **Amortization expense of intangible assets ** | $210,000 | $203,000 |\n| **Net gain on write-off of right-of-use asset and lease liability ** | $116,000 | - |\n| **Net cash used in operating activities ** | $12,307,000 | $11,703,000 |\n| **Net cash used in investing activities ** | $201,000 | $104,000 |\n| **Net proceeds of issuance of Series D preferred stock ** | $5,000,000 | - |\n| **Redemption of Series D preferred stock ** | $44,000 | - |\n| **Net cash (used in) provided by financing activities ** | $4,300,000 | - |\n| **Reclassification of preferred stock redemption liability into equity upon redemption of preferred stock ** | $44,000 | - |\n| **Accretion of discount and redemption feature of convertible preferred stock ** | $87,000 | - | \n| **Accumulated deficit ** | $438.4 million | $428.6 million |\n| **Stockholders' equity ** | $28.2 million | $38.9 million |\n| **Future minimum lease payments under non-cancellable leases as of July 31, 2022** | $43,000 | - |\n| **Total outstanding warrants as of July 31, 2022** | 377,818 | - |\n| **Aggregate proceeds from warrant exercises** | Approximately $3.8 million | - |\n| **Net income for Q3 2022** | $4,642,000 | - |\n| **Revenue for Q3 2022** | $0 | $250,000 |\n| **COVID-19 impact on business, operations, financial condition or liquidity** | Unknown extent, duration or scope | - | \n| **Berlins Employment Agreement, dated as of April 10, 2018** | - | - | \n| **Quarterly report filed under Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 90 days** | Yes | Yes |",
        "target": [
            "|   | **Nine Months Ended July 31, ** |   |",
            "|   | **2022 ** | **2021 ** |",
            "| --- | --- | --- |",
            "| **Gain on change in value of warrants ** | (4,642)  | (1,814)  |",
            "| **Loss on disposal of property and equipment ** | - | 1,530  |",
            "| **Abandonment of intangible assets ** | 159  | 90  |",
            "| **Impairment charges on intangible assets ** | 3,005  | - |",
            "| **Depreciation expense ** | 45  | 366  |",
            "| **Amortization expense of intangible assets ** | 210  | 203  |",
            "| **Net gain on write-off of right-of-use asset and lease liability ** | - | (116)  |",
            "| **Net cash used in operating activities ** | (12,307)  | (11,703)  |",
            "| **Net cash used in investing activities ** | (201)  | (104)  |",
            "| **Net proceeds of issuance of Series D preferred stock ** | 4,312  | - |",
            "| **Redemption of Series D preferred stock ** | (5,250)  | - |",
            "| **Net cash (used in) provided by financing activities ** | (956)  | 31,886  |",
            "| **Reclassification of preferred stock redemption liability into equity upon redemption of preferred stock ** | 44  | - |",
            "| **Accretion of discount and redemption feature of convertible preferred stock ** | 1,025  | - |"
        ]
    },
    "form10-q_fileoutpart18": {
        "predict": "|   | **July 31, 2022 ** | **October 31, 2021 ** |\n| --- | --- | --- |\n| **Exercise Price ** | $20.00 to $224.00 per share |   |\n| **Stock Price ** |   |   |\n| Level 3 liabilities measured at fair value (in thousands) | Unobservable inputs | Unobservable inputs |\n| Assets carried at fair value measured on a recurring basis (in thousands) | Approximately $287,000 | Approximately $4,929,000 |",
        "target": [
            "|   | **July 31, 2022 ** | **October 31, 2021 ** |",
            "| --- | --- | --- |",
            "| **Exercise Price ** | $ 20.00  | - |",
            "| **Stock Price ** | $ 3.73  | $ 38.80  |"
        ]
    },
    "pir-10q_20181201_fileoutpart15": {
        "predict": "|   | **13 Weeks December 1, 2018 ** | **Ended November 25, 2017 ** | **39 Weeks December 1, 2018 ** | **Ended November 25, 2017 .1** |\n| --- | --- | --- | --- | --- |\n| **EBITDA (non-GAAP) ** | $3.3 million | $28.5 million | $8.9 million | $69.9 million |\n| **Less: Income tax provision (bene\ufb01t) ** | $17.9 million | $3.7 million | $31.9 million | $9.9 million |\n| **Depreciation ** | $23.6 million | $25.6 million | $73.2 million | $76.4 million |\n| **Net income (loss) (GAAP) ** | ($50.4) million | $7.4 million | ($133.2) million | $22.7 million |",
        "target": [
            "|   | **13 Weeks December 1, 2018 ** | **Ended November 25, 2017 ** | **39 Weeks December 1, 2018 ** | **Ended November 25, 2017 .1** |",
            "| --- | --- | --- | --- | --- |",
            "| **EBITDA (non-GAAP) ** | $ (16.9 )  | $ 26.7  | $ (84.8 )  | $ 41.2  |",
            "| **Less: Income tax provision (bene\ufb01t) ** | 17.9  | 3.7  | (2.3 )  | (4.2)  |",
            "| **Depreciation ** | 12.4  | 12.8  | 38.1  | 40.0  |",
            "| **Net income (loss) (GAAP) ** | $ (50.4 )  | $ 7.4  | $ (130.0 )  | $ (3.4)  |"
        ]
    },
    "pir-10q_20181201_fileoutpart11": {
        "predict": "|   | **13 Weeks Ended ** |   | **39 Weeks Ended ** |   |<NEWLINE>| **Key Performance Indicators ** | **December 1, 2018 ** | **November 25, 2017 ** | **December 1, 2018 ** | **November 25, 2017 ** |<NEWLINE>| --- | --- | --- | --- | --- |<NEWLINE>| **Total sales decline ** | $146 million | $29 million | $146 million | $29 million |<NEWLINE>| **Company comparable sales growth (decline) ** | -11.4% | -0.7% | -11.3% | -3.5% |<NEWLINE>| **Gross pro\ufb01t as a % of sales ** | 30.7% | 33.2% | 30.7% | 34.0% |<NEWLINE>| **Selling, general and administrative expenses as a % of sales ** | 40.5% | 33.6% | 37.6% | 34.1% |<NEWLINE>| **Operating income (loss) as a % of sales ** | -17.9% | 1.3% | -14.3% | -2.0% |<NEWLINE>| **Net income (loss) (in millions) ** | -$50.4 million | $7.4 million | -$139.2 million | -$45.4 million |<NEWLINE>| **EBITDA (in millions) (1) ** | -$27.4 million | $17.3 million | -$51.3 million | -$8.1 million |<NEWLINE>",
        "target": [
            "|   | **13 Weeks Ended ** |   | **39 Weeks Ended ** |   |",
            "| **Key Performance Indicators ** | **December 1, 2018 ** | **November 25, 2017 ** | **December 1, 2018 ** | **November 25, 2017 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Total sales decline ** | (11.9 %)  | - | (11.3%)  | - |",
            "| **Company comparable sales growth (decline) ** | (10.5 %)  | - | (10.1%)  | - |",
            "| **Gross pro\ufb01t as a % of sales ** | 31.6 %  | 37.7%  | 30.2%  | 36.4%  |",
            "| **Selling, general and administrative expenses as a % of sales ** | 35.6 %  | 32.1%  | 37.6%  | 33.3%  |",
            "| **Operating income (loss) as a % of sales ** | (7.0 %)  | 2.9%  | - | - |",
            "| **Net income (loss) (in millions) ** | $ (50.4 )  | $ 7.4  | $ (130.0)  | $ (3.4)  |",
            "| **EBITDA (in millions) (1) ** | $ (16.9 )  | $ 26.7  | $ (84.8)  | $ 41.2  |"
        ]
    },
    "pir-10q_20181201_fileoutpart14": {
        "predict": "|   | **13 Weeks Ended ** |   |   |   | **39 Weeks Ended ** |   |   |   |\n|   | **December 1, 2018 ** |   | **November 25, 2017 ** |   | **December 1, 2018 ** |   | **November 25, 2017 ** |   |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| **Total selling, general and administrative ** | $428.7 million | - | - | - | $1.140 billion | - | - | - | \n| **Net sales** | $413.2 million | - | $469.2 million | - | $1.105 billion | - | $1.322 billion | - |\n| **Net loss** | $50.4 million | - | - | - | ($178.6) million | - | ($47.7) million | - |\n| **EBITDA** | ($16.9) million | - | $26.7 million | - | ($84.8) million | - | $41.2 million | - |\n| **Adjusted EBITDA** | - | - | - | - | $47.8 million | - | $111.8 million | - |\n| **Gross profit** | - | - | - | - | $344.1 million | - | $468.4 million | - |\n| **Depreciation expense** | - | - | - | - | $38.1 million | - | $40.0 million | - |\n| **Income tax provision** | - | - | - | - | ($0.4) million | - | ($16.6) million | - |\n| **Cash and cash equivalents** | $71.1 million | - | $80.2 million | - | $71.1 million | - | $80.2 million | - |",
        "target": [
            "|   | **13 Weeks Ended ** |   |   |   | **39 Weeks Ended ** |   |   |   |",
            "|   | **December 1, 2018 ** |   | **November 25, 2017 ** |   | **December 1, 2018 ** |   | **November 25, 2017 ** |   |",
            "| --- | --- | --- | --- | --- | --- | --- | --- | --- |",
            "| **Total selling, general and administrative ** | $ 147.0  | 35.6%  | $ 150.4  | 32.1%  | $ 428.7  | 37.6%  | $ 428.7  | 33.3%  |"
        ]
    },
    "pir-10q_20181201_fileoutpart16": {
        "predict": "|   | **13 Weeks Ended ** |   | **39 Weeks Ended ** |   |<NEWLINE>|   | **December 1, 2018 ** | **November 25, 2017 ** | **December 1, 2018 ** | **November 25, 2017 ** |<NEWLINE>| --- | --- | --- | --- | --- |<NEWLINE>| **EBITDA (Non-GAAP) ** | ($16.9) million | $26.7 million | ($84.8) million | $41.2 million |<NEWLINE>| **Add back: Legal and regulatory matters ** | - | - | $22.8 million | $9.0 million |<NEWLINE>| **Adjusted EBITDA (Non-GAAP) ** | $47.8 million | $26.7 million | ($62.0) million | $50.2 million |<NEWLINE>| **Net income (loss) (GAAP) ** | ($50.4) million | $7.4 million | ($127.6) million | $1.7 million |<NEWLINE>| **Add back: Legal and regulatory matters, net of tax (1) ** | - | - | $16.2 million | $6.4 million |<NEWLINE>| **Adjusted net income (loss) (Non-GAAP) ** | ($34.2) million | $7.4 million | ($111.4) million | $8.1 million |<NEWLINE>| **Earnings (loss) per share (GAAP) ** | ($0.62) | $0.09 | ($1.56) | $0.02 |<NEWLINE>| **Adjusted earnings (loss) per share (Non-GAAP) ** | ($0.42) | $0.09 | ($1.36) | $0.10 |<NEWLINE>",
        "target": [
            "|   | **13 Weeks Ended ** |   | **39 Weeks Ended ** |   |",
            "|   | **December 1, 2018 ** | **November 25, 2017 ** | **December 1, 2018 ** | **November 25, 2017 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **EBITDA (Non-GAAP) ** | $ (16.9 )  | $ 26.7  | $ (84.8)  | $ 41.2  |",
            "| **Add back: Legal and regulatory matters ** | - | - | - | 6.6  |",
            "| **Adjusted EBITDA (Non-GAAP) ** | $ (16.9 )  | $ 26.7  | $ (84.8)  | $ 47.8  |",
            "| **Net income (loss) (GAAP) ** | $ (50.4 )  | $ 7.4  | $ (130.0)  | $ (3.4)  |",
            "| **Add back: Legal and regulatory matters, net of tax (1) ** | - | - | - | 3.7  |",
            "| **Adjusted net income (loss) (Non-GAAP) ** | $ (50.4 )  | - | $ (130.0)  | $ 0.3  |",
            "| **Earnings (loss) per share (GAAP) ** | $ (0.62 )  | $ 0.09  | $ (1.62)  | $ (0.04)  |",
            "| **Adjusted earnings (loss) per share (Non-GAAP) ** | $ (0.62 )  | $ 0.09  | $ (1.62)  | $ 0.01  |"
        ]
    },
    "eaco-20230531x10q_fileoutpart14": {
        "predict": "|   | **Nine Months Ended May 31, ** |   | **$ Change ** |\n|   | **2023 ** | **2022 ** |   |\n| --- | --- | --- | --- |\n| **Income tax provision ** | $1,622,000 | $1,878,000 | ($256,000) |\n| **Percent of pre-tax income ** | 25.6% | 26.1% | (0.5%) |",
        "target": [
            "|   | **Nine Months Ended May 31, ** |   | **$ Change ** |",
            "|   | **2023 ** | **2022 ** |   |",
            "| --- | --- | --- | --- |",
            "| **Income tax provision ** | $ 5,216  | $ 5,471  | $ 255  |",
            "| **Percent of pre-tax income ** | 25.6 %  | 26.1 %  |   |"
        ]
    },
    "eaco-20230531x10q_fileoutpart10": {
        "predict": "|   | **Three Months Ended May 31, ** |   | **$ Change ** |\n|   | **2023 ** | **2022 ** |   |\n| --- | --- | --- | --- |\n| **Income tax provision ** | $1,772,000 | $1,878,000 | $(106,000) |\n| **Percent of pre-tax income ** | 25.6% | 26.1% | (0.5%) |",
        "target": [
            "|   | **Three Months Ended May 31, ** |   | **$ Change ** |",
            "|   | **2023 ** | **2022 ** |   |",
            "| --- | --- | --- | --- |",
            "| **Income tax provision ** | $ 1,772  | $ 1,878  | $ (106)  |",
            "| **Percent of pre-tax income ** | - | 26.1 %  |   |"
        ]
    },
    "riv10q123120_fileoutpart39": {
        "predict": "|   | **December 31, 2020 ** | **March 31, 2020 ** |\n| --- | --- | --- |\n| **Total nonperforming assets ** | $256,000 | $0 |\n| **Foregone interest on non-accrual loans (1) ** | $13,000 | $0 |\n| **Total nonperforming loans to total loans ** | 0.52% | 0.00% |\n| **Total nonperforming loans to total assets ** | 0.44% | 0.00% |\n| **Total nonperforming assets to total assets ** | 0.53% | 0.00% | \n| **Loans delinquent 30-89 days** | Commercial business and consumer loans | Consumer loans |\n| **Loans delinquent 30-89 days as a % of total loans** | 0.04% | 0.03% |\n| **Purchased SBA loan portfolio** | $53.7 million | $74.8 million |\n| **Loan modifications (non-COVID-19 related)** | $462,000 (2 loans) | - |\n| **Loan modifications (COVID-19 related)** | 43 loans totaling $6.7 million | 43 loans totaling $10.1 million |\n| **Provision for loan losses** | $6.3 million | - |\n| **Loans receivable, net** | $912.3 million | $898.9 million |\n| **Non-interest income** | $2.8 million (3 months ended Dec. 31, 2020) $8.3 million (9 months ended Dec. 31, 2020) | $3.2 million (3 months ended Dec. 31, 2019) $9.5 million (9 months ended Dec. 31, 2019) |",
        "target": [
            "|   | **December 31, 2020 ** | **March 31, 2020 ** |",
            "| --- | --- | --- |",
            "| **Total nonperforming assets ** | $ 393  | - |",
            "| **Foregone interest on non-accrual loans (1) ** | $ 42  | - |",
            "| **Total nonperforming loans to total loans ** | 0.04%  | - |",
            "| **Total nonperforming loans to total assets ** | 0.03%  | 0.12%  |",
            "| **Total nonperforming assets to total assets ** | 0.03%  | 0.12%  |"
        ]
    },
    "algn-20200630_fileoutpart45": {
        "predict": "|   | **Three Months Ended June 30, ** |   | **Six Months Ended June 30, ** |   |\n|   | **2020 ** | **2019 ** | **2020 ** | **2019 ** |\n| --- | --- | --- | --- | --- |\n| **Provision for (benefit from) income taxes ** | $32.9 million | $43.1 million | $1.5 billion | not material |\n| **Effective tax rates ** | 44.8% | 22.2% | not mentioned | not mentioned |",
        "target": [
            "|   | **Three Months Ended June 30, ** |   | **Six Months Ended June 30, ** |   |",
            "|   | **2020 ** | **2019 ** | **2020 ** | **2019 ** |",
            "| --- | --- | --- | --- | --- |",
            "| **Provision for (benefit from) income taxes ** | $ (32.9)  | $ 43.1  | $ (1,497.7)  | $ 51.9  |",
            "| **Effective tax rates ** | 44.8 %  | 22.2 %  | 7,437.0 %  | 18.6 %  |"
        ]
    },
    "pssr-20220131_fileoutpart7": {
        "predict": "| **Revenue by type of customer: ** | **Three Months Ended January 31, 2022 ** | **Three Months Ended January 31, 2021 ** |\n| --- | --- | --- |\n| **Other ** | $1,512,000 | $1,698,000 |\n| **Total Revenue ** | N/A | N/A |",
        "target": [
            "| **Revenue by type of customer: ** | **Three Months Ended January 31, 2022 ** | **Three Months Ended January 31, 2021 ** |",
            "| --- | --- | --- |",
            "| **Other ** | 192,000  | 68,000  |",
            "| **Total Revenue ** | $ 1,512,000  | $ 1,698,000  |"
        ]
    },
    "brhc10031933_10qa_fileoutpart2": {
        "predict": "|   | **Three Months Ended September 30, ** | **Nine Months Ended September 30, ** | **For the Period from January 24, 2020 (Inception) Through September 30, ** |\n|   | **2021 ** | **2021 ** | **2020 ** |\n| --- | --- | --- | --- |\n| **Operating and formation costs ** | $271,647 | $531,533 | $5,056 |\n| **Loss from operations ** | $- | $- | $- |\n| **Change in fair value of warrants ** | $8,640,000 | $10,240,000 | $- |\n| **Transaction costs allocated to warrants ** | $- | $853,386 | $11,766,856 |\n| **Interest earned on investments held in Trust Account ** | $14,169 | $32,532 | $- |\n| **Net income (loss) ** | $8,382,522 | $8,887,613 | $- |\n| **Weighted average shares outstanding, Class A ordinary shares ** | $- | $- | $- |\n| **Weighted average shares outstanding, Class B ordinary shares ** | $- | $- | $- | \nNote: The financial report segment does not provide information for the table cells related to shares outstanding, and therefore they remain empty.",
        "target": [
            "|   | **Three Months Ended September 30, ** | **Nine Months Ended September 30, ** | **For the Period from January 24, 2020 (Inception) Through September 30, ** |",
            "|   | **2021 ** | **2021 ** | **2020 ** |",
            "| --- | --- | --- | --- |",
            "| **Operating and formation costs ** | - | - | $ 5,056  |",
            "| **Loss from operations ** | - | - | (5,056)  |",
            "| **Change in fair value of warrants ** | 8,640,000  | 10,240,000  | - |",
            "| **Transaction costs allocated to warrants ** | - | (853,386)  | - |",
            "| **Interest earned on investments held in Trust Account ** | 14,169  | 32,532  | - |",
            "| **Net income (loss) ** | - | - | $ (5,056)  |",
            "| **Weighted average shares outstanding, Class A ordinary shares ** | 20,000,000  | - | - |",
            "| **Weighted average shares outstanding, Class B ordinary shares ** | 5,000,000  | - | - |"
        ]
    },
    "brhc10031933_10qa_fileoutpart5": {
        "predict": "|   | **Nine Months Ended September 30, 2021 ** | **For the Period from January 24, 2020 (Inception) Through September 30, 2020 ** |\n| --- | --- | --- |\n| **Net income (loss) ** | $8,887,613 | ($5,056) |\n| **Adjustments to reconcile net income (loss) to net cash used in operating activities: Formation cost paid by Sponsor in exchange for issuance of founder shares ** | $5,000 | $25,000 |\n| **Interest earned on marketable securities held in Trust Account ** | $32,532 |   |\n| **Change in fair value of warrants ** | $10,240,000 |   |\n| **Transaction costs allocated to warrants ** | $853,386 |   |\n| **Net cash used in operating activities ** | ($636,628) | ($56) |\n| **Investment of cash in Trust Account ** | $200,032,532 | $10,000,000 |\n| **Net cash used in investing activities ** |   |   |\n| **Proceeds from issuance of Class B ordinary shares to Sponsor ** |   | $250,000 |\n| **Proceeds from sale of Private Placements Warrants ** | $6,000,000 |   |\n| **Repayment of promissory note \u2013 related party ** | $250,000 |   |\n| **Cash \u2013 End of period ** | $724,452 | $4,025,944 |\n| **Deferred underwriting fee payable ** | $7,000,000 |   |",
        "target": [
            "|   | **Nine Months Ended September 30, 2021 ** | **For the Period from January 24, 2020 (Inception) Through September 30, 2020 ** |",
            "| --- | --- | --- |",
            "| **Net income (loss) ** | - | $ (5,056)  |",
            "| **Adjustments to reconcile net income (loss) to net cash used in operating activities: Formation cost paid by Sponsor in exchange for issuance of founder shares ** | - | 5,000  |",
            "| **Interest earned on marketable securities held in Trust Account ** | (32,532)  | - |",
            "| **Change in fair value of warrants ** | (10,240,000)  | - |",
            "| **Transaction costs allocated to warrants ** | 853,386  | - |",
            "| **Net cash used in operating activities ** | (636,628)  | (56)  |",
            "| **Investment of cash in Trust Account ** | (200,000,000)  | - |",
            "| **Net cash used in investing activities ** | (200,000,000)  | - |",
            "| **Proceeds from issuance of Class B ordinary shares to Sponsor ** | - | 25,000  |",
            "| **Proceeds from sale of Private Placements Warrants ** | 6,000,000  | - |",
            "| **Repayment of promissory note \u2013 related party ** | (250,000)  | - |",
            "| **Cash \u2013 End of period ** | $ 724,452  | - |",
            "| **Deferred underwriting fee payable ** | $ 7,000,000  | - |"
        ]
    },
    "iot-20220730_fileoutpart38": {
        "predict": "|   | **July 31, 2021 ** | **% ** | **July 31, 2021 ** | **% ** |\n| --- | --- | --- | --- | --- |\n| **Sales and marketing ** | $8.4 million | 12% | $13.1 million | 12% |\n| --- | --- | --- | --- | --- |\n| **Percentage of revenue ** | N/A | N/A | N/A | N/A | \n\n(Note: No updates to the table were required based on the given financial report segment.)",
        "target": [
            "|   | **July 31, 2021 ** | **% ** | **July 31, 2021 ** | **% ** |",
            "| **Sales and marketing ** | - | 65 %  | - | 66 %  |",
            "| --- | --- | --- | --- | --- |",
            "| **Percentage of revenue ** | 55 %  |   | 57 %  |   |"
        ]
    },
    "iot-20220730_fileoutpart42": {
        "predict": "|   | **Three Months Ended ** |   |   | **Six Months Ended ** |   |   |\n|   | **July 30, 2022 ** | **July 31, 2021 ** | **% ** | **July 30, 2022 ** | **July 31, 2021 ** | **% ** |\n| --- | --- | --- | --- | --- | --- | --- |\n| **Provision for income taxes ** | $0.4 million | $0.4 million |   | $0.8 million | $0.4 million |   |\n| **Effective tax rate ** | (0.1)% | (1.2)% |   | (0.6)% | (0.5)% |   |",
        "target": [
            "|   | **Three Months Ended ** |   |   | **Six Months Ended ** |   |   |",
            "|   | **July 30, 2022 ** | **July 31, 2021 ** | **% ** | **July 30, 2022 ** | **July 31, 2021 ** | **% ** |",
            "| --- | --- | --- | --- | --- | --- | --- |",
            "| **Provision for income taxes ** | - | - | (89)%  | - | - | 107 %  |",
            "| **Effective tax rate ** | (0.1 %)  | (1.2 %)  |   | (0.6 %)  | (0.5 %)  |   |"
        ]
    },
    "sodi_10q_fileoutpart6": {
        "predict": "|   | **For the three months ended May 31, 2020 ** | **For the three months ended May 31, 2019 ** |\n| --- | --- | --- |\n| **Net income (loss) ** | $369,000 | ($249,000) |\n| **Depreciation and amortization ** | $75,000 | $62,000 |\n| **Accounts receivable ** | $357,000 | $439,000 |\n| **Inventories ** | $1,685,000 | $1,387,000 |\n| **Prepaid expenses and other current assets ** | $31,000 | $26,000 |\n| **Net cash provided by operating activities ** | $538,000 | $334,000 |\n| **Proceeds from sale of securities ** | $35,000 | $0 |\n| **Purchases of securities ** | ($19,000) | $0 |\n| **Purchases of property and equipment ** | $3,000 | $3,000 |\n| **Net cash (used in) provided by investing activities ** | $13,000 | $0 |\n| **Cash and cash equivalents - beginning of the year ** | $1,332,000 | $945,000 |\n| **Cash and cash equivalents - end of period ** | $1,549,000 | $1,123,000 |",
        "target": [
            "|   | **For the three months ended May 31, 2020 ** | **For the three months ended May 31, 2019 ** |",
            "| --- | --- | --- |",
            "| **Net income (loss) ** | $ 369  | $ (249)  |",
            "| **Depreciation and amortization ** | 59  | - |",
            "| **Accounts receivable ** | 79  | 357  |",
            "| **Inventories ** | (420)  | 547  |",
            "| **Prepaid expenses and other current assets ** | (61)  | - |",
            "| **Net cash provided by operating activities ** | 293  | 538  |",
            "| **Proceeds from sale of securities ** | 169  | 35  |",
            "| **Purchases of securities ** | (222)  | (19)  |",
            "| **Purchases of property and equipment ** | (23)  | (3)  |",
            "| **Net cash (used in) provided by investing activities ** | (76)  | 13  |",
            "| **Cash and cash equivalents - beginning of the year ** | 1,332  | - |",
            "| **Cash and cash equivalents - end of period ** | $ 1,549  | $ 945  |"
        ]
    },
    "sodi_10q_fileoutpart4": {
        "predict": "|   | **For the three months ended ** | **For the three months ended .1** |\n|   | **May 31, 2020 ** | **May 31, 2019 ** |\n| --- | --- | --- |\n| **Net sales ** | $2,498,000  | $2,557,000  |\n| **Cost of sales ** | $1,642,000  | $2,366,000  |\n| **Gross pro\ufb01t ** | $856,000  | $191,000  |\n| **Selling, general and administrative expenses ** | $486,000  | $444,000 |\n| **Operating income (loss) ** | $370,000  | ($253,000)  |\n| **Dividend income ** | $6,000  | $1,000  |\n| **Realized gain (loss) on investments ** | $15,000  | ($16,000)  |\n| **Unrealized gain (loss) on investments ** | ($22,000)  | $19,000  |\n| **Net income (loss) ** | $369,000  | ($249,000)  |",
        "target": [
            "|   | **For the three months ended ** | **For the three months ended .1** |",
            "|   | **May 31, 2020 ** | **May 31, 2019 ** |",
            "| --- | --- | --- |",
            "| **Net sales ** | $ 2,498  | $ 2,557  |",
            "| **Cost of sales ** | 1,642  | 2,366  |",
            "| **Gross pro\ufb01t ** | 856  | 191  |",
            "| **Selling, general and administrative expenses ** | 486  | 444  |",
            "| **Operating income (loss) ** | 370  | (253)  |",
            "| **Dividend income ** | 6  | 1  |",
            "| **Realized gain (loss) on investments ** | 15  | (16)  |",
            "| **Unrealized gain (loss) on investments ** | (22)  | 19  |",
            "| **Net income (loss) ** | $ 369  | $ (249)  |"
        ]
    },
    "EAPHEDGARfilingSept30_21_fileoutpart9": {
        "predict": "|   | **September 30, 2021 ** | **December 31, 2020 ** |\n| --- | --- | --- |\n| **Cash Flows from Operating Activities Net Income (Loss) ** | ($84,350) | ($46,315) |\n| **Net Cash Flows from Operating Activities ** | ($59,350) |   |\n| **Cash Flows from Investing Activities Deposit on real estate ** | $180,150 |   |\n| **Net Cash Flows from Investing Activities ** |   |   |\n| **Service Revenue** |   |   |",
        "target": [
            "|   | **September 30, 2021 ** | **December 31, 2020 ** |",
            "| --- | --- | --- |",
            "| **Cash Flows from Operating Activities Net Income (Loss) ** | $(84,350)  | $(46,315)  |",
            "| **Net Cash Flows from Operating Activities ** | (59,350)  | (43,415)  |",
            "| **Cash Flows from Investing Activities Deposit on real estate ** | (18,797)  | (18,797)  |",
            "| **Net Cash Flows from Investing Activities ** | (18,797)  | (18,797)  |"
        ]
    },
    "fvt-20210930_fileoutpart6": {
        "predict": "|   | **For the nine months ended September 30, 2021 ** | **For the period from August 28, 2020 (inception) through September 30, 2020 ** |\n| --- | --- | --- |\n| **Net loss ** | $238,057 | N/A |\n| **Interest income from investments held in Trust Account ** | $2,960 | N/A |\n| **Decrease in fair value of warrant liabilities ** | ($3,664,000) | N/A |\n| **Fair value in excess of cash received for Private Placement Warrants ** | N/A | $7,600,000 |\n| **Offering costs related to warrant liabilities ** | $495,479 | N/A |\n| **Accounts payable and accrued expenses ** | Recorded values approximate fair values | N/A |\n| **Franchise tax payable ** | Recorded values approximate fair values | N/A |\n| **Cash deposited in Trust Account ** | $230,021,750 | N/A |\n| **Proceeds from issuance of Class F common stock to Sponsor ** | $25,000 | N/A |\n| **Repayment of Sponsor loan ** | N/A | $61,000 |\n| **Proceeds received from issuance of Private Placement Warrants ** | N/A | $7,600,000 |\n| **Cash - end of the period ** | $323,244 | N/A |\n| **Deferred underwriting commissions payable in connection with the Initial Public Offering ** | $8,050,000 | $8,050,000 |",
        "target": [
            "|   | **For the nine months ended September 30, 2021 ** | **For the period from August 28, 2020 (inception) through September 30, 2020 ** |",
            "| --- | --- | --- |",
            "| **Net loss ** | $ (238,057)  | $ (17,217)  |",
            "| **Interest income from investments held in Trust Account ** | (21,750)  | - |",
            "| **Decrease in fair value of warrant liabilities ** | (7,574,721)  | - |",
            "| **Fair value in excess of cash received for Private Placement Warrants ** | 2,396,195  | - |",
            "| **Offering costs related to warrant liabilities ** | 495,479  | - |",
            "| **Accounts payable and accrued expenses ** | - | 17,217  |",
            "| **Franchise tax payable ** | 149,589  | - |",
            "| **Cash deposited in Trust Account ** | (230,000,000)  | - |",
            "| **Proceeds from issuance of Class F common stock to Sponsor ** | - | 25,000  |",
            "| **Repayment of Sponsor loan ** | (61,000)  | - |",
            "| **Proceeds received from issuance of Private Placement Warrants ** | 7,600,000  | - |",
            "| **Cash - end of the period ** | $ 323,244  | - |",
            "| **Deferred underwriting commissions payable in connection with the Initial Public Offering ** | $ 8,050,000  | - |"
        ]
    },
    "fvt-20210930_fileoutpart3": {
        "predict": "|   | **For the three months ended September 30, 2021 ** | **For the nine months ended September 30, 2021 ** | **For the period from August 28, 2020 (inception) through September 30, 2020 ** |\n| --- | --- | --- | --- |\n| **General and administrative expenses ** | $1,000,000 | $3,000,000 | $2,000,000 |\n| **Franchise tax expense ** | $500,000 | $1,500,000 | $1,000,000 |\n| **Loss from operations ** | $(1,500,000) | $(4,500,000) | $(3,000,000) |\n| **Interest income ** | $250,000 | $750,000 | $500,000 |\n| **Decrease in fair value of warrant liabilities ** | $(1,000,000) | $(3,000,000) | $(2,000,000) |\n| **Fair value in excess of cash received for Private Placement Warrants ** | $(500,000) | $(1,500,000) | $(1,000,000) |\n| **Offering costs related to warrant liabilities ** | $(200,000) | $(600,000) | $(400,000) |\n| **Net income (loss) ** | $(3,500,000) | $(10,500,000) | $(7,000,000) |\n| **Weighted average shares outstanding, Class A common stock ** | 23,000,000 | 23,000,000 | 23,000,000 |\n| **Weighted average shares outstanding, Class F common stock ** | 5,750,000 | 5,750,000 | 5,750,000 | \n| **Interest expenses** | - | - | - |\n| **Fair value of Public Warrants** | $4,784,000 | $4,784,000 | - |\n| **Initial Public Offering** | - | - | $25,000 |\n| **Proceeds from Private Placement Warrants** | $7,600,000 | $7,600,000 | - |\n| **Trust Account** | $230,021,750 | $230,021,750 | - |\n| **Material weakness identified in internal controls over financial reporting** | - | - | Yes |\n| **Shares of preferred stock issued and outstanding** | - | - | - |\n| **Number of shares of Class A common stock issuable upon conversion of all shares of Class F common stock** | - | - | - | \n| **Cash held outside of the Trust Account as of September 30, 2021** | - | - | $323,244 |\n| **Promissory note** | - | - | Non-interest bearing, unsecured and due on the earlier of July 31, 2021 and the closing of the Initial Public Offering |\n| **Restrictions on share redemption** | - | - | A Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a \u201cgroup\u201d (as defined under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A common stock sold in the Initial Public Offering, without the prior consent of the Company |\n| **Exemption from financial accounting standards** | - | - | Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards (4) |\n| **Adjusted exercise price of warrants** | - | - | If the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of common stock, the exercise price of the warrants will be adjusted to be equal to 115% of the newly issued price |\n| **Private Placement Warrants** | - | - | Substantially concurrently with the closing of the Initial Public Offering, the Sponsor purchased an aggregate 5,066,667 Private Placement Warrants in the Private Placement Securities registered pursuant to Section 12(b) of the Act: The Company accounts for its outstanding Public Warrants and Private Placement Warrants in accordance with the guidance contained in FASB ASC Subtopic 815-40 \u201cDerivatives and Hedging - Contracts in Entity\u2019s Own Equity\u201d (\u201cASC 815-40\u201d) and determined that the Warrants do not meet the criteria for equity treatment thereunder |\n| **Liquidation plan** | - | - | If the Company is unable to complete a Business Combination within 24 months (January 2023) from the closing of the Initial Public Offering (the \u201cCombination Period\u201d), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding Public Shares which redemption will completely extinguish Public Stockholders\u2019 rights as stockholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholder and the Company\u2019s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements of applicable law |\n| **Trading of Class A common stock and Public Warrants** | - | - | On February 22, 2021, the Company announced that, commencing February 25, 2021, the holders of the Company\u2019s Units may elect to separately trade the Class A common stock and Public Warrants comprising the Units |\n| **Redemption of Public Shares** | - | - | The Public Stockholders will be entitled to redeem their Public Shares for a pro-rata portion of the amount in the Trust Account (approximately $10.00 per share as of September 30, 2021), plus any pro-rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay for the Company\u2019s tax obligations, calculated as of two business days prior to the consummation of the Business Combination |\n| **Reconciliation of financial statements** | $- | $- | The following presents a reconciliation of the condensed balance sheets, condensed statements of operations, condensed statements of changes in stockholders\u2019 equity and condensed statements of cash flows from the prior periods previously reported to the restated amounts as of June 30, 2021 and March 31, 2021, for the three and six months ended June 30, 2021 and for the three months ended March 31, 2021 |\n| **Off-balance sheet arrangements** | - | - | As of September 30, 2021, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K |\n| **Internal controls over financial reporting** | - | - | In connection with the restatement, the Company\u2019s management reassessed the effectiveness of its disclosure controls and procedures as of September 30, 2021 |\n| **Transfers to/from Levels 1, 2 and 3** | - | - | Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period |\n| **Money market fund** | - | - | government securities, within the meaning set forth in Section 2(a) (16) of the Investment Company Act of 1940, as amended, (\u201cInvestment Company Act\u201d), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by us meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account as described below | \n----",
        "target": [
            "|   | **For the three months ended September 30, 2021 ** | **For the nine months ended September 30, 2021 ** | **For the period from August 28, 2020 (inception) through September 30, 2020 ** |",
            "| --- | --- | --- | --- |",
            "| **General and administrative expenses ** | $ 307,395  | $ 4,793,265  | $ 17,217  |",
            "| **Franchise tax expense ** | 50,411  | 149,589  | - |",
            "| **Loss from operations ** | - | - | (17,217)  |",
            "| **Interest income ** | 2,960  | 21,750  | - |",
            "| **Decrease in fair value of warrant liabilities ** | 3,664,000  | 7,574,721  | - |",
            "| **Fair value in excess of cash received for Private Placement Warrants ** | - | (2,396,195)  | - |",
            "| **Offering costs related to warrant liabilities ** | - | (495,479)  | - |",
            "| **Net income (loss) ** | $ 3,309,154  | $ (238,057)  | $ (17,217)  |",
            "| **Weighted average shares outstanding, Class A common stock ** | 23,000,000  | 23,000,000  |   |",
            "| **Weighted average shares outstanding, Class F common stock ** | 5,750,000  | - | - |"
        ]
    },
    "pse_10q_fileoutpart3": {
        "predict": "|   | **As of November 30, ** | **As of August 31, ** |\n|   | **2020 ** | **2020 ** |\n| --- | --- | --- |\n| **Cash and cash equivalents ** | $22,509 |   |\n| **Inventory ** | $2,177 |   |\n| **Total Current Assets ** | $24,686 | $24,959 |\n| **TOTAL ASSETS ** |   |   |\n| **Accounts payable and accrued liabilities ** | $24,444 |   |\n| **Common stock payable ** | $1,500 |   |\n| **Total Current Liabilities ** | $26,041 | $25,944 |\n| **Common stock: 220,000,000 shares authorized; $0.001 par value; 14,375,000 and 14,100,000 shares issued and outstanding respectively. ** |   |   |\n| **Total Stockholders' De\ufb01cit ** |   |   |\n| **TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT ** |   |   |",
        "target": [
            "|   | **As of November 30, ** | **As of August 31, ** |",
            "|   | **2020 ** | **2020 ** |",
            "| --- | --- | --- |",
            "| **Cash and cash equivalents ** | $ 22,509  | $ 22,690  |",
            "| **Inventory ** | 2,177  | 2,269  |",
            "| **Total Current Assets ** | 24,686  | 24,959  |",
            "| **TOTAL ASSETS ** | $ 24,686  | $ 24,959  |",
            "| **Accounts payable and accrued liabilities ** | $ 26,041  | $ 24,444  |",
            "| **Common stock payable ** | - | 1,500  |",
            "| **Total Current Liabilities ** | 26,041  | 25,944  |",
            "| **Common stock: 220,000,000 shares authorized; $0.001 par value; 14,375,000 and 14,100,000 shares issued and outstanding respectively. ** | 14,375  | 14,100  |",
            "| **Total Stockholders' De\ufb01cit ** | (1,355)  | (985)  |",
            "| **TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT ** | $ 24,686  | $ 24,959  |"
        ]
    },
    "pse_10q_fileoutpart4": {
        "predict": "|   | **Three Months Ended November 30, ** |   |<NEWLINE>|   | **2020 ** | **2019 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **General and administrative ** | $113 | $555 |<NEWLINE>| **Professional fees ** | $7,625 | $18,835 |<NEWLINE>| **Net loss before income taxes ** |   |   |<NEWLINE>| **Net loss ** |   |   |<NEWLINE>",
        "target": [
            "|   | **Three Months Ended November 30, ** |   |",
            "|   | **2020 ** | **2019 ** |",
            "| --- | --- | --- |",
            "| **General and administrative ** | 113  | 555  |",
            "| **Professional fees ** | 7,625  | 18,835  |",
            "| **Net loss before income taxes ** | (5,870)  | (19,300)  |",
            "| **Net loss ** | $ (5,870)  | $ (19,300)  |"
        ]
    },
    "pse_10q_fileoutpart9": {
        "predict": "|   | **November 30, 2020 ** | **August 31, 2020 ** |\n| --- | --- | --- |\n| **Cash ** | $22,509 |   |\n| **Total Assets ** | $24,686 | $24,959 |\n| **Total Liabilities ** | $26,041 | $25,944 |\n| **Working Capital (De\ufb01ciency) ** | ($1,355) | ($985) |<NEWLINE>",
        "target": [
            "|   | **November 30, 2020 ** | **August 31, 2020 ** |",
            "| --- | --- | --- |",
            "| **Cash ** | $ 22,509  | $ 22,690  |",
            "| **Total Assets ** | 24,686  | 24,959  |",
            "| **Total Liabilities ** | 26,041  | 25,944  |",
            "| **Working Capital (De\ufb01ciency) ** | $ (1,355)  | $ (985)  |"
        ]
    },
    "pse_10q_fileoutpart10": {
        "predict": "| **The following table presents our working capital (de\ufb01ciency) position as at November 31, 2020: ** | **30, 2020 November 30, 2020 ** | **and August August 31, 2020 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Current Assets ** | $24,686 | $24,959 |<NEWLINE>| **Current Liabilities ** | $26,041 | $25,944 |<NEWLINE>| **Working Capital (De\ufb01ciency) ** | ($1,355) | ($985) |<NEWLINE>|",
        "target": [
            "| **The following table presents our working capital (de\ufb01ciency) position as at November 31, 2020: ** | **30, 2020 November 30, 2020 ** | **and August August 31, 2020 ** |",
            "| --- | --- | --- |",
            "| **Current Assets ** | $ 24,686  | $ 24,959  |",
            "| **Current Liabilities ** | 26,041  | 25,944  |",
            "| **Working Capital (De\ufb01ciency) ** | $ (1,355)  | $ (985)  |"
        ]
    },
    "jbt-20220630_fileoutpart40": {
        "predict": "|   | **Six Months Ended June 30, ** |   | **Favorable/(Unfavorable) ** |\n| **(In millions, except %) ** | **2022 ** | **2021 ** | **Change ** |\n| --- | --- | --- | --- |\n| **Total revenue ** | $66.8 | $118.2 | -$51.4 |\n| **Gross profit % ** | 27.9% | 31.5% | -360 bps |\n| **Selling, general and administrative expense ** | $1.6 | - | - |\n| **Operating income % ** | 6.7% | 10.5% | -380 bps |",
        "target": [
            "|   | **Six Months Ended June 30, ** |   | **Favorable/(Unfavorable) ** |",
            "| **(In millions, except %) ** | **2022 ** | **2021 ** | **Change ** |",
            "| --- | --- | --- | --- |",
            "| **Total revenue ** | - | - | $ 118.2  |",
            "| **Gross profit % ** | 28.7 %  | 31.7 %  | -300 bps  |",
            "| **Selling, general and administrative expense ** | - | - | (20.7)  |",
            "| **Operating income % ** | 7.2 %  | 9.5 %  | -230 bps  |"
        ]
    },
    "jbt-20220630_fileoutpart38": {
        "predict": "|   | **Three Months Ended June 30, ** |   | **Favorable/(Unfavorable) ** |\n| --- | --- | --- | --- |\n| **(In millions, except %) ** | **2022 ** | **2021 ** | **Change ** |\n| --- | --- | --- | --- |\n| **Total revenue ** | $66.8 | $- | $- |\n| **Gross profit % ** | - | - | - |\n| **Selling, general and administrative expense ** | $1.6 | $1.4 | $0.2 |\n| **Operating income % ** | 12.0% | 13.8% | (180) bps | \nNote: The table has not been updated as the financial report segment does not provide any additional information about gross profit %.",
        "target": [
            "|   | **Three Months Ended June 30, ** |   | **Favorable/(Unfavorable) ** |",
            "| **(In millions, except %) ** | **2022 ** | **2021 ** | **Change ** |",
            "| --- | --- | --- | --- |",
            "| **Total revenue ** | - | - | $ 66.8  |",
            "| **Gross profit % ** | 27.9 %  | 31.5 %  | -360 bps  |",
            "| **Selling, general and administrative expense ** | - | - | (6.7)  |",
            "| **Operating income % ** | 7.8 %  | 9.9 %  | -210 bps  |"
        ]
    },
    "jbt-20220630_fileoutpart43": {
        "predict": "| **(In millions) ** | **Six Months Ended June 30, ** |   |<NEWLINE>|   | **2022 ** | **2021 ** |<NEWLINE>| --- | --- | --- |<NEWLINE>| **Cash provided by operating activities ** | $44.8 | $130.3 |<NEWLINE>| **Cash required by investing activities ** | ($31.9) | ($23.3) |<NEWLINE>| **Cash (required by) provided by financing activities ** | ($9.3) | $59.8 |<NEWLINE>",
        "target": [
            "| **(In millions) ** | **Six Months Ended June 30, ** |   |",
            "|   | **2022 ** | **2021 ** |",
            "| --- | --- | --- |",
            "| **Cash provided by operating activities ** | $ 44.8  | - |",
            "| **Cash required by investing activities ** | (44.2)  | - |",
            "| **Cash (required by) provided by financing activities ** | (9.3)  | 59.8  |"
        ]
    }
}